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Abstract
Cells undergo autophagy or self-eating as a means of recycling their 
constituents in order to maintain homeostasis. Autophagy is up regulated by 
stress, including amino acid deprivation for which it is best characterised.
Upon amino acid starvation double or multiple lamellar vesicles termed 
autophagic vacuoles (AV) or autophagosomes appear throughout the cell’s 
cytoplasm. From their content they can be seen to have sequestered cytoplasm, 
often including organelles. Screens for autophagy defective mutants in 
Saccharomyces cerevisiae resulted in the AuTophaGy (ATG) genes. I have 
studied the ubiquitously expressed mammalian orthologue of Atg9p (Atg9Ll), 
a multi-spanning transmembrane protein shown to be essential in yeast for 
autophagy. I studied Atg9Ll in the hope that, as it is a multi-spanning 
transmembrane protein, it might provide clues as to the origin of the 
autophagosomal membranes. Initially addressing the protein’s topology I show 
that both the N-and C-termini of Atg9Ll are cytosolic, and predict that Atg9Ll 
spans the membrane six times. siRNA mediated depletion of Atg9L 1 using 
adenovirus in hepatocytes did not significantly reduce the number of early or 
initial autophagosomes (AVi) arising upon starvation but did result in smaller 
A Vi and a greater number of degradative autophagosomes (AVd). By 
immunofluorescence and subcellular fractionation analysis I found that Atg9Ll 
is located in the TGN and late endosomes. In immunofluorescence Atg9Ll 
colocalises with TGN46, the cation-independent mannose-6-phosphate receptor 
(CI-MPR), Rab7 and Rab9. Amino acid starvation alters the distribution of 
Atg9Ll causing a relocalisation of the protein from the TGN to a peripheral,
3
endosomal, population occasionally colocalising with GFP-LC3, a well 
characterised marker of autophagosomes. siRNA mediated depletion of the 
mammalian homologue of Atglp, ULK1, inhibits the starvation dependent 
relocalisation of Atg9Ll. The starvation induced relocalisation of Atg9Ll 
requires PtdIns-3-kinase activity, and is reversed after restoration of amino 
acids. I speculate that starvation induced autophagy may rely on an alteration 
of the steady state trafficking of Atg9Ll, in a ULK1 dependent manner.
4
Dedication
To my mother and my fiancee
5
A cknowledgments
I would like to thank my supervisor Sharon Tooze for continuous support, for 
encouragement and discussions, and for giving me the possibility to work in her 
lab.
I would like to thank Per Seglen for letting me come to his lab in Oslo and 
allowing his staff to take time out to help me. From Per’s lab I am grateful to 
Franck Satre for his infinite patience in teaching me the rat perfusion. I am also 
grateful to Monica Fengsrud and Marianne Lunde-Sneve for showing me the 
autophagosome preparation, my preparations would not have been nearly as 
good without their help.
I would like to thank the members of the Secretory Pathways Lab, past and 
present, for their discussions and advice. I am especially grateful to my fellow 
PhD student Robert Kochi for essentially teaching me molecular biology and to 
Grant Otto for critical reading of this thesis. Finally I would like to thank my 
collaborators, Samuel Crawshaw and Stephen High, without whose help the 
topology experiment would not have been so convincing.
6
Table o f  contents
Abstract................................................................................................................. 3
Dedication............................................................................................................. 5
Acknowledgments................................................................................................6
Table of contents..................................................................................................7
List of figures......................................................................................................13
List of tables........................................................................................................16
Abbreviations / Acronyms.................................................................................17
Publications.........................................................................................................20
1 INTRODUCTION...................................................................................... 21
1.1 Intracellular protein degradation............................................................. 21
1.1.1 Why degrade proteins?...................................................................... 21
1.1.2 Where are proteins degraded?.......................................................... 22
1.1.2.1 Proteasome................................................................................. 22
1.1.2.2 Lysosomes................................................................................. 23
1.2 Autophagy................................................................................................. 25
1.2.1 The different types of autophagy..................................................... 25
1.2.1.1 Macroautophagy....................................................................... 25
1.2.1.2 Microautophagy........................................................................ 26
1.2.1.3 Chaperone mediated autophagy................................................26
1.2.1.4 Cytoplasm to Vacuole Targeting pathway............................... 28
1.2.1.5 Pexophagy................................................................................. 28
1.2.1.6 Mitophagy.................................................................................. 29
1.2.2 Origins of the autophagosomal membrane.......................................30
1.2.3 Identification of the Atg proteins...................................................... 31
1.2.4 Atg protein complex formation and ubiquitination-like conjugation
reactions..........................................................................................................33
1.2.5 Order of the effect of the ATG genes and their colocalisation at the 
PAS ............................................................................................................ 38
1.2.6 Signalling pathways controlling autophagic induction................... 40
1.2.6.1 Upstream of mTOR...................................................................41
1.2.6.2 Downstream of TOR.................................................................43
7
1.2.7 A tg9L l.............................................................................................. 46
1.2.8 Atg gene transgenic mice.................................................................48
1.2.9 Autophagy in cancer........................................................................ 50
1.3 Membrane trafficking...................................................................................51
1.3.1 The secretory pathway..................................................................... 51
1.3.1.1 The Endoplasmic Reticulum.......................................................51
1.3.1.2 N-linked glycosylation............................................................... 53
1.3.1.3 The Golgi apparatus....................................................................55
1.3.2 Vesicular transport............................................................................ 57
1.3.2.1 Coatomer..................................................................................... 57
1.3.2.2 ARFs.............................................................................................58
1.3.2.3 Brefeldin A effect........................................................................ 59
1.3.2.4 Vesicle targeting.........................................................................60
1.3.2.5 Endocytosis..................................................................................61
1.3.2.5.1 Pinocytosis...........................................................................61
1.3.2.5.2 Clathrin mediated endocytosis........................................... 62
1.3.2.6 Transport from the TGN to endosomes....................................65
1.3.2.7 Transport from Endosomes to TGN......................................... 67
1.3.2.7.1 Rab9 / TIP47.......................................................................67
1.3.2.7.2 Retromer.............................................................................. 67
1.3.2.7.3 VFT complex.......................................................................68
1.3.2.8 Rabs.............................................................................................68
1.3.2.8.1 Rab GTPases........................................................................68
1.3.2.8.2 Rabs on early endosomes  ....................................... 71
1.3.2.8.3 Rabs on late endosomes..................................................... 71
1.3.2.8.4 Rab mutants.......................................................................... 72
1.4 Objectives................................................................................................... 73
2 MATERIALS AND METHODS............................................................... 75
2.1 Reagents......................................................................................................75
2.1.1 General...............................................................................................75
2.1.2 Antibodies......................................................................................... 75
2.1.3 Atg9Ll antibodies............................................................................. 76
2.1.4 Animals..............................................................................................76
8
2.2 Methods.....................................................................................................77
2.2.1 DNA techniques................................................................................. 77
2.2.1.1 Restriction enzyme digests........................................................ 77
2.2.1.2 Polymerase Chain Reaction (PCR)........................................... 77
2.2.1.3 DNA agarose gel electrophoresis.............................................. 78
2.2.1.4 Ligation........................................................................................79
2.2.1.5 Bacterial transformation.............................................................80
2.2.1.6 Bacterial cryo-storage................................................................80
2.2.1.7 Preparation of plasmid DNA..................................................... 80
2.2.1.8 DNA concentration determination............................................ 80
2.2.1.9 Site-Directed Mutagenesis......................................................... 81
2.2.1.10 DNA sequencing........................................................................ 82
2.2.1.11 Northern Blot analysis................................................................83
2.2.2 Protein techniques..............................................................................84
2.2.2.1 Preparation of cell lysates.......................................................... 84
2.2.22 Protein concentration determination......................................... 84
2.2.2.3 SDS -  polyacrylamide gel electrophoresis (SDS-PAGE) 84
2.2.2.4 Western blotting..........................................................................86
2.2.3 Cell culture.........................................................................................87
2.2.3.1 Maintenance of cultured cell lines............................................ 87
2.2.3.2 Transient transfections............................................................... 87
2.2.3.3 Storage and recovery of cultured cell lines.............................. 88
2.2.4 Immunofluorescence..........................................................................89
2.2.5 Primary rat hepatocyte preparation and culture............................... 90
2.2.5.1 Isolation of primary rat hepatocytes.......................................... 90
2.2.5.2 Culturing of primary rat hepatocytes........................................94
2.2.6 Preparation of rat liver Golgi stacks.................................................95
2.2.7 Preparation of Endosomes from rat liver......................................... 97
2.2.8 Purification of autophagosomes....................................................... 99
2.2.9 RNAi................................................................................................. 101
2.2.9.1 Lipid based reagent mediated siRNA transfections............... 101
2.2.9.1.1 Reagents............................................................................. 101
2.2.9.1.2 siRNA transfection protocol.............................................102
9
2.2.9.2 Adenovirus mediated RNAi....................................................103
2.2.9.2.2 Infection protocol............................................................. 103
2.2.10 Protein degradation assay................................................................104
2.2.11 High throughput microscopy.......................................................... 105
2.2.12 Conventional electron microscopy and quantification of 
autophagosomes...........................................................................................105
2.2.13 Immuno-electron microscopy......................................................... 106
2.2.14 In vivo glycosylation analysis......................................................... 106
2.2.15 In vitro topology analysis................................................................107
2.2.16 Real Time PCR................................................................................108
RESULTS.........................................................................................................109
3 Localisation of Atg9Ll..............................................................................109
3.1 A im ..........................................................................................................109
3.2 Expression levels of ATG9L1 in different tissues.............................. 110
3.3 Development of Atg9Ll antibodies..................................................... 110
3.4 Atg9Ll localises to the trans-Golgi network....................................... 114
3.5 Endosomal localisation of Atg9Ll........................................................123
3.5.1 Subcellular fractionation.................................................................123
3.5.2 Atg9Ll colocalises with the late endosomally associated Rab proteins 
7 & 9 ...............................................................................................................126
3.6 Discussion...............................................................................................128
4 Topology..................................................................................................... 132
4.1 A im ..........................................................................................................132
4.2 Glycosylation analysis........................................................................... 135
4.3 Protease Protection experiments...........................................................139
4.4 Atg9Ll colocalises with clathrin adaptor proteins.............................. 143
4.5 Discussion...............................................................................................146
5 Atg9Ll redistributes upon starvation in a PI3-kinase and ULK1 (Atgl)
dependent manner...........................................................................................148
5.1 A im ..........................................................................................................148
5.2 Atg9Ll disperses upon starvation, colocalising with GFP-LC3 and
Rab 7 .................................................................................................................. 149
10
5.3 Atg9Ll’s redistribution upon starvation or rapamycin treatment is PI3- 
Kinase dependent............................................................................................. 151
5.4 Atg9Ll trafficking is dependent on ULK1 (A tgl)...........................154
5.5 Atg9Ll is found on purified autophagosomes..................................... 157
5.6 Discussion............................................................................................... 163
5.6.1 A tg9L l’s juxta-nuclearpool disperses upon starvation.............. 163
5.6.2 Possible molecular mechanisms o f Atg9 dispersion upon starvation 
.......................................................................................................... 164
5.6.4 Role o f  ULK1 in A tg9Ll’s cycling................................................. 167
5.6.5 Effect o f  knocking down other Atg proteins on A tg9L l................169
5.6.6 A tg9L 1 localises to autophagosomes............................................. 170
Investigating the pathway by which ULK1 effects Atg9Ll.................172
6.1 A im .......................................................................................................... 172
6.2 Dominant negative Rab mutants cause Atg9Ll to remain in the juxta- 
nuclear area after starvation.............................................................................173
6.3 Constitutively active Rab mutants cause an accumulation of Atg9Ll in 
enlarged endosomes.........................................................................................175
6.4 Overexpression of ULK1 also causes an accumulation of Atg9Ll in 
large puncta, presumably enlarged endosomes.............................................. 176
6.5 siRNA mediated knockdown of the ULK1 binding protein syntenin 
inhibits the redistribution of Atg9Ll upon starvation................................... 179
6.6 siRNA mediated knockdown of the ULK1 binding protein syntenin 
inhibits LC3-I to II conversion....................................................................... 180
6.7 Discussion............................................................................................... 181
6.7.1 Additional evidence that Atg9Ll is cycling from the TGN to 
endosomes.....................................................................................................181
6.7.2 Constitutively active /  dominant negative Rab mutants can mimic 
the effect o f ULK1 overexpression /  knockdown, respectively, suggesting 
ULK1 ’s effect on Atg9 is through Rabs......................................................183
6.7.3 ULK1 ’s effect on Atg9Ll is most likely through the syntenin 
proteins and a GAP ..................................................................................... 185
6.7.4 Suggestions for additional experiments before proceeding further .. 
 186
11
6.7.5 Concluding remarks........................................................................ 186
7 Effect of Atg9Ll knockdown on autophagy.........................................188
7.1 A im .......................................................................................................... 188
7.2 Atg9Ll knockdown inhibits LC3 lipidation......................................... 188
7.3 Atg9Ll knockdown inhibits GFP-LC3 puncta formation....................193
7.4 Effect of Atg9L 1 knockdown on long-lived protein degradation 195
7.5 Atg9Ll knockdown results in smaller immature AVs......................... 197
7.6 Discussion...............................................................................................200
7.6.1 A Vis are smaller upon Atg9Ll knockdown....................................200
7.6.2 Experimental detail.........................................................................202
7.6.3 Atg9L2 knockdown did not affect LC3 lipidation in HEK293 cells... 
 202
8 Concluding remarks................................................................................. 204
REFERENCES................................................................................................ 208
Appendix...........................................................................................................238
12
List o f figures
Figure 1.1. Atgl2 undergoes a ubiquitin-like conjugation to Atg5.....................36
Figure 1.2 Atg8 undergoes a ubiquitin-like conjugation to
phosphatidylethanolamine............................................................................ 37
Figure 1.3. Model fo r  two distinct Ptdlns 3-kinase complexes in yeast............38
Figure 1.4. Tree diagram o f the ULK family members....................................... 46
Figure 1.5. Co-translational targeting in a eukaryotic cell................................53
Figure 1.6. N-linked oligosaccharide processing...............................................55
Figure 1.7. Role o f  ARF in coat protein dynamics..............................................59
Figure 1.8. Endocytic recycling pathways...........................................................64
Figure 1.9. Localisation o f Rab proteins within the cell....................................70
Figure 2.1. Perfusion apparatus..........................................................................93
Figure 2.2. Perfusion relevant liver anatomy..................................................... 94
Figure 3.1. Atg9Ll transcript levels in various different tissues.....................111
Figure 3.2. Testing the various Atg9Ll affinity purified rabbit antibodies.... 113 
Figure 3.3. Characterisation o f the Atg9Ll antibodies in immunofluorescence
....................................................................................................................... 115
Figure 3.4. Assessing the colocalisation o f Atg9LI with various endomembrane
markers..........................................................................................................116
Figure 3.5. BFA and nocodazole treatment ofHEK293 cells to determine
whether the juxta-nuclear pool o f Atg9LI corresponds to medial or trans
Golgi............................................................................................................. 119
Figure 3.6. Distribution ofAtg9Ll between the Golgi preparation fractions......
 121
Figure 3.7. Immuno-electron microscopy analysis shows Atg9Ll on TGN
membranes....................................................................................................122
Figure 3.8. Distribution o f Atg9Ll across the endosomepreparation gradient
fractions........................................................................................................ 125
Figure 3.9. Colocalisation o f Atg9LI with endosomally associated Rabs 7 & 9 
....................................................................................................................... 127
13
Figure 3.10. Immuno-electron microscopy analysis confirms A tg9L l’s
presence on endosomal membranes........................................................... 128
Figure 4.1. Hydrophobicity plots fo r Atg9Ll.....................................................133
Figure 4.2. TopPredll models fo r  A tg9L l’s topology and predictions for the
locations o f  its TMDs................................................................................... 134
Figure 4.3. Glycosylation analysis.....................................................................136
Figure 4.4. Diagramatic representation o f the principle o f  the protease
protection experiments on Atg9Ll containing ER microsomes................140
Figure 4.5. Protease protection experiments.....................................................142
Figure 4.6. Colocalisation o f Atg9Ll with Clathrin andclathrin adaptors... 144
Figure 4.7. Atg9Ll mutants................................................................................146
Figure 5.1. Colocalisation o f Atg9Ll with GFP-LC3 upon starvation........... 150
Figure 5.2. Atg9Ll and CI-MPR re-distribute upon starvation in a reversible,
PI3-kinase dependent manner..................................................................... 153
Figure 5.3. The starvation induced dispersal o f Atg9Ll can be blocked by
knockdown o f ULK1 but not ULK2............................................................ 155
Figure 5.4. EM  analysis o f the final purified autophagosomal fraction .........159
Figure 5.5. Atg9Ll is enriched over the course o f the autophagosome
preparation...................................................................................................160
Figure 5.6. Immuno-EM o f rat hepatocytes showing autophagosomes labelled
with Atg9Ll antibody................................................................................... 162
Figure 6.1. Overexpression o f GFP tagged Rab5N1331 causes Atg9Ll to
remain in the juxta-nuclear area after starvation..................................... 174
Figure 6.2. Overexpression o f GFP tagged, dominant negative, Rab9S21N
causes Atg9Ll to remain in the juxta-nuclear area after starvation 175
Figure 6.3. Overexpression o f GFP tagged, constitutively active, Rab5Q79L or
Rab7Q67L caused Atg9 to accumulate in enlarged endosomes.............. 176
Figure 6.4. Overexpression o f the wt and kinase dead but not the C-terminal 
deletion mutant ofU LKl causes a redistribution o f Atg9LI into punctate
structures.......................................................................................................178
Figure 6.5. siRNA mediated knockdown o f syntenin inhibits the starvation
induced redistribution o f Atg9L 1 ............................................................... 180
14
Figure 6.6. Syntenin knockdown increased the amount o f lipidated LC3 present
after starvation............................................................................................. 181
Figure 7.1. siRNA mediated knockdown o f Atg9Ll in primary rat hepatocytes 
inhibits the processing o f LC3-I to the smaller autophagosomally
associated LC3-II fo rm ................................................................................190
Figure 7.2. siRNA mediated knockdown o f Atg9Ll in HEK293 cells inhibits
GFP-LC3-I to II conversion........................................................................192
Figure 7.3. siRNA mediated knockdown o f Atg9Ll in primary rat hepatocytes 
decreases the number o f GFP-LC3 puncta observed upon starvation.... 194 
Figure 7.4. siRNA mediated knockdown o f Atg9Ll in primary rat hepatocytes
did not inhibit long-lived protein degradation...........................................197
Figure 7.5. Atg9Ll knockdown results in smaller immature autophagosomes 
(AVis)............................................................................................................ 199
15
List o f tables
T able 1.1. The Atg proteins and their functions.................................................32
Table 1.2. Classification of Atg mutants.............................................................39
Table 2.1. PCR cycling parameters....................................................................78
Table 2.2. Cycling parameters for site-directed mutagenesis............................81
Table 2.3. Sequencing PCR parameters..............................................................82
Table 2.4. SDS-PAGE running gel recipes......................................................... 85
Table 2.5. SDS-PA GE stacking gel recipes........................................................ 86
Table 2.6. Endosomepreparation solutions.......................................................95
Table 4.1. Potential clathrin adaptor binding motifs within A tg9Ll..............132
Table 5.1. Quantification o f GFP-LC3, Rab7 andAtg9Ll colocalisation 151
Table 5.2. Percent colocalisation o f Atg9Ll with TGN46 upon starvation after
knockdown o f various Atg proteins............................................................ 157
16
Abbreviations/Acronyms
AA Amino Acid
ATG Autophagy gene / protein
AV Autophagic Vacuole (or Autophagosome)
A Vi Immature Autophagic Vacuole
AVd Degradative Autophagic Vacuole
BFA Brefeldin A
CI-MPR Cation-Independent Mannose-6-Phosphate Receptor
CMA Chaperone Mediated Autophagy
C-terminus Carboxy-terminus
EEA1 Early Endosome Associated protein 1
EM Electron Microscopy
Endo H Endoglycosidase H
ER Endoplasmic Reticulum
ERGIC ER Golgi Intermediate Compartment
ES Earle’s Saline (starvation medium)
FCS Foetal Calf Serum
FM Full Medium
GAP GTPase Activating Protein
GFP Green Fluorescent Protein
GST Glutathione-S-Transferase
h Hours
Hepes 4-(2-hydroxyl)-l-piperazine ethane sulphonic acid
HRP Horseradish Peroxidase
IF Immunofluorescence
17
KLH Keyhole Limpet Haemocyanin
LAMP Lysosomal associated membrane protein
Mannll Mannosidase II
mRFP monomeric Red Fluorescent Protein
MW Molecular Weight
NCBI National Centre for Biotechnology Information
N-terminus Amino-terminus
PAGE Polyacrylamide Gel Electrophoresis
PAS Preautophagosomal Structure
PBS Phosphate Buffered Saline
PE Phosphatidylethanolamine
PFA Paraformaldehyde
PI3-kinase Phosphatidylinositol-3-kinase
POP Phosphatidylinositol-3-phosphate
PNGase F Peptide N-Glycosidase F
PNS Post Nuclear Supernatant
RE Restriction Enzyme
RNAi RNA interference
RPM Revolutions Per Minute
SDS Sodium Dodecyl Sulphate
SDM Site Directed Mutagenesis
SEM Standard Error of the Mean
SSC Saline Sodium Citrate
siRNA Small Inhibitory RNA
TGN Trans Golgi Network
18
TMD Transmembrane Domain
TOR Target of Rapamycin
Tris 2-amino-2-(hydroxymethyl)-1,3 -p r o p a n e d io l
TX-100 Triton X-100
U Unit
ULK1 Unc51.1 Like Kinase
UTR Untranslated Region
wt Wild Type
19
Publications
Young ARJ, Chan EYW, Hu XW, Kochi R, Hailey DW, Lippincott-Schwartz J, 
Crawshaw S, High S, Tooze SA (2006). Starvation and UKL1 -dependent 
cycling of mammalian Atg9 between the TGN and endosomes. Journal o f Cell 
Science 119(18) 3888-3900.
Webber J, Young ARJ, Tooze SA (2007). Atg9 trafficking in mammalian cells. 
Autophagy. 3(1) 54-6.
20
Chapter 1, INTRODUCTION
1 INTRODUCTION
1.1 Intracellular protein degradation
1.1.1 Why degrade proteins?
The balance between the rate of synthesis and degradation of any 
macromolecule governs its relative cellular abundance and the time span of its 
activity. By this balance of synthesis and degradation cells carefully control the 
levels of their proteins, for example signalling receptors. Increasing the rate of 
degradation is the fastest means of modulating the cellular levels of proteins 
(Lorentzen and Conti, 2006). A basal level of protein degradation is also 
required for homeostasis. For example, protein maturation is an imperfect 
process that produces faulty polypeptides, which could be harmful to the cell 
and must be properly disposed of (Meusser et al., 2005).
Protein degradation activity is also inducible. Cells which are subject to stress 
such as starvation, heat shock, chemical insult, mutation or oxidative stress 
respond by increasing their rates of proteolysis (Wilkinson, 1995). Oxidative 
stress (e.g. that caused by an acute bout of skeletal muscle contraction (Ji et al., 
2006)) has been shown to damage a variety of proteins and cause them to be 
rapidly degraded (Kiffin et al., 2006).
One of the first observations of increased protein degradation due to amino acid 
deficiency was reported in the early 1980s (Seglen et al., 1980). One function 
of this enhanced proteolysis is thought to be to salvage amino acids from non- 
essential proteins so that they can then used to synthesise proteins which are
21
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more essential under the circumstances, or for their subsequent metabolism to 
provide energy.
1.1.2 Where are proteins degraded?
Lysosomes accounted for the degradation of 80% of short-lived proteins and 
90% of long-lived proteins in primary rat hepatocyte homogenate (Ahlberg et 
al., 1985). The cytosol contributed 20% of the total protein breakdown of 
short-lived proteins, whereas insignificant proteolysis of long-lived proteins 
occurred in the cytosol. The mechanism for cytosolic protein degradation can 
now mostly be put down to the proteasome. The lysosome is mostly concerned 
with degrading endocytosed material, however, and so rates of lysosomal 
intracellular protein degradation are therefore skewed.
1.1.2.1 Proteasome
The proteasome is large macromolecular structure found in the cytoplasm 
concerned with degrading, as mentioned above, short-lived proteins. It was 
isolated under a variety of different names from a wide variety of eukaryotic 
cells and tissues, reviewed by Rivett (Rivett, 1989). Proteasome like proteins 
are present in all biological kingdoms and in most organisms. The eukaryotic 
proteasome is composed of four seven membered rings stacked on top of each 
other (Groll et al., 1997). This forms a hollow barrel with openings on both 
sides. The subunits are arranged such that the active sites line the central 
chamber. The central pore of the outer rings are constricting, allowing only 
polypeptides in an extended, unfolded, conformation to be threaded through to
22
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the catalytic centres. The proteasome complex associates with additional 
proteins that facilitate the targeting and unfolding of their substrates (unfoldases 
and helicases, respectively) (Lorentzen and Conti, 2006).
Cellular proteins are targeted for degradation by the proteasome by 
polyubiquitin chains. A 76 amino acid protein called ubiquitin is attached via a 
lysine residue in the target protein. Another ubiquitin molecule is then attached 
to lysine residue 48 in the first ubiquitin molecule and so on to form 
polyubiquitin chains. An activating enzyme, E l, transfers ubiquitin to a carrier 
E2 enzyme, which in turn tags ubiquitin to the doomed substrate with the help 
of an E3 enzyme. Comparative genome analysis reveals few genes encoding 
E 1 enzymes, tens of E2 encoding genes and hundreds of genes encoding E3 
ligases (Semple, 2003).
1.1.2.2 Lysosomes
Lysosomes are cytoplasmic organelles, delimited by a single membrane, 
containing enzymes that are capable of degrading virtually all cellular 
macromolecules (Holtzmann, 1989). Keeping all the digestive enzymes inside 
one membrane bound compartment serves not only to concentrate the enzymes, 
maximising their efficiency and allowing them to work in a low pH 
environment, but also keeps these enzymes contained separated from the rest of 
the cytoplasm which they would otherwise degrade. The enzymes of the 
lysosome are Cathepsins and other peptidases; galactosidase and glucosidase of
23
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the glycanolytic pathway and; phospholipases of the lipolytic pathway 
(Holtzmann, 1989).
Sorting of soluble lysosomal enzymes in mammals largely relies on the 
mannose 6-phosphate receptor (MPR) (Dell'Angelica and Payne, 2001). As the 
name implies this receptor recognises certain proteins that are glycosylated.
Two MPRs with overlapping functions have been described: cation- 
independent MPR (CI-MPR) and cation-dependent MPR (CD-MPR). MPR, 
bound to its glycosylated protein cargo, is sorted from the secretory pathway by 
selective incorporation into vesicles that bud from the TGN destined for 
endosomes. Within endosomes the hydrolases dissociate from MPR and are 
delivered to the lysosome, while MPR is retrieved to the TGN to pick up more 
cargo. MPR also visits the plasma membrane, where it recruits mis-sorted 
mannose 6-phosphate tagged lysosomal enzymes and directs them into the 
endocytic pathway. Deficiencies in both MPRs, or in the machinery 
responsible for the addition of the mannose 6-phosphate tag, result in massive 
secretion of lysosome enzyme precursors into the extracellular milieu (Brown 
et al., 1995; Davidson, 1995).
The major mechanism by which cytosolic proteins are degraded en masse is via 
the sequestration of portions of the cytoplasm and the delivery of that material 
to the endosomal / lysosomal pathway, a process known as autophagy.
24
Chapter 1, INTRODUCTION
1.2 Autophagy
Autophagy was first described by Clark (Clark, 1957) in EM studies of the 
kidneys of newborn mice. The term autophagy was coined at the first 
international symposium on lysosomes in London in 1963 (de Duve, 2005). 
‘Auto’ from the Greek word autos meaning self and ‘phagy’ from the Greek 
word phagein meaning to eat. It was to refer to the sequestration of 
cytoplasmic content into membrane vesicles, termed autophagic vacuoles or 
autophagosomes, for subsequent degradation.
Autophagy was generally assumed to be a non-specific process because the 
autophagic vacuoles (AVs) contain a mixture of cytosol and organelles in a 
fairly random manner (Holtzmann, 1989). However more recently, particularly 
in yeast where nutrient deprivation induced degradation of cytoplasm within the 
yeast vacuole was first demonstrated much later (Takeshige et al., 1992), it has 
become apparent that autophagy can be a much more specific process.
1.2.1 The different types of autophagy
1.2.1.1 Macroautophagy
When people refer to autophagy, they usually mean macroautophagy and 
indeed when I use the term autophagy throughout this text I will be referring to 
macroautophagy. Macroautophagy is the process of the en masse sequestration 
of cytosol into a membrane bound compartment for its subsequent delivery to 
the endosomal / lysosomal system.
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1.2.1.2 Microautophagy
Microautophagy refers to the uptake of cytoplasm by the invagination of the 
lysosomal membrane. Isolated lysosomes often contained internal vesicles 
(Wattiaux et a l, 1978). That isolated lysosomes can take up material from their 
surroundings, can be demonstrated by incubating isolated lysosomes in a 
solution of colloidal silica particles (Percoll). Percoll particles can then be seen 
by EM in vesicles inside the lysosomes (Marzella et a l, 1980). An EM study 
by Muller and co-workers beautifully captured tubules emanating inwards from 
the vacuolar membrane of S. cerevisiae (Muller et a l, 2000). They are 
dynamic and often branched structures showing a sharp kink of the vacuolar 
membrane at the site of invagination. However, to date, mutants selectively 
defective in microautophagy of soluble cytosolic components have not been 
identified.
1.2.1.3 Chaperone mediated autophagy
A third route for proteins to be delivered to the lysosome is Chaperone
Mediated Autophagy (CMA). In CMA proteins are specifically recognised and 
translocated through the lysosomal membrane, unlike macroautophagy where 
proteins are degraded in bulk. CMA was originally suggested by experiments 
microinjecting radioactively labelled RNase A into IMR90 human lung 
fibroblasts where the radioactive sugar label (on the RNase A) accumulated in 
the lysosome (McElligott and Dice, 1985). Using different peptides of the N- 
terminus of RNase A, a recognition motif was subsequently identified as 
KFERQ (Dice et a l, 1986). Hsp70 was found to be the protein involved in 
recognising this motif (Chiang et a l, 1989). Proteins containing this motif
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were found to be selectively depleted from the liver and heart, but not skeletal 
muscle, of fasted rats (Wing et al., 1991). Subsequently, LAMP-2 A 
(Lysosomally Associated Membrane Protein 2A) was identified as a receptor 
for the selective import of proteins into lysosomes (Cuervo and Dice, 1996). 
However, in LAMP-1 / LAMP-2 double deficient fibroblasts no effect on 
protein degradation could be detected, under conditions where CMA should 
have been active (Eskelinen et al., 2004). However, this could be due to the 
limited nature of CMA substrates not having a great effect on the extent of 
overall cellular protein degradation.
What is the physiological role of CMA? Morphological and metabolic 
measurements indicate that macroautophagy reaches maximal activation around 
6h after nutrient removal and then progressively decays (Massey et al., 2004). 
The time course of activation of CMA overlaps only partially with 
macroautophagy, with CMA reaching maximal activity later on. An increase in 
CMA activity is apparent after 8-1 Oh of starvation but rates of CMA 
progressively increase up to 88h of starvation (Massey et al., 2004). If 
starvation persists, non-selective degradation of cytosolic components would no 
longer be desirable, since it could lead to elimination of essential cellular 
components or components just resynthesised. Under these conditions, some 
selectivity of substrates could be preferable (Massey et al., 2004).
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1.2.1.4 Cytoplasm to Vacuole Targeting pathway
The cytoplasm to vacuole targeting pathway was originally identified by
Klionsky and co-workers, in the yeast S. cerevisiae, on the basis that 
aminopeptidase I (API) was not transported to the vacuole by the normal route 
through the secretory pathway and therefore its delivery represented a novel 
pathway (Klionsky et al., 1992). It was subsequently discovered that the 
method of API transport to the vacuole was vesicular (Scott et al., 1997). A 
screen for mutants unable to mature API identified proteins involved in the 
process (Harding et al., 1995) and it was later shown that the cvt proteins 
overlapped with the proteins involved in autophagy (Harding et al., 1996). The 
receptor protein for API was originally identified in a genome wide protein- 
protein interacting yeast-two-hybrid screen (Uetz et al., 2000). This was later 
followed up on by two independent groups (Leber et al., 2001; Scott et al.,
2001), who characterised the protein and identified it as the receptor for API. 
There is, however, no evidence for a Cvt pathway equivalent in mammalian 
cells (Scott et al., 2001).
1.2.1.5 Pexophagy
The degradation of peroxisomes by autophagy or pexophagy has mainly been 
studied in the yeast Pichia pastoris. Pexophagy becomes evident when P. 
pastoris cells adapted to growth on methanol are placed in a glucose based 
medium. The peroxisomal enzymes and peroxisomes that were accumulated in 
order to allow growth on a methanol based medium become superfluous when 
the cells have a source of glucose and are degraded. The degradation takes 
place en masse by either micro- or macroautophagy (Tuttle et al., 1993). In the
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microautophagic degradation of the peroxisomes the P. pastoris Atg9 protein 
(PpAtg9) has been shown to be localised to the sequestering membranes 
protruding from the vacuole (Chang et al., 2005). Recently it has been 
demonstrated that autophagy is also necessary for the removal of peroxisomes 
from mammalian cells (Iwata et a l, 2006).
1.2.1.6 Mitophagy
Selective mitochondrial autophagy is termed mitophagy. Evidence for 
selectivity in mitochondrial removal in yeast comes from a study where the 
absence of the outer mitochondrial membrane protein Uthlp was shown to be 
required for the rapamycin induced degradation of mitochondria and to 
significantly delay their starvation induced degradation (Kissova et a l, 2004). 
Kissova et al. also showed that UTH1 deletion mutants were resistant to 
nitrogen starvation. The UTH1 gene was identified by screening a promoter- 
probe gene bank for oxidative stress-responsive promoters (Bandara et al., 
1998). Interestingly, the same gene was also isolated by Austriaco (Austriaco,
1996) by complementing the paraquat sensitivity of a mutant showing an 
extended lifespan. At present however there is no known mammalian 
orthologue of Uthlp.
Evidence for the selective degradation of mitochondria in mammalian cells 
comes from the work of Xue et al. (Xue et al., 2001). Xue et al. deprived 
neurons of NGF in the presence of the pan caspase inhibitor Boc.Aspartyl(0- 
methyl)CH2F (BAF) and when they returned them to medium containing NGF
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they observed an absence of mitochondria within the cells, although other 
organelles were not effected.
The selective removal of mitochondria from cells is of the utmost interest 
because of the central role mitochondria play in programmed cell death in the 
form of apoptosis. Removal of mitochondria before they can signal apoptosis 
would allow cell survival, perhaps in circumstances where this is not to the 
benefit of the organism, like in the development of cancer.
1.2.2 Origins of the autophagosomal membrane
The origin of autophagic vesicles in mammalian cells is still unclear. Different
studies have found evidence for different sources: Some studies (Dunn, 1990; 
Ericsson, 1969; Novikoff and Shin, 1978; Ueno etal., 1991) have found 
evidence of resident proteins of the Endoplasmic Reticulum (ER) present on the 
autophagosomal membranes. Others have found similar evidence but for Golgi 
membranes (Locke and Sykes, 1975; Yamamoto et al., 1990). Some have 
found no evidence of marker proteins and have concluded that the membranes 
are formed de novo (Hamberg, 1983; Stromhaug et al., 1998).
As I will demonstrate in this thesis, the only characterised transmembrane 
protein required for autophagy in mammals, Atg9L 1, resides on the TGN and 
endosomes, suggesting that autophagosomes receive at least some membrane 
contribution from these two sources.
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1.2.3 Identification of the Atg proteins
A major leap forward for autophagy research in recent years came from the 
identification of over fifteen genes involved in autophagy in the yeast S. 
cerevisiae by two independent research groups (Thumm et al., 1994; Tsukada 
and Ohsumi, 1993). Both screens were based on identifying mutations that 
inhibited the appearance of autophagic bodies in the yeast vacuole, in the 
presence of the protease inhibitor PMSF. A later screen by Harding and co­
workers (Harding et al., 1995) looking for mutants of the cytoplasm to vacuole 
protein targeting (cvt) pathway was based on the processing, or maturation, of 
aminopeptidase I upon its delivery to the vacuole. Harding et al.9s screen found 
a number of mutants which overlapped with those of the two previous screens.
Genes involved in pexophagy have been isolated from a number of screens. 
Peroxisome degradation via autophagy (PAG) (Sakai et al., 1998), pexophagy 
zeocin-resistant (PAZ) (Mukaiyama et al., 2002), peroxisome degradation- 
deficient (PDD) (Titorenko et al., 1995), and glucose-induced selective 
autophagy (GSA) the first mutants of which were described by Tuttle and Dunn 
in 1995 (Tuttle and Dunn, 1995).
The nomenclature of the proteins identified in the screens described in the 
previous paragraph has recently been unified (Klionsky et al., 2003) and the 
corresponding Apg, Aut, Cvt, GSA, PAG, PAZ and PDD proteins have been 
renamed Atg (Table 1.1), for simplicity only the GSA pexophagy mutants 
names are listed.
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Table 1.1. The Atg proteins and their functions. Modified from (Klionsky
et al., 2003).
New
Name
Previous nomenclature Human
ortholog
Function Reference(s)
ATG APG AUT CVT GSA
1 1 3 10 10 ULK1 Serine / Threonine Protein 
kinase
(Matsuura et al., 
1997)
(Straub et al., 1997)
2 2 8 11 Uncharac
-terised
Peripheral membrane 
protein, interacts with 
Atg9
(Shintani et al., 2001)
3 3 1 20 Atg3L E2-like enzyme, 
conjugates Atg8 to 
phosphatidyl- 
ethanolamine (PE)
(Ichimura et al., 
2000)
4 4 2 Atg4L Cysteine protease, cleaves 
C-terminal extension or 
PE from Atg8
(Kirisako et al., 
2000)
(Lang e ta l., 1998)
5 5 — — Atg5L Conjugated to Atg 12 
through internal lysine
(Kametaka et al., 
1996)
6 6 — — Beclin Component o f the PI3- 
kinase complex
(Kihara et al., 2001b)
7 7 — 2 7 Atg7L El-like enzyme, activates 
Atg8 and Atg 12
(Tanida e ta l., 1999)
8 8 7 5 LC3 Specific autophagosome 
marker, ubiquitin-like 
protein conjugated to PE
(Kirisako et al., 
2000)
9 9 9 7 14 Atg9Ll
& L2
Integral membrane protein (Lang et a l., 2000) 
(N odae/tf/., 2000)
10 10 — — Uncharac
-terised
E2-like enzyme, 
conjugates Atg 12 to Atg5
(Shintani eta l., 1999)
12 12 Uncharac
-terised
Ubiquitin-like protein 
conjugated to PE, 
conjugated to Atg5
(Mizushima et al., 
1998)
13 13 — — Uncharac
-terised
Modifier o f A tgl activity, 
hyperphosphorylated
(Funakoshi et al., 
1997)
14 14 — 12 — Uncharac
-terised
Component o f PI3-kinase 
complex
(Kametaka et al., 
1998)
15 5 17 Uncharac
-terised
Putative lipase required 
for breakdown of 
intra-vacuolar vesicles
(Epple et al., 2001)
16 16 — 11 A tgl6L Component o f Atg 12- 
Atg5 complex
(Mizushima et al., 
1999)
17 17 — Uncharac
-terised
Modifier o f Atgl activity (Kamada et al., 2000)
18 10 18 12 Wipi49 Peripheral membrane 
protein, required for 
localisation o f Atg2
(Barth et al., 2001)
22 4 Uncharac
-terised
Integral membrane protein 
involved in autophagic 
body breakdown
(Suriapranata et al., 
2000)
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Mutations of the ATG genes in various species reveals a variety of phenotypes, 
such as defective sporulation in S. cerevisiae (Tsukada and Ohsumi, 1993), 
defective fruiting body formation in Dictyostelium discoideum (Otto et al.,
2003), abnormal dauer formation in Caenorhabditis elegans (Melendez et al.,
2003) and premature death from the third larval to pupal stages in Drosophila 
melanogaster (Scott et al., 2004). Thus autophagy is not only an important 
process in cellular survival during stress but it is also required for the normal 
development of multi-cellular organisms.
1.2.4 Atg protein complex formation and ubiquitination-like 
conjugation reactions
Some of the Atg proteins have been identified to take part in one (or both) of
two ubiquitination-like conjugation reactions (see Figure 1.1). Like the 
classical ubiquitination conjugation pathway, the Atg ubiquitination like 
pathways also require El and 2 (like) enzymes.
In one pathway, Atg 12 is coupled to Atg5. This reaction requires the El-like 
enzyme Atg7 and the E2-like enzyme Atg 10 (Mizushima et al., 1998). The 
Atg5-12 complex then binds to the coiled-coil protein Atgl6 and dimerises. 
The function of the Atg5-12-16 complex is not fully known, only that it is 
required for autophagosome formation and the recruitment of Atg8 to 
membranes (Suzuki et al., 2001).
33
Chapter 1, INTRODUCTION
In the second ubiquitin like conjugation pathway (Ichimura et al., 2000) Atg8 
becomes membrane associated after conjugation to, what was first described as 
molecule X (Kirisako et al., 2000) and was later shown to be, 
phosphatidylethanolamine (PE) (Ichimura et al., 2000). It has also recently 
been shown that in vitro Atg8 can be conjugated to phosphatidylserine (Sou et 
al., 2006). Like the Atg5-12 conjugation, the lipidation of Atg8 / LC3 also 
requires the El-like enzyme Atg7 but the E2-like enzyme here is Atg3. Before 
lipidation can occur however Atg8 / LC3 is cleaved by the cysteine protease 
Atg4, resulting in a terminal glycine (Kirisako et al., 2000). Lipidation of Atg8 
causes it to localise to the autophagosomal membrane, both forming and 
completed (Kirisako et al., 1999). There are several Atg8 homologues in 
mammals, including GATE-16 (Golgi-associated ATPase enhancer of 16kDa), 
GABARAP (y-aminobutyric acid receptor associated protein) and microtubule 
associated protein light chain 3 (MAP-LC3) or LC3 for short. Of these three, 
so far only LC3 has been demonstrated to be involved in autophagy although all 
three have been shown to undergo the ubiquitin-like lipid conjugation (Tanida 
et al., 2004). The lipidated form of LC3 is designated LC3-II and the cytosolic 
form as LC3-I.
A further autophagy associated complex brings together atg proteins and a PI3- 
kinase central in membrane traffic, Vps34. Atg6/Vps30 functions as a subunit 
of two distinct Vps34p Phosphatidylinositol-3-kinase (PI3-kinase) complexes. 
Apgl4p and Vps38p are interchangeable subunits of the Vps34/Vps 15/Vps30 
complex, specific for autophagy or CPY sorting (see section 1.3.2.6), 
respectively. The mammalian orthologue of Atg6/Vps30 is Beclinl (Liang et
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al., 1999). Beclinl has been shown to associate with hVps34 (Kihara et al., 
2001a). Recently Zeng et al. (2006) showed that in mammalian cells whereas 
Beclinl is essential for engagement of hVps34 in the process of 
macroautophagy, it is dispensable for the normal function of hVps34 in 
endocytic trafficking or lysosomal enzyme sorting (Zeng et a l, 2006).
35
Chapter 1, INTRODUCTION
Atg7-SH+ATP
AMP+PP
AtglO-SH
Atg7-SH
Atg5-NH
Gly
AtglO-S f^ A tg lO -S H
Gly
Atg5-N
Formation of complexes with Atg 16
/  \
Autophagosome formation   Recruitment of Atg8
to membranes
Figure 1.1. A tg l2 undergoes a ubiquitin-like conjugation to Atg5. Figure 
modified from Abeliovich and Klionsky (2001).
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Atg8
Arg — Gly —
Atg4
arginine
Atg8
PE
Gly —
HS — Atg7 
+
AMP+PP;
Atg8Atg8
Atg3
Gly —Gly —
NH
Atg7
Atg8
membrane bilayer
PE
HS—Atg7Gly — 
I
S
I
Atg3
Figure 1.2. Atg8 undergoes a ubiquitin-like conjugation to 
phosphatidylethanolamine. See text for details. Figure modified from 
Abeliovich and Klionsky (2001).
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complex I « complex II
Ptdlns Ptdlns(3)P
Autophagy
Ptdlns Ptdlns(3)P
CPY sorting
Figure 1.3. Model for two distinct PI 3-kinase complexes in yeast. Vpsl5p is 
anchored to membrane by myristic acid attached to the N-terminus of Vpsl5p. 
Apgl4p and Vps38p act as connectors between Vps30p and Vps34p. Figure 
taken from Kihara et al. (2001a).
1.2.5 Order of the effect of the ATG genes and their colocalisation 
at the PAS
In a seminal paper, Suzuki and co-workers (Suzuki et a l , 2001) examined the 
localisation of GFP-Atg8 and Atg5-GFP in different autophagy mutants in an 
attempt to group the autophagy proteins in terms of the stage at which they 
function. The Vps34 PI3-kinase complex including Vps30 / Atg6 as well as 
Atg9 were required for the localisation of Atg5 to the PAS. The Atg5-12
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conjugation system was required for the recruitment of Atg8 to the PAS. The 
Atgl kinase complex and Atg2 functioned after the recruitment of Atg8 to the 
PAS.
Table 1.2. Classification of Atg mutants into late acting mutants (Class A), 
intermediate acting mutants (Class B) and early acting mutants (Class C) 
(Suzuki et al., 2001), depending on whether Atg5-GFP and GFP-Atg8 localise 
to the PAS in each knockout. See text for further details.
Class Classification Genes
Atg5 on PAS Atg8 on PAS
Class A + + Atg 1, Atg2, Atg 13, Atg 17
Class B + - Atg3, Atg4, Atg7, Atg 10, Atg 12
Class C - - Atg6, Atg9, Atg 14, Atg 16
Of note is that the proteins grouped into the classes identified by Suzuki et al. 
(2001) correlate with what is known about how the proteins interact into 
complexes. For instance, the serine / threonine kinase Atgl, discussed later, 
associates with Atg 13 and Atg 17. Also, as described above, Atg7 and 10 are 
involved in the formation of the Atg5-12 complex and Atg3, 4 and 7 are 
involved in the lipidation of Atg8.
Suzuki et al. (2001) also noticed that many of the Atg proteins accumulated at 
the same peri-vacuolar punctate structure upon induction of autophagy with 
rapamycin (see section 1.2.6). They named this structure the 
preautophagosomal structure (PAS). Kim et al. (Kim et al., 2002) also
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observed the same convergence of multiple Atg proteins at a peri-vacuolar 
compartment. They both proposed that the structure may be the origin of the 
autophagosomal membrane.
1.2.6 Signalling pathways controlling autophagic induction
One of the few drugs known to be able to induce autophagy is rapamycin
(Sarkar et al., 2005). Rapamycin is an anti-fungal metabolite of the bacterium, 
Streptomyces hygroscopicus, discovered in a soil sample from the Easter 
Islands in the 1970s. Rapamycin was found to inhibit the proliferation of 
mammalian cells and also to possess immunosuppressive properties 
(Wullschleger et a l, 2006). The protein targeted by rapamycin was discovered 
in screens in S. cerevisiae for mutants resistant to the drug and was named 
target of rapamycin (TOR) (Heitman et al., 1991). TOR signalling has since 
been discovered to regulate not only translation but also metabolism and is 
hence central to cell growth.
Most of the work concerning how amino acids affect growth is via their ability 
to affect the TOR signalling pathway. TOR is known regulate autophagy as 
rapamycin treatment of yeast or mammalian cells induces autophagy.
However, the molecular detail of how the signalling downstream of TOR leads 
to the induction of autophagy is largely undetermined.
Recently a rapamycin resistant TOR complex (mTORC2) has been discovered, 
however so far this has only been characterised as mediating actin organisation
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and so how this would lead to autophagy is quite undetermined. Here then 
when I refer to TOR I refer to TORC1.
1.2.6.1 Upstream of mTOR
The binding of insulin (or insulin-like growth factors) to its cognate receptor 
leads to the recruitment and phosphorylation of insulin receptor substrate (IRS) 
and the subsequent recruitment of class I PI3-kinase. The class I PI3-kinase 
bound to IRS phosphorylates phosphatidylinositol-4,5-phosphate (PIP2) to 
produce PI(3 ,4 ,5 )P3 (or PIP3). This process is antagonized by the lipid 
phosphatase PTEN (Maehama and Dixon, 1998). In terms of the TOR 
pathway, the PIP3 activates pleckstrin homology (PH) domain containing 
protein kinase B (PKB) (Didichenko et al., 1996), which phosphorylates and 
functionally inactivates tuberous sclerosis (TSC) 2 (tuberin) (Potter et al.,
2002). TSC2 acts as a GTPase-activating protein (GAP) for the small GTPase 
Rheb (Inoki et al., 2003a). Rheb-GTP binds TOR, activating it (Long et al., 
2005a). For a recent review of the TOR signalling pathway see (Dann and 
Thomas, 2006). The above is a linearised description of the how insulin 
activates mammalian TOR (mTOR), however this is an oversimplification and 
other pathways are known to be able to influence this process.
TOR has also been shown to be sensitive to the energy status of the cell. AMP 
activated protein kinase (AMPK) senses the energy status of the cell, 
responding to changes in the intracellular AMP/ATP ratio. Activation of 
AMPK by AICAR, an AMP analogue, inhibits the mTOR dependent
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phosphorylation of S6K1 and 4E-BP1 (Kimura et al., 2003). This effect has 
been shown to be mediated through AMPK’s phosphorylation of TSC2, which 
enhances TSC2’s GAP activity (Inoki et al., 2003b). The tumour suppressor 
LKB1 has been shown to be upstream of AMPK (Hawley et al., 2003) and also 
to regulate the mTOR pathway in that LKB1 mutant cells exhibit hyperactive 
mTOR signalling (Shaw et al., 2004).
The TOR pathway is also responsive to amino acids, although how this is 
mediated is controversial. The concrete observation is that amino acid 
starvation, in particular the absence of leucine, results in a rapid 
dephosphorylation of the mTOR effectors S6K1 and 4E-BP1, whereas 
readdition of amino acids restores S6K1 and 4E-BP1 phosphorylation 
in an mTOR-dependent manner (Hay and Sonenberg, 2004). Inactivation of 
TSC2 renders cells resistant to amino acid withdrawal, suggesting that the 
amino acids signal via TSC1-TSC2 (Gao et al., 2002). However, amino acid 
withdrawal still downregulated mTOR signalling in TSC2 deficient cells (Smith 
et al., 2005). Long et al. (Long et al., 2005b) suggested that the binding of 
Rheb to mTOR is regulated by amino acid. However, Smith et al. (2005) 
amongst others failed to detect this. Indeed, in S. cerevisiae TOR responds to 
nutrients despite the absence of functional Rheb and TSC orthologues in this 
organism. Recent studies suggest that the class III PI3K hVps34 signals amino 
acid availability directly to mTOR independently of TSC2 or Rheb (Nobukuni 
et al., 2005).
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Other stimuli have been shown to input into the TOR pathway but their 
implications for autophagy have not so far been studied. Hypoxia has been 
shown to effect mTOR via REDD which is induced by the hypoxia inducible 
factor (HIF) (Brugarolas et al., 2004). p53 activated upon DNA damage 
inhibits mTOR activity via the AMPK-TSC2 signalling pathway (Feng et al.,
2005). The Ras MEK ERK signalling pathway has also been shown to input 
into the TOR pathway. Activated Erkl/2 directly phosphorylates TSC2 at sites 
that differ from the Akt target sites, thereby causing functional inactivation of 
the TSC1-TSC2 complex (Ma et al., 2005).
By the fact that TOR integrates all of these signals mentioned above (growth 
factors, energy status, amino acid levels and more) it can be seen TOR is a 
central player in a cell’s growth, development, metabolism and survival.
1.2.6.2 Downstream of TOR
TOR signalling regulates not only autophagy but also translation & 
transcription, ribosome biogenesis, metabolism and actin organisation. The 
most often discussed targets of TOR are ribosomal S6 kinase (S6K) and eIF4E 
binding proteins (4E-BPs). S6K’s phosphorylation of the 40S ribosomal 
protein S6 leads to increased translation of a subset of mRNAs that contain a 5’ 
tract of oligopyrimidine (TOP). The 5’TOP mRNAs encode components of the 
translation apparatus, such as ribosomal proteins and elongation factors. Thus, 
via increased translation of 5’TOP mRNAs, S6K upregulates general
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translation capacity. TOR also promotes cap-dependent translation initiation 
through phosphorylation of 4E-BPs (Wullschleger et al., 2006).
Autophagy is ordinarily inducible with rapamycin. However in atg mutants 
cells it is not, indicating that the site of action of TOR is upstream of those of 
Atg proteins (Noda and Ohsumi, 1998). The pathway by which TOR inhibits 
autophagy, via the Atg proteins, is still unresolved. Atgl is, to date, the only 
(non-ribosomal) protein kinase downstream of TOR known to regulate 
autophagy. Screens for other kinases that regulate autophagy are underway in 
several laboratories (various personal communications). Atgl associates with 
Atg 13 and when Atg 13 is hypersphosphorylated then Atgl is active, but what 
phosphorylates Atg 13 remains undetermined. Rapamycin can induce the 
kinase activity of Atglp, as shown in an in vitro kinase assay (Kamada et al., 
2000). How TOR affects A tg l’s kinase activity, i.e. whether its is a direct or 
indirect effect, is still unresolved. The most straightforward connection would 
be that TOR regulates the activity of a phosphatase capable of 
dephosphorylating A tgl3. However this link has not been proven 
experimentally and indeed a human orthologue of Atg 13 is still unforthcoming. 
This may not be relevant to autophagy, however, as it has been shown that 
A tg l’s kinase activity is not required for the induction of autophagy in S. 
cerevisiae (Abeliovich et al., 2003).
The ULK (Unc51 Like Kinase) family of proteins are the human orthologues of 
Atgl (Kuroyanagi et al., 1998). Unc refers to uncoordinated, any mutant of C. 
elegans that shows any detectable defect in the normal wave-like motion of
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movement behaviour is called uncoordinated (Brenner, 1974). Mutation of the 
UNC51 gene results in a paralysed, egg laying defective and dumpy phenotype 
(Hedgecock et al., 1985). In such mutants, most of the neurons exhibit an 
aberrant axon elongation with premature termination or deregulated numbers of 
axons growing in abnormal directions (Desai et al., 1988). Interestingly, fine 
structural analysis indicated atypical membranous vesicles and cistemae like 
structures in axons and ectopic varicosities near the cell bodies (Mclntire et al., 
1992).
There are five paralogues within the ULK family in humans, Figure 1.4, 
although of those five only ULK1, 2 and Fused have been characterised. To 
date, not much is known about the ULKs in addition to that already discovered 
for Unc51. ULK1 has also been shown to be involved in axonal elongation in 
mice (Tomoda et al., 2004) whereas ULK2 has so far essentially only been 
cloned (Yan et al., 1999). Of the Unc51 orthologues only Fused (essentially 
ULK5) has been well studied. Fused has been most actively studied in terms of 
Hedgehog signalling in Drosophila, being an integral part of the signalling 
pathway leading to Hedgehog activated gene transcription (Kalderon, 1997).
ULK1 is comprised of three domains, an N-terminal kinase domain, a spacer 
domain and a C-terminal domain. The target(s) of the kinase domain are as yet 
unknown. The C-terminal domain is, to date, known to bind to two proteins 
SynGAP and Syntenin. SynGAP is a synaptic GTPase Activating Protein 
(GAP; (Chen et al., 1998; Kim et al., 1998)) for Ras and Rab5 (Tomoda et al.,
2004). Syntenin is an endocytic vesicular membrane protein (Grootjans et al.,
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1997) which contains two PDZ domains that bind the cytoplasmic domains of 
various proteins, including syndecan, neurofascin, glutamate receptors, and 
ephrin-B2 (Grootjans et al., 1997; Hirbec et al., 2003; Koroll et al., 2001; Lin 
et al., 1999), often serving as a scaffolding molecule (Hirbec et al., 2003).
ULK1 has also been shown to bind to MAP-LC3 related proteins GABARAP 
and GATE-16, see section 1.2.4, through its proline / serine rich domain which 
is adjacent to the kinase domain (Okazaki et al., 2000).
ULK3
U L K 1  =  , ,Fused
ULK2 ULK4
Figure 1.4. Tree diagram o f the JJLK family members. Adapted from Manning 
et al. (2002).
1 .2 .7  A t g 9 L l
As can be seen from Table 1.1, there have been two integral membrane proteins 
identified to be involved in autophagy, Atg9 and Atg22. The best studied is
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Atg9. Atg9 was first characterised in S. cerevisiae (Lang et al., 2000; Noda et 
al., 2000). In S. cerevisiae ScAtg9 displays a unique punctate subcellular 
distribution, distinct from endosomes (Noda et al., 2000). Part of this punctate 
distribution was later shown to be the PAS (Kim et al., 2002). ScAtg9 cycles to 
and from the PAS in an A tgl-13 dependent manner (Reggiori et al., 2004).
This cycling also depended on Atg2 and the phophatidylinositol-3-phosphate 
(PI3P) binding protein A tgl8 (Reggiori et al., 2004). The actin cytoskeleton 
was found to be necessary for the cycling of ScAtg9 (Reggiori et al., 2005a). 
Recently part of the non-PAS punctate proportion of the Atg9 contingent was 
shown to be associated with mitochondria (Reggiori et al., 2005b).
In the yeast Pichia pastoris Atg9 is involved in the degradation of peroxisomes 
(Chang et al., 2005). In the microautophagic degradation of the peroxisomes 
PpAtg9 was shown to be localised to the sequestering membranes protruding 
from the vacuole (Chang et al., 2005).
Interestingly, Atg9Ll expression was recently found to be suppressed by myc 
activity (unpublished data referred to in Science News (Marx, 2006)).
During the course of this study a second ATG9-like gene was discovered, both 
in our laboratory and by Robb et al. (Robb et al., 2004), Atg9L2. However, 
whereas Atg9Ll was found to be ubiquitously expressed between different 
tissues the expression of Atg9L2 is confined to the placenta and pituitary gland.
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1.2.8 Atg gene transgenic mice
Transgenic mice systemically expressing GFP-LC3 gave great insight into the 
levels of autophagy occurring normally in vivo (Mizushima et al., 2004). Liver, 
muscle (including heart), pancreas and kidney all showed low basal levels of 
autophagy that could be up regulated upon starvation. Interestingly, autophagy 
was constitutively active in the epithelium and medulla of the thymus, 
occurring without starvation treatment and was not further induced by nutrient 
deprivation. However despite a high enough expression of GFP-LC3, GFP- 
LC3 puncta were not observed in the brain, ovary, testis, and adipocytes.
To date, knockout mice have been made for Atg5, Atg6 and Atg7. Atg5 
homozygous knockout mice displayed minimal abnormalities at birth but died 
within 1 day of delivery (Kuma et al., 2004). They displayed a lack of milk in 
their stomachs but even hand fed, using a gavage, they did not survive more 
than 2 days. Using the same GFP-LC3 mice as described above (Kuma et a l ,
2004) showed that autophagy was up regulated in a variety of tissues within 3h 
after birth. Thus indicating a requirement for autophagy after the detachment 
from the placenta, absent in the Atg5 knockout mouse.
Beclinl homozygous knockout mice die during embryonic development (Yue 
et al., 2003). Beclin heterozygous knockout mice develop normally and are 
fertile, however they suffer from a high incidence of spontaneous tumours (Yue 
et al., 2003).
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Atg7 homozygous knockout mice had significantly lower body weight after 
birth and died within one day (Komatsu et al., 2005). In the conditional 
knockout adult mice, autophagosomes were smaller with no observable 
mitochondria inside. An accumulation of sick or damaged mitochondria could 
be seen throughout the cytoplasm, as well a collection of peroxisomes. 
Concentric ring like structures were prevalent as were ubiquitin aggregates. 
Indeed Komatsu et al. (Komatsu et al., 2006) went on to show that mice lacking 
Atg7 specifically in the central nervous system displayed a notable 
accumulation of polyubiquitinated proteins in autophagy deficient neurons as 
inclusion bodies, which increased in size and number with ageing. There was, 
however, no obvious alteration in proteasome function. This polyubiquitinated 
aggregate accumulation was thought to cause neurodegeneration. A 
consecutive paper with mice deficient for Atg5 specifically in neural cells (Hara 
et al., 2006) also found polyubiquitin aggregates associated with 
neurodegeneration.
In keeping with the Atg conjugation pathways described above, the Atg7-/- 
mice had no Atg5-12 complex, only free Atg5. Also there was no detectable 
LC3-II, even after starvation, in all three knockout mice. These results are 
therefore consistent with the studies in yeast demonstrating that the ubiquitin- 
like Atg5-12 complex formation is required for the formation of lipidated Atg8. 
Moreover, these studies confirm that the yeast autophagy genes are also 
necessary for autophagy in mammals.
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1.2.9 Autophagy in cancer
Many of the factors in the pathways which regulate autophagy are involved in 
cancer. The tumour suppressor PI3-phosphatase PTEN is lost or mutated in 
glial, prostate and endometrial cancers (Kim and Mak, 2006) as well as breast 
and thyroid cancer including Cowden disease (Liaw et al., 1997). In a study of 
252 primary breast carcinomas, for example, (Tokunaga et a l, 2006) 33.3% 
were positive for phosphorylated Akt expression and this was significantly 
associated with loss of heterozygosity at the PTEN gene locus. PTEN 
positively regulates autophagy through inhibiting the PKB/Akt pathway (Arico 
et al., 2001).
p53, which is mutated in slightly more than 50% of cancers (Levine, 1997), has 
been shown to regulate the mTOR pathway (Feng et al., 2005). p53 can induce 
PTEN (Stambolic et al., 2001) and TSC2 expression (Feng et al., 2005). The 
LKB1 gene product, which regulates AMPK (Hawley et al., 2003; Woods et 
al., 2003) and in turn mTOR and autophagy, is a mediator of p53 dependent 
cell death (Karuman et al., 2001). More recently a more direct connection has 
been made between p53 and autophagy. p53 induction upregulates the 
expression a protein called DRAM (Damage-Regulated Autophagy Modulator), 
which is itself capable of inducing autophagy (Crighton et al., 2006).
Beclinl homozygous knockout mice are embryonic lethal, but the heterozygous 
mice suffered from spontaneous tumour development and Beclinl was 
therefore termed a heterozygous tumour suppressor (Yue et al., 2003).
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1.3 Membrane trafficking
Autophagy is a process involving intracellular membranes and presumably the 
mechanisms inherent in membrane trafficking. In this thesis I study one of the 
previously uncharacterised mammalian Atg proteins, Atg9Ll, a potential 
transmembrane protein. I describe its localisation to membranes of the both the 
secretory pathway and endocytosis. Hence, in this section I will attempt to 
describe the aspects of these processes that are relevant to the results described 
for Atg9Ll.
1.3.1 The secretory pathway
Cytosolic proteins are synthesised on free ribosomes in the cytosol whereas 
those destined for secretion and all transmembrane proteins are synthesised at 
the endoplasmic reticulum. Proteins destined for secretion or for residency in 
the plasma membrane or for certain other intracellular membranes then go on to 
pass through the Golgi complex which, amongst other things, sorts proteins 
according to their destination. This traffic of proteins from the ER to Golgi and 
out is termed the secretory pathway and was originally defined by George 
Palade and his co-workers (Palade, 1975).
1.3.1.1 The Endoplasmic Reticulum
The endoplasmic reticulum (ER) is a major site of lipid and protein
biosynthesis. As the name suggests, structurally it resembles a net throughout 
the cytoplasm. All integral membrane proteins as well as those destined for 
secretion are synthesised on the ER’s membranes. Protein synthesis is initiated 
in the cytoplasm on free ribosomes but if the protein contains a signal sequence
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then it is recognised by a cytoplasmic protein called the signal recognition 
particle (SRP), which delays any further elongation (for a review see Lecomte 
(Lecomte et al., 2003)). Signal sequences show no conservation of sequence. 
They are simply stretches of between 20 and 30 residues in length, 
characterised by a central hydrophobic core of approximately 10 to 15 (but no 
less than 6) residues, with a marked preference for leucines or alanines (Stroud 
and Walter, 1999). They are flanked on the N-terminal side by a positively 
charged stretch of polar residues and by a neutral, but polar, C-terminal region 
(von Heijne, 1985).
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Figure 1.5. Co-translational targeting in a eukaryotic cell. Schematic 
overview of the co-translational targeting of proteins destined for secretion or 
membrane insertion, known as the Signal Recognition Particle (SRP) cycle.
SRP interacts with the signal sequence as soon as it emerges from the ribosome. 
Peptide elongation is retarded in eukaryotes upon SRP ribosome / nascent chain 
complex formation. The complex is targeted to the ER membrane by the 
interaction of SRP with the SRP receptor (SR), for which GTP binding to both 
SRP and SR is a prerequisite. The polypeptide is then transferred to the 
protein-conducting channel in the membrane (the translocon) and, triggered by 
GTP hydrolysis in SRP and SR, the SRP-SR complex dissociates. Figure 
reproduced from Halic and Beckmann (2005).
1.3.1.2 N-linked glycosylation
Most of the soluble and membrane bound proteins that are synthesised in the 
ER are glycosylated. There are two types of glycosylation, Asparagine-linked 
or N-linked and O-linked. Of the two, N-linked glycosylation is the best
53
Chapter 1, INTRODUCTION
studied. N-linked glycosylation begins in the ER with the en bloc co- 
translational transfer of the precursor oligosaccharide by oligosaccharyl 
transferase from its lipid anchor dolichol to the forming polypeptide chain 
(Tabas et al., 1978). This precursor oligosaccharide comprises of two N- 
acetylglucosamine (GlcNAc) residues, nine mannose residues and three glucose 
residues, left hand molecule in Figure 1.6 (Li et al., 1978). There are two broad 
classes of N-linked oligosaccharides, complex oligosaccharides and the high- 
mannose oligosaccharides. Sometimes both types are found attached, in 
different places, to the same protein. Complex oligosaccharides are generated 
by a combination of trimming the precursor oligosaccharide added in the ER 
and the subsequent addition of further sugars. By contrast, high-mannose 
oligosaccharides have no new sugars added to them in the Golgi.
The processing reactions that modify the initial precursor to form complex 
oligosaccharides are depicted in Figure 1.6. The sequential trimming and 
addition of residues was established by Komfeld et al. (Komfeld et al., 1978), 
analysing the oligosaccharides of vesicular stomatitis virus (VSV) G protein by 
chasing it for various times after its synthesis, and are reviewed by Komfeld 
and Komfeld (Komfeld and Komfeld, 1985). Golgi processing begins by the 
trimming of the three mannose residues by the enzyme al,2-Mannosidase I 
(Mann I). Next addition of a single GlcNAc residue by pi ,2-N- 
acetylglucosaminyltransferase I (NAGT I) functions to facilitate the removal of 
two further mannose residues by al,3-al.6-mannosidase II (Man II), which 
results in the final tri-mannose core. NAGT II then adds a second GlcNAc. 
Glycosylation then terminates with the sequential additions of galactose by
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(31,4-galctosyltransferase (Gal T) and sialic acid by a2,6-siayltransferase 
(Sialyl T), resulting in the final mature form of the oligosaccharide.
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Figure 1.6. N-linked oligosaccharide processing. See text for details. Endo H 
= Endoglycosidase H. Figure taken from (Alberts et al., 2002).
1.3.1.3 The Golgi apparatus
The Italian anatomist Camillo Golgi first described an “internal reticular 
apparatus” in neurons in 1898. This has since become known as simply the 
“Golgi apparatus”. This observation was confirmed in the mid-1950s by the 
use of the electron microscope. It was doubtless one of the first intracellular 
organelles to be described due to its characteristic and prominent structure. It 
consists of a set of closely apposed cistemae, located in a juxta-nuclear location 
within the cell. It is a single copy organelle and although several stacks can 
often be observed in one cell by electron microscopy (EM) more thorough 
studies using high-voltage EM (Rambourg et al., 1981) revealed that the
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organelle undulates throughout the cytoplasm, consisting of many stacks 
connected by tubular extensions thus giving the impression of a multi-copy 
organelle in single section.
The role of this structure within cells has since been attributed as a sorting 
station in the secretory pathway and also the glycosylation of those secreted 
proteins. There are two main models which have been proposed to explain how 
Golgi subcompartmentalisation is maintained. The first proposes that the 
cistemae are stable entities containing a specific cohort of enzymes and that 
vesicles selectively transport transiting proteins forward through the Golgi. The 
second model proposes that Golgi cistemae constantly mature into later 
compartments by disposing of their enzymes while accepting a new cohort of 
enzymes from distal cistemae. The transport of enzymes between cistemae 
occurring via active sorting into vesicles. Although the two models are 
conceptually distinct they are not necessarily mutually exclusive.
Blocking ER export results in redistribution of Golgi residents proteins into the 
ER, which suggests that the Golgi functions in dynamic equilibrium with the 
ER, rather than as a stable entity (Ward et al., 2001). When the block is 
removed the Golgi can reform (Puri and Linstedt, 2003). It is thought that the 
cistemae reform by the coalescence of the COPII vesicles (see below) into 
pleiomorphic vesicles termed vesicular tubular clusters (VTCs) and then the 
subsequent fusion of VTCs into cistemae.
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Both microtubules (Thyberg and Moskalewski, 1999) and actin (Egea et a l,
2006) have roles in mediating the characteristic shape of the Golgi apparatus. 
The microtubule organising centre is usually the location of the Golgi and it 
was therefore proposed to be anchored to it. A more comprehensive model 
however suggests that microtubules mediate transport to and from the Golgi 
complex and the location of the Golgi stacks reflects the flux through this zone.
1.3.2 Vesicular transport
The mechanism by which proteins are transported from one membrane 
enclosed compartment’s lumen to another is via vesicular transport. This was 
originally worked out by Palade (Palade, 1975).
1.3.2.1 Coatomer
Intra-Golgi transport, like ER to Golgi transport, occurs via vesicles with non- 
clathrin based coats. Analysis of the composition of the purified vesicles led to 
the identification of coat protein (COP) (Malhotra et al., 1989). The complex 
of the different COP subunits is known as coatomer. Coatomer binds to 
membranes via ARF and promotes the deformation of that membrane, or its 
budding into a vesicle. Hydrolysis of GTP by ARF provides the timing for the 
dissociation of the coatomer complex and allows the docking of the vesicle 
with the target membrane. COPI was identified first and is responsible for 
retrograde transport and COPII is responsible for anterograde transport.
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1.3.2.2 ARFs
Adenosine diphosphate-ribosylation factors (ARFs) are a family of Ras-like 
small GTPases, ubiquitous among eukaryotes. ARFs regulate both membrane 
traffic and the actin cytoskeleton. Like other GTP binding proteins from the 
Ras superfamily, binding and hydrolysis of GTP by ARF require catalytic 
assistance from accessory proteins. Guanine nucleotide exchange factors 
(GEF) catalyze the exchange of guanosine diphosphate (GDP) for GTP, 
whereas GTPase-activating proteins (GAP) catalyze the hydrolysis of GTP to 
form GDP.
The process that has been most directly linked to ARF action in membrane 
traffic is the recruitment of membrane coat proteins including COPI, clathrin, 
and the clathrin adaptors. GTP binding and hydrolysis by ARF is directly 
linked to the binding and dissociation of coat proteins to membranes (Figure 
1.7). Activation of ARF results in ARF binding to a membrane. Coatomer is 
subsequently recruited by binding directly to ARF-GTP. A coat 
then assembles with consequent budding of a transport vesicle. When the GTP 
bound to ARF is hydrolyzed to GDP by the action of a GAP, ARF dissociates 
from the coated vesicle and triggers the dissociation of coatomer from the 
vesicle. The uncoated vesicle would then dock and fuse with the acceptor 
membrane.
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Figure 1.7. Role o f ARF in coat protein dynamics. (A) GTP binding and 
hydrolysis are tightly linked to coat binding and dissociation. (B) ARF has a 
role in coat recruitment but does not trigger coat dissociation. Figure 
reproduced from Randazzo et al 2000.
1.3.2.3 Brefeldin A effect
Brefeldin A (BFA) is a unique fungal metabolite. It was originally described to 
block protein secretion, without affecting protein synthesis, by causing a 
marked dilation of the ER by Misumi et al. (Misumi et al., 1986). However it 
was later shown that this effect was due to the loss of a discemable Golgi 
complex as it had redistributed into the ER membrane (Lippincott-Schwartz et 
al., 1990; Lippincott-Schwartz et al., 1989). The molecular mechanism of BFA 
action has since been elucidated; BFA inhibits the activity of a subset of Sec7 
domain ARF GEFs by binding to an ARF-GDP-ARF GEF complex (Peyroche 
et al., 1999). BFA therefore prevents the activation of ARF and thereby its
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membrane binding and coatomer recruitment, which in turn prevents transport 
vesicle formation.
Unlike the Golgi cistemae however the TGN does not redistribute into the ER 
but fuses with endosomes in a microtubule facilitated fashion to form an 
extensive TGN-endosomal network (Lippincott-Schwartz et a l, 1991; Wood et 
al., 1991). It is therefore possible to use BFA treatment as a method to 
determine whether a Golgi resident protein localises to the Golgi cistemae or 
the TGN as, although the Golgi also tubulates, the two tubular networks remain 
distinct (Lippincott-Schwartz et al., 1991).
1.3.2.4 Vesicle targeting
The mechanism of how vesicles are targeted to their destination membrane was 
finally elucidated in the early 1990s with the identification of a family of 
proteins termed SNAREs (Soluble NSF Attachment Receptors) (Malhotra et 
al., 1989). Although they had been previously identified as components of 
synaptic membranes and termed syntaxin A and B (Bennett et al., 1992), 
SNAP25 (soluble NSF Attachment protein 25) (Oyler et al., 1989) and 
synaptobrevin (Baumert et al., 1989). The fact that SNAP25 and the syntaxins 
are present in synaptic membranes and that synaptobrevin is present in synaptic 
vesicles led to the proposal that these molecules are involved in the specificity 
of membrane fusion and the SNARE hypothesis (Rothman and Warren, 1994). 
Vesicular SNAREs (v-SNAREs) are incorporated into secretory vesicles and 
target SNAREs (t-SNAREs) in the acceptor compartment, thereby inherently
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enabling specificity as the v-SNAREs can only recognise their complimentary 
t-SNAREs. A subsequent study demonstrated that v-SNAREs (synaptobrevin) 
and t-SNARES (syntaxin and SNAP25) could form complexes with each other 
(Sollner et al., 1993).
There are now doubts as to whether SNAREs are the sole determinants of the 
specificity of membrane fusion and current models of membrane trafficking are 
more inclusive of other components including Rabs and tethers, which are 
described as part of the section below.
1.3.2.5 Endocytosis
Endocytosis is essentially the invagination of the plasma membrane to form a 
vesicle. There are many different pathways including phagocytosis, caveolae- 
mediated uptake, pinocytosis, receptor mediated clathrin based endocytosis and 
constitutive non-clathrin uptake. The best characterised in clathrin mediated 
endocytosis.
1.3.2.5.1 Pinocytosis
Pinocytosis is the internalization of plasma membrane ruffles together with 
extracellular fluid, hence pinocytosis represents an efficient way of non- 
selective fluid-phase uptake (Swanson and Watts, 1995). The word is derived 
from the Greek word pin(ein), meaning to drink. Many growth factors 
stimulate pinocytosis, probably to enhance uptake of nutrients required for cell 
growth and also possibly to stimulate cell motility. Pinocytosis is initiated by
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signal induced membrane ruffling which is caused by actin driven formation of 
membrane protrusions. Formation of these protrusions is triggered by 
activation of small GTPases of the Rho family (Ridley, 2001) and after 
elongation they collapse and fuse with the plasma membrane. Though 
pinocytosis is most likely tightly controlled, little is known about the exact 
regulation of this process.
1.3.2.5.2 Clathrin mediated endocytosis
Roth and Porter described the basic aspects of coated pit formation, relying on 
the analysis of electron micrographs in 1964 (Roth and Porter, 1964). Clathrin 
was first identified as the single major protein species of coats isolated from pig 
brain (Pearse, 1975). Clathrin forms a coat around the lipid, restraining the 
lipid into a vesicle within its superstructure. Adaptor proteins link clathrin to 
the vesicles cargo. Adaptor proteins were first purified from bullock brain by 
gel filtration chromatography (Pearse and Robinson, 1984). Despite the 
different trafficking pathways in which adaptor complexes are involved, they 
are all heterotetramers that are composed of two large, one medium, and one 
small adaptin subunit; y, |3, p and a, respectively. Clathrin/AP-2-coated 
vesicles form at the plasma membrane and facilitate clathrin-mediated 
endocytosis. Adaptor proteins bind cargo proteins through strict motifs 
(Bonifacino and Traub, 2003). Tyrosine-based motifs, a family of sorting 
signals based on the amino acid sequence YXX0 (where X is any amino acid 
and 0  is an amino acid with a bulky hydrophobic side chain) is one of the best- 
characterized sorting motifs, along with dileucine motifs (D/E)XXXL(L/I). It
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has been observed that these motifs direct not only internalization from the 
plasma membrane but also endosomal / lysosomal targeting and sorting at the 
TGN (Bonifacino and Traub, 2003).
The endocytic pathway can be roughly divided into early and late endosomes 
with lysosomes as the terminal compartment of the pathway The commonly 
used term ‘early endosome’ actually describes two distinct endosomal 
organelles, the sorting endosome and the recycling endosome -  see Figure 1.8 
(Maxfield and McGraw, 2004). After shedding their clathrin coats, newly 
formed endosomes fuse with one another and with pre-existing sorting 
endosomes. Sorting endosomes are peripherally located, tubular-vesicular 
structures. The sorting endosome is the first main branch point in the receptor- 
mediated endocytosis pathway and, as its name implies, the function of the 
sorting endosome is to target molecules to their correct destinations. There are 
three known destinations after the sorting endosome, proteins can either return 
to the plasma membrane, traffic to the recycling endosome or stay with the 
endosome as it matures into a late endosome.
The recycling endosome is mainly a collection of tubular organelles with 
diameters of about 60nm that are associated with microtubules, first described 
by Yamashiro et al. (Yamashiro et al., 1984). From the recycling endosome 
proteins either pass back to the sorting endosome but mainly pass either to the 
plasma membrane or to the TGN.
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Figure 1.8. Endocytic recycling pathways. The model shows the post- 
endocytic itineraries of several molecules, reproduced from Maxfield and 
McGraw (2004) Of interest for the purposes of this thesis are CI-MPR and 
TGN38. (LDLR = Low-density-lipoprotein receptor).
One example of a protein that cycles though the compartments described above 
is TGN38 (the rat equivalent of TGN46 in H. sapiens (Banting and 
Ponnambalam, 1997; Luzio et a l, 1990). Although primarily localised to the 
TGN, TGN38 constitutively cycles between the TGN and the cell surface 
(Reaves et al., 1993). Incubation of cells in the presence of BafAl (a specific 
inhibitor of the vacuolar ATPase and therefore endosome acidification) led to
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an accumulation of TGN38 in swollen early endosomal structures (Reaves and 
Banting, 1994). The total population of TGN38 molecules was observed to be 
redistributed from the TGN to the swollen early endosomes within lh  (Reaves 
and Banting, 1994), indicating that TGN38 molecules complete the TGN to cell 
surface to TGN cycle at least once every hour. TGN38 is rapidly internalised 
from the cell surface via its YXX0 motif (Bonifacino and Traub, 2003). 
However the transmembrane domain of TGN38 was sufficient to localise it to 
the TGN (Ponnambalam et al., 1994). TGN38 is thought to be delivered to the 
TGN directly from early endosomes rather than from a later endocytic 
compartment (Reaves et al., 1996).
1.3.2.6 Transport from the TGN to endosomes
Clathrin and clathrin-adaptor coated vesicles have been characterised in the
TGN as well as the endosomal pathway (McNiven and Thompson, 2006). AP- 
1 is thought to be involved in vesicle formation on the TGN, mediating the 
sorting of lysosomal hydrolases via endosomes. However, studies on p i A 
deficient fibroblasts showed that lysosomal enzyme delivery was normal, while 
the localisation of MPRs was shifted to an endosomal compartment (Meyer et 
al., 2000). These data suggest that AP-1 may rather have important functions 
in the retrograde transport of proteins from endosomes to the TGN. The role of 
AP-1 is still controversial.
The recently discovered monomeric clathrin adaptor family of GGA proteins 
has been shown to mediate TGN to endosomal trafficking. The GGA protein
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was functionally identified in a yeast-two-hybrid screen through interaction 
with an activated form of ARF 3 (Boman et a l, 2000). GGA proteins contain 
an N-terminal VHS domain (a domain found in Vps27, Hrs (hepatocyte growth 
factor receptor-regulated tyrosine kinase) and STAM (signal-transducing 
adaptor molecules)) and a C-terminal domain with -70% identity to the C- 
terminal ‘ear’ domain of y-adaptin. GGA proteins are localised to the TGN and 
overexpression of GGA altered the localisation of TGN38 and MPR (Boman et 
a l, 2 0 0 0 ).
The AP-3 adaptor complex is another coat complex involved in transport to 
lysosomes. Studies in yeast revealed that yeast cells have two distinct pathways 
for transporting proteins to the vacuole. These two pathways are defined by the 
different trafficking itineraries of the proteins CPY and alkaline phosphatase 
(ALP). The delivery of CPY in yeast uses the classical Vps TGN to endosome 
to vacuole pathway, similar to MPR’s transport of lysosomal enzymes in 
mammalian cells. However, the transport of ALP from the TGN to the yeast 
vacuole bypasses the endosomal compartments. Instead, ALP is directly sorted 
from the TGN to the vacuole. A number of naturally occurring mutations in 
AP-3 genes have been found in Drosophila, mouse, and human cells. They all 
show common defects in the biogenesis of lysosome related organelles such as 
melanosomes (Bonifacino and Traub, 2003). AP-3 has been shown to be 
involved in the lysosomal transport of several lysosomal integral membrane 
proteins, such as Lysosomally Associated Membrane Protein 1 (LAMP1) (Le 
Borgne et a l, 1998).
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1.3.2.7 Transport from Endosomes to TGN
1.3.2.7.1 Rab9 / TIP47
As mentioned above, TIP47 has been shown to be required for MPR transport 
from late endosomes to the TGN. The binding of TIP47 to CI-MPR seems to 
depend on the membrane-proximal region, as well as the secondary structure of 
the CI-MPR tail (Orsel et a l, 2000). The binding of TIP47 to MPR is thought 
to collect these receptors into a newly forming vesicle bound for the TGN.
1.3.2.7.2 Retromer
Vps genes were identified in screens for mutants that secrete the yeast vacuolar 
enzyme carboxypeptidase Y (Bankaitis et a l, 1986; Rothman and Stevens, 
1986). A pentameric complex of Vps5p, Vpsl7p and Vps26p, Vps29p and 
Vps35p was identified through the application of chemical crosslinkers 
(Seaman et a l, 1998). Because the complex was thought to function in 
endosome to Golgi retrieval, it was called retromer. The culmination of 
subsequent studies led to the hypothesis that retromer is a vesicle coat complex 
that mediates the retrieval of Vps 1 Op from endosomes to the Golgi. Although 
Vps 1 Op shares no significant sequence homology with the MPRs it has an 
essentially identical function and, like the MPRs, rapidly cycles between the 
late Golgi and an endosome (Seaman, 2005). siRNA mediated knockdown of 
mVps26 has shown that the mammalian retromer complex is also required for 
CI-MPR exit from endosomes (Arighi et al., 2004).
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1.3.2.7.3 VFT complex
A screen of yeast mutants with vacuolar sorting defects revealed a multimeric 
complex composes of Vps52p, Vps53p, and Vps54p required for retrograde 
transport to the TGN (Conibear and Stevens, 2000), termed the Vps Fifty Three 
(VFT) or Golgi Associated Retrograde Protein (GARP) complex. The mutant 
strains all fail to transport a number of late Golgi proteins (including Vps 1 Op) 
back to the TGN, resulting in the mis-localisation of these proteins to the 
vacuole. These data suggest that the VFT complex is yet another complex 
involved in TGN retrieval. It has been speculated that this complex is a tether 
involved in the docking and fusion of the retrograde transport vesicles with the 
late Golgi compartment. Recently the mammalian orthologues of the VFT 
complex have been cloned and shown to interact as a complex also (Liewen et 
al., 2005).
1.3.2.8 Rabs
1.3.2.8.1 Rab GTP uses
Rab proteins are members of the Ras superfamily of monomeric GTPases. Rab 
proteins are involved in regulating membrane trafficking events, different Rabs 
being specific for different organelles (Figure 1.9). The Rabs themselves 
essentially form an anchor for the Rab effectors, coordinating the timing of the 
effector’s association with the membrane in question via their GTP hydrolysis. 
Rabs are anchored to membranes by the addition of one or two geranylgeranyl 
groups attached to a cysteine based motif at their C-terminus (Kinsella and
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Maltese, 1992). Initial studies on endosomal Rabs suggested that a 
hypervariable domain in the C-terminus acts as a targeting signal to different 
membranes (Chavrier et al., 1991). However, more recently a study of a wide 
range of Rabs has shown that this region is neither necessary nor sufficient (Ali 
et al., 2004). Instead, it appears that multiple parts of the rest of the protein 
contribute to organelle specificity (Ali et al., 2004).
Inactive, GDP associated Rabs, are cytosolic. This inactive, GDP bound state, 
is mediated by interacting with a factor called GDP dissociation inhibitor (GDI) 
(Sasaki et al., 1990; Ullrich et a l, 1993). Only a few isoforms of GDI are 
known in mammalian cells whereas there are greater than 60 Rabs known.
Upon recruitment to membranes the GDI is displaced by the, membrane 
localised, GDI displacement factor (GDF) (Dirac-Svejstrup et al., 1997). Rabs, 
like most GTPases, have a low activity towards nucleotide exchange. A Rab 
guanine nucleotide exchange factor (GEF) catalyses the conversion of GDP to 
GTP which stabilises the binding of the Rab to the membrane. A Rab GTPase 
activating protein (GAP) stimulates the GTP hydrolysis. After inactivation 
GDI associates with the Rab again removing it from the membrane and 
completing the Rab’s cycle.
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Figure 1.9. Localisation o f Rab proteins within the cell. Figure taken from 
Zerial, 2001.
As mentioned above, Rabs serve as the anchors that coordinate the association 
of other proteins with that membrane. Examples of Rab effectors are tethers 
and microtubule motors. There are also many examples of Rab proteins 
interacting with the actin-based myosin motors (for a review see (Seabra and 
Coudrier, 2004)). Examples of these are discussed, in context, in the section 
below.
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1.3.2.8.2 Rabs on early endosomes
Rab5 functions in early endosomes motility as well as in early endosome 
homotypic fusion (Gorvel et al., 1991; Nielsen et al., 1999). A well 
characterised tether associated with Rab5 is EEA1, which has been shown to 
facilitate early endosome fusion (Christoforidis et al., 1999). Rab5 has also 
been shown to interact with the minus-end directed microtubule motor dynein 
(Huang et al., 2001). Upon stimulation with insulin, Huang et al. observed a 
significant decrease in the levels of GTP-Rab5, which resulted in a concomitant 
reduction in dynein association and inhibition of minus-end transport.
Rab4 is also involved in early endocytic sorting events (van der Sluijs et al.,
1992), where it regulates the direct recycling of receptors from early endosomes 
back to the plasma membrane (Pagano et al., 2004). Rabl 1 is involved in 
receptor recycling. It is concentrated on recycling endosomes and controls the 
traffic through this organelle (Ullrich et al., 1996). In addition to the three Rab 
proteins described above, there are a number of other, less well characterised 
Rab proteins involved in the early endocytic pathway, some of which are 
expressed in a tissue specific manner. Rab22, for example, is expressed in 
heart and brain (Olkkonen et al., 1993), where it localises to both early 
endosomes and late endosomes, and functions in late endosomes to Golgi 
traffic (Mesa et al., 2005).
1.3.2.8.3 Rabs on late endosomes
Rab7 and Rab9 both localise to late endosomes. However, they localise to 
distinct micro-domains (Barbero et al. 2002) and have quite distinct functions.
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Rab7 has been shown to regulate the traffic between early endosomes and late 
endosomes as mutation of Rab7 lead to an accumulation of endocytosed 
material in early endosomes (Feng et al., 1995). Rab7 has been shown to play a 
role in late endosomes fusion / progression and therefore lysosome biogenesis 
(Bucci et al., 2000). More recently, Rab7 has also been shown to regulate 
autophagosomes maturation (Gutierrez et al., 2004; Jager et al., 2004).
Unlike Rab7’s role in traffic between endosomes and onto lysosomes, Rab9 
mediates traffic between late endosomes and the TGN. Overexpression of 
Rab9 caused an increase in endosome to TGN traffic and sequestration of Rab9 
using antibodies caused a decrease (Lombardi et al., 1993). Rab9 also regulates 
the size of late endosomes, with siRNA mediated knockdown of Rab9 causing a 
decrease in the size of late endosomes and a destabilisation of CI-MPR (Ganley 
et al. 2004). Rab9 plays a role in mannose-6 -phosphate receptor accumulation 
during vesicle formation via its effector tail-interacting protein of 47kDa 
(TIP47) (Carroll et al., 2001). TIP47 is important for Rab9’s and CI-MPR’s 
stability and localisation (Aivazian et al., 2006; Ganley et al. 2004).
1.3.2.8.4 Rab mutants
There are three classes of mutation affecting guanine nucleotide binding 
domain of Rabs. A mutation at around amino acid (aa) 20, usually of T to N 
e.g. Rab7T22N, causes the Rab to become locked in the GDP bound state. A 
mutation at around aa 80, usually of Q to L, causes the Rab to become locked in 
the GTP state. Finally mutation at around aa 130, usually of N to I, causes an 
‘empty state’, distinct from the GDP-bound state .
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Mutants of Rab proteins have been shown to affect intracellular membrane 
traffic. For example, while Rab7N125I and Rab7T22N have no effect on the 
short term rate of the internalisation of horseradish peroxidase or SV5 HN 
protein (a paramyxovirus envelope protein, used as an integral membrane 
transport marker) the mutant Rab proteins markedly inhibited the subsequent 
cleavage of the SV5 HN protein, indicating a block in endosomal maturation 
and SV5 HN trafficking (Feng et al., 1995).
1.4 Objectives
Membrane trafficking has been, and is being, actively studied in many 
organisms and the increased availability of many powerful tools in recent years 
have made elucidation of outstanding problems in this field more attainable. 
One pathway that remains somewhat of a mystery is autophagy, where the 
source of the membrane for the formation of autophagosomes is still unclear, 
the signalling networks that regulate autophagy are just being addressed and the 
molecular functions of specific Atg proteins are largely unknown except that 
they are required for the process of autophagy. These questions are of basic 
interest but are even more important when considered alongside the fact that 
autophagy has a critical role in development, cellular stress, cancer and other 
processes.
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Of the Atg proteins Atg9 in particular is interesting as it is a transmembrane 
protein and as such, if Atg9Ll is present on autophagosomes, it offers the 
promise of revealing the source of the autophagosomal membrane. At the time 
that this study began Atg9 was partially characterised in yeast but totally 
uncharacterised in mammalian cells. I set out to investigate this protein in 
mammalian cells with the aim of addressing its role in autophagy. I will begin 
by addressing the localisation of the protein both by immunofluorescence and 
subcellular fractionation. Effectors of Atg9Ll’s localisation, in particular the 
Atgl serine/ threonine kinase (known to affect Atg9 from work in S. cerevisiae 
(Reggiori et al., 2004)), will also investigated to try to establish the mechanism 
of their effect upon Atg9Ll. Finally the role of Atg9Ll in autophagy will be 
investigated by knocking down the protein and investigating its effect on the 
autophagy process.
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2 MATERIALS AND METHODS
2.1 Reagents
2.1.1 General
Chemicals were purchased from Sigma (UK) unless otherwise stated. Cell 
culture dishes from Coming (USA).
Distilled water, Phosphate Buffered Saline (PBS), Loria Broth (LB), SOC 
medium, sterile glycerol, Taq DNA polymerase, Earle’s Saline (ES; 123.2mM 
NaCl, 5.366mM KC1, 2.388mM CaCl2, 1.662mM MgS04, 5.55ImM D- 
Glucose, 13.094mM NaHCOs), Dulbecco’s Modified Eagle’s Medium 
(DMEM), DMEM minus antibiotics and glutamine were provided by Cancer 
Research UK central services.
2.1.2 Antibodies
Rabbit polyclonal: anti-CI-MPR was raised in house (Dittie et al., 1999). Anti- 
GFP, anti-Mannosidase II, anti-p58, anti-Rab7, and anti-Rab9 antibodies were 
kind gifts from Dr T. Hunt (CRUK, London), Dr G. Warren (Yale Univ., USA), 
Dr. J Saraste (Univ. of Bergen, Norway), Dr. A. Wadinger-Ness (Univ. of New 
Mexico, USA), and Dr S. Pfeffer (Stanford Univ., USA) respectively. 
Commerical antibodies used were: anti-TGN46 (Serotec, UK), anti-actin and 
anti-FLAG (Sigma, USA), anti-EEAl, anti-GM130 and anti-LAMP2 (BD 
Biosciences, USA), anti-HA (Covance, UK), anti-CI-MPR and anti-Superoxide 
Dismutase 1 (AbCam, UK), anti-PDI (StressGen, Canada), and anti-TGN38 
(Affinity Bioreagents, USA).
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2.1.3 Atg9Ll antibodies
Polyclonal rabbit antisera were raised against KLH conjugated peptides. 
Peptides were coupled to KLH using an Imject Maleimide Activated mcKLH 
kit from Pierce (USA).
ST0214 and 215 was raised against an N-terminal peptide (amino acids 1-18): 
MAQFDTE Y QRLE AS Y SDS [C]
ST0216 and 217 were raised against an internal peptide (amino acids 338-357): 
CYLRHFNELEHELQSRLNRG
ST0218 and 219 were raised against a C-terminal peptide (amino acids 818- 
836 of 839):
[C]RHPEPVPEEGSEDELPPQV
The extra cysteine residues added to the N- and C-terminal peptides, indicated 
above as [C], were added as the mcKLH kit’s chemistry is designed to couple 
via the free sulph-hydryl group of cysteine residues.
2.1.4 Animals
Animals were obtained from Charles River (UK). For the endosome and 
autophagosome preparations male Wistar rats were used. For the Golgi 
preparation, female Sprague-Dawley rats were used. Wistar rats were 
purchased at a weight of approximately 250g and kept in the in-house animal 
facility for at least a week before use. This was to allow them to become
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comfortable with their new environment and therefore to alleviate as much 
stress as possible before the experiment, particularly the autophagosome 
preparation. For the autophagosome and Golgi preparations the rats were 
starved overnight before sacrifice. British law prevented any further starvation 
or placing the animals on a controlled diet.
2.2 Methods
2.2.1 DNA techniques
2.2.1.1 Restriction enzyme digests
Restriction enzyme (RE) digests were carried out in 20pi reaction volumes. 
These were made up of 1 pg DNA, 5units (U) of restriction enzyme (New 
England Biolabs, NEB) and 2pl of the lOx RE buffer supplied with the enzyme. 
Digests were usually performed for 2h at the temperature specified by the 
manufacturer for that enzyme. However, if the subsequent ligation was 
unsuccessful then the digest was repeated for a longer duration, often overnight.
2.2.1.2 Polymerase Chain Reaction (PCR)
PCR reactions were carried out in 4 x 25pl reactions, subdivided from a lOOpl
mix. The PCR mix contained 50ng DNA template, 250pM dNTPs (Amersham 
Pharmacia), 2pM of each of the forward and reverse primers and 2.5U of either 
PFU or Taq polymerase. Cycling parameters were as per Table 2.1.
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Table 2.1. PCR cycling parameters.
Segment Cycles Phase Temperature (°C) Time (min)
1 1 Denaturing 94 5
2 35 Denaturing 94 1
Annealing Primer dependent 1
Extension 72 2min / Kb
Primers used to make HA-Atg9Ll (including Kozak sequence and 5’ EcoPl 
site) were:
Forward: GG AAT C ACC AAT GGC AT ACCC AT ACG ACGT CCC AG ACT AC
GCTGG AGCGC AGTTT G AC ACT G AAT ACC AGCGCCT AG
Reverse: GCTCTAGAGCGCTCAGCCTTGTCTATACCTTGTGCACCTG
Primers used to make HA-Atg9Ll truncation to 519aa, minus the C-terminal 
domain after the last TMD, were:
Forward: CT AT AGGGCGGCCGCG AATTCC ACC AT GGC AT ACCC 
Reverse (including stop codon and Hindlll site): 
GCGAACATCCATCTGAAGCTTCTAGCAGGTTATCTCCCAC
2.2.1.3 DNA agarose gel electrophoresis
Depending on the size of the DNA fragment of interest, a 0.8 -  2% (w/v)
agarose gel was prepared by adding an appropriate volume of TAE buffer 
(40mM Tris-HCl pH 8.0, 20mM acetic acid, ImM EDTA) to the appropriate
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amount of agarose (Invitrogen) in a conical flask of at least 2-3x the volume 
and heating in a microwave (on medium power) to dissolve, with occasional 
swirling. Ethidium bromide was added (5pg/ml, final concentration) to enable 
visualisation of the DNA. When sufficiently cool, the agarose solution was 
added to the gel holder, taped at either end with autoclave tape. 5x sample 
buffer (50% glycerol, ImM EDTA pH 8.0, containing a small amount of 
Bromophenol blue) was added to the DNA prior to loading. Gel tanks were 
filled with TAE buffer and electrophoresis performed at a constant 100V for 
<lh. The DNA was visualised by placing the gel on a UV irradiator. If the 
DNA was from a RE digest, and of the expected size, then it was cut out of the 
gel using a scalpel and purified from the gel slice using a QIAquick gel 
extraction kit (Qiagen) for subsequent ligation.
2.2.1.4 Ligation
Gel purified DNA fragments and vectors were mixed at a ratio of 3:1 and 
ligated using T4 DNA ligase (NEB). The reaction mix consisted of 3-12pl RE 
digest or PCR DNA fragment, l-4pl vector DNA, 400U T4 DNA ligase, 2pl 
lOx ligase buffer (supplied with the enzyme) and made up to 2 0 pl with distilled 
water. The reaction mix was prepared on ice and when all the ingredients were 
added it was incubated either at room temperature for lh  or overnight in a 16°C 
water bath in a cold room. 5-20pl of the reaction mix was then transformed 
into bacteria, section 2.2.1.5.
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2.2.1.5 Bacterial transformation
A 50pl aliquot of XL 1-Blue subcloning grade competent cells (Stratagene) was 
mixed with approximately lOOng DNA and incubated on ice for 20min. The 
bacteria were heat-shock treated by placing them at 42°C for 45sec. 0.9ml of 
pre-warmed SOC medium was added and the bacteria incubated at 37°C for 
>30min. After this time, lOOjil of the bacteria was spread out onto an agar 
plate of the appropriate antibiotic resistance. The remaining bacteria were 
pelleted by centrifugation at 5000rpm in a bench top micro-centrifuge for 5min 
and the pellet resuspended in lOOpl LB medium. This was then spread out onto 
a second agar plate.
2.2.1.6 Bacterial cryo-storage
0.3ml of sterile glycerol was added to 0.6ml of the bacterial culture in pre­
labelled Nunc cryo-vial and stored at -80°C.
2.2.1.7 Preparation of plasmid DNA
Plasmid purifications were performed using either Qiagen’s Mini or Maxi Prep 
kits and bacteria were grown up in either 5ml or 100ml LB cultures, 
respectively. LB cultures included the appropriate selection antibiotic, usually 
either kanamycin or ampicillin (each at 50pg/ml final).
2.2.1.8 DNA concentration determination
DNA concentration was determined using a spectrophotometer. An absorbance 
value of 1 at a wavelength of 260nm corresponds to a 50pg/ml solution of 
double stranded DNA. To assess the purity of the sample, the absorbance ratio
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260/280nm was measured. Ideally this should be 1.8 but values from 1.7 to 2.2 
were used for ligation with success. A value higher than 1.8 indicates possible 
RNA contamination, whereas a value lower than 1.8 indicates more protein 
than DNA.
2.2.1.9 Site-Directed Mutagenesis
Site-directed mutagenesis (SDM) was carried out using a QuikChange Multi kit 
from Stratagene according to the manufacturer’s instructions. Mutagenic 
primers were designed using the company’s website 
http://labtools.stratagene.com/QC and purchased from Sigma-Genosys.
Cycling parameters were as outlined in Table 2.2.
Segment Cycles Temperature (°C) Time (min)
1 1 95 1
2 30 95 1
55 1
65 2min / Kb of plasmid length
Table 2.2. Cycling parameters for site-directed mutagenesis.
After the cycling reaction was complete, the parent (methylated) DNA plasmid 
was digested by the addition of 10U Dpnl and incubation at 37°C for lh. The 
single-stranded unmethlylated DNA strand was then transformed into XL 10- 
Gold Ultracompetent bacteria (Stratagene) as per section 2.2.1.5.
81
Chapter 2, MATERIALS AND METHODS
Primers used for SDM were:
Y8 A & LI 1 A: GACACTGAAGCCCAGCGCGCAGAGGCCTCC 
L25A & L26A: AGGGGAGGAGGACGCGGCGGTGCACGTCGCCG
2.2.1.10 DNA sequencing
DNA sequencing was performed by the Cancer Research UK sequencing 
service. PCR reactions were set up as follows: 500ng DNA template, 3.2pmol 
forward or reverse primer, 8  pi ABI dye terminator kit reaction mix, made up to 
20pl with distilled water. Cycling parameters were as per Table 2.3.
Cycles Phase Temperature (°C) Time
25 Denaturing 96 lOsec
Annealing 50 5
Extension 60 4min
Table 2.3. Sequencing PCR parameters.
After the PCR, primers and unincorporated labelled dNTPs were removed and 
the labelled DNA fragments purified using a DyeEx 2.0 kit (Qiagen). Cancer 
Research UK central services then performed the loading and running of the 
DNA sequencer.
The resultant sequences were aligned with their corresponding National Centre 
for Biotechnology Information (NCBI) database entry using Sequencher 4.2.2 
software (Gene Codes Corporation).
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2.2.1.11 Northern Blot analysis
A ready-to-hybridize FirstChoice Northern Human Blot I was purchased from 
Ambion. A radioactive probe was produced using a Prime-It II Random Primer 
Labelling Kit (Stratagene) according to the manufacturer’s instructions. This 
essentially produced a radioactive copy of the template using a Klenow 
polymerase fragment, via incorporation of [32P]-dCTP. The probe template was 
produced using restriction enzyme Nhel, which cuts HsATG9Ll at 1771 and 
2278bp, where 1 = A of the translation initiating ATG (the final base pair of the 
stop codon would then be 2520bp). After synthesis the probe was purified 
using a NICK column (Amersham Pharmacia) and lOOjil of lOmg/ml Salmon 
sperm DNA was added. The blot membrane was placed in QuikHyb 
Hybridisation Solution (Stratagene) and pre-incubated with it, i.e. pre­
hybridised, for 15min at 6 8 °C in the glass cylindrical container of a 
hybridisation oven. The radioactive probe was denatured by boiling for 5min, 
diluted in 1ml of the pre-hybridised QuikHyb solution and added to the glass 
container. Care was taken to avoid pipetting directly onto the blot. The probe 
was incubated with the membrane for lh at 6 8 °C. After hybridisation the 
membrane was washed twice with 60°C 2x sodium saline citrate (2x SSC; 0.3M 
NaCl, 30mM NaCitrate, pH 7.0) solution before incubating for 15min at 60°C 
in 2x SSC containing 0.1% (w/v) SDS. The membrane was then incubated for 
15min at 60°C in 0.2x SSC containing 0.1% (w/v) SDS and finally for 15min at 
6 8 °C in 0.2x SSC alone. The blot was then blotted dry and exposed to either 
film or a phosphoimager cassette screen overnight. After use the blot was
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stored at -20°C. Including untranslated regions (UTRs) the HsATG9Ll cDNA 
is ~3.8kb. The blot was tested by the manufacturer for equal loading.
2.2.2 Protein techniques
2.2.2.1 Preparation of cell lysates
Hepatocytes or HEK293 cells were washed once with ice cold PBS and then 
scraped in TNTE (20mM Tris-HCl pH7.5, 150mM NaCl, 0.3% (w/v) Triton X- 
100 (TX-100), 5mM EDTA) containing a protease inhibitor cocktail, CLAPP 
(50pg/ml Chymostatin, 0.5pg/ml Leupeptin, 50pg/ml Antipain, 0.5pg/ml 
Pepstatin A and O.lpg/ml Pefabloc (Roche)). Insoluble debris was removed by 
centrifugation in a bench top microcentrifuge for lOmin at 16000g, at 4°C. The 
supernatants were stored at -20°C.
2.2.2.2 Protein concentration determination
The protein concentration of samples was measured using the BioRad protein
reagent. IgG was used as the standard. Both standards and samples were 
diluted in 800pl water and incubated with 2 0 0 pl protein assay reagent for 
a:15min. The absorbance at 595nm was measured and compared to the standard 
curve to calculate protein concentrations.
2.2.2.3 SDS -  polyacrylamide gel electrophoresis (SDS-PAGE)
Samples were mixed with 5x Laemmli SDS-PAGE sample buffer (0.3125M
Tris-HCl pH6 .8 , 16% (v/v) (3-mercaptoethanol, 15% (w/v) SDS, 50% (w/v) 
glycerol, 0.015% (w/v) bromophenol blue) and then denatured by boiling for 
5min. SDS-PAGE gels were prepared as per Table 2.4 and Table 2.5, and run
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at a constant 90V for 20min then 120V for lh, or until the dye front reached the 
bottom of the gel. The electrophoresis system used was the Bio-Rad mini- 
protean II cell with 1.5mm spacers. With this system, for equal protein loading, 
60pg total protein was run per lane for a 1 0  well gel with a maximum volume 
of 60-70pl per well.
7.5% gel 10% Gel 12% Gel
4x Lower buffer 2.250ml 2.250ml 2.25ml
30% Acrylamide / 
0.8% Bis-acrylamide
2.250ml 2.993ml 3.60ml
Distilled water 4.451ml 3.708ml 3.10ml
Temed 4.5pl 4.5pl 4.5jil
10% (w/v) APS 45 pi 45pl 45 pi
Table 2.4. SDS-PAGE running gel recipes. 4x Lower buffer (6 M Tris-HCl 
pH8 .8 , 1.6% (w/v) SDS). The volumes in one column are sufficient to make 
one Bio-Rad system mini gel. The acrylamide mix was purchased from 
National Diagnostics.
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4.5% Gel
4x Upper buffer 1 ml
30% Acrylamide 
0.8% Bis-acrylamide
0 . 6  ml
Distilled water 2.356 ml
Temed 4 pi
10% (w/v) APS 40 pi
Table 2.5. SDS-PAGE stacking gel recipes. 4x Upper buffer (2M Tris-HCl 
pH6 .8 , 1.6% (w/v) SDS). The volumes shown in the column are sufficient to 
make one Bio-Rad system mini gel.
2.2.2.4 Western blotting
After SDS-PAGE, proteins were transferred to a nitrocellulose membrane 
(Schleicher & Schuell) using the Genie blotting system (Idea Scientific 
Company). The SDS-PAGE gel and nitrocellulose membrane were embedded 
in a sandwich of 2 sheets of Whatmann 3MM paper with several Scotch pads 
on each side. Proteins were transferred at 4°C for 50min at a constant 25V in 
blotting buffer (20mM Tris-NaOH, 150mM glycine, 20% methanol). Transfer 
and equal protein loading was tested by Ponceau-S staining. Blots were 
blocked by incubating the membrane in PBS containing 5% (w/v) skimmed 
milk powder (Marvel) and 0.2% (w/v) TX-100 for lh at room temperature or 
overnight at 4°C. Membranes were then incubated with the primary antibody in 
PBS milk 0.2% (w/v) TX-100 for at least lh at room temperature, after which 
they were washed 3x in PBS milk 0.2% (w/v) TX-100 and then incubated with
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the HRP-conjugated secondary antibody (Amersham) diluted 1:2500 in PBS 
milk 0.2% (w/v) TX-100. Membranes were then washed 2x lOmin in PBS milk 
0.2% (w/v) TX-100 and then 5x 5min in 0.2% TX-100 (w/v) in PBS. After 
washing membranes were then incubated in enhanced chemiluminescence 
substrate (ECL, Amersham) for lmin before placing on a plastic or glass plate, 
covering in Saran wrap (Dow Chemical Company) and then exposing to film 
(XAR film, Kodak) in a dark room.
2.2.3 Cell culture
2.2.3.1 Maintenance of cultured cell lines
HEK293A cells were purchased from Invitrogen, ‘A’ designates that they have 
been clonally selected for adherence. Cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% (v/v) foetal calf 
serum (FCS), 4.8mM glutamine, 100,000U/L penicillin and 100U/L 
streptomycin. When the cells became confluent they were split and diluted out. 
For this, the cells were washed once with versene (0.02% (w/v) EDTA, 1% 
phenol red in PBS) and then incubated in trypsin / versene (0.05% (w/v) trypsin 
in versene) until the cells detached from the plastic. The cells were then either 
diluted into a new flask (a 1 : 1 0  dilution would normally be confluent again in 
3-4 days) or seeded into cell culture dishes for experiments.
2.2.3.2 Transient transfections
The following is based on 1 well of a 6  well dish. For more than one well, or 
for larger dishes, the amounts were simply scaled up. HEK293 cells were split
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as described in section 2 .2 .3.1, usually a day before transfection, counted using 
a Neubauer (Germany) grided microscope slide and seeded at a density of 
2xl05 cells per well. One hour before the addition of the transfection reagent, 
cells were placed in Opti-MEM (Invitrogen) or DMEM without antibiotics.
2pg of DNA plasmid was added to 750pl Opti-MEM. In a separate tube, 3 pi of 
the transfection reagent, Lipofectamine 2000 (Invitrogen), was added to 750pl 
Opti-MEM. After 5min the DNA and transfection reagent were mixed and then 
incubated at room temperature for s  20min. The cell culture medium was then 
aspirated and 1.5ml of the DNA transfection mix added to each well. The 
transfection mix was left on the cells for at least 6 h before returning the cells to 
their normal growth medium.
2.2.3.3 Storage and recovery of cultured cell lines
At the time of splitting the cells (section 2.2.3.1) for subsequent freezing, cells
were seeded in round, 10cm diameter, cell culture dishes. Once confluent, the 
cells from one 1 0 cm dish were placed in one vial as described below.
A ‘freezing solution’ of FCS containing 20% DMSO was prepared and 
incubated on ice. The cells were trypsinised as described in section 2.2.3.1, 
resuspended in 0.5ml of growth medium per 10cm dish and incubated on ice for 
5min. An equal volume of the freezing solution was then added and the cells 
aliquoted into the pre-labelled freezing vials (Nunc). Cells were first frozen at 
-80°C in a Cryo Freezing Container (Nalgene) filled with isopropanol to allow
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slow freezing (~1°C / min). After a week, the cells were transferred to liquid 
nitrogen for long term storage.
To recover the cells, aliquots were rapidly thawed using a waterbath at 37°C. 
Once the liquid around the edge of the tube had thawed just enough to loosen 
the ice plug in the middle it was transferred to a T75 flask containing 25ml 
growth medium at 37°C. The medium was replaced either later the same day or 
early the following day, depending on whether the cells had attached to the 
plastic.
2.2.4 Immunofluorescence
22mm square, number 1.5, coverslips were used for immunofluorescence. All 
steps were performed at room temperature. The coverslips were first 
pre-treated by covering them with 1 mg/ml poly-D-lysine and incubating them 
in it for >15min before washing 3 times with water. For subsequent staining 
with Rab antibodies or for automated GFP-LC3 puncta quantification, cells 
were first pre-permeabilised with either 0.05% or 0.0625% (w/v) saponin, 
respectively, in 80mM Pipes pH 6 .8 , ImM MgCL, 5mM EGTA for 5min 
before fixation. Cells were fixed using 3% (v/v) formaldehyde (Agar 
Scientific) in PBS containing 84pM MgCL and 96pM CaCl2 . Cells were then 
incubated in 50mM NH4CI for lOmin. For permeabilisation, cells were 
incubated in 0.2% (w/v) Triton X-100 (TX-100) in PBS for 5min. The 
coverslips were then washed 3 times in PBS and 3 times with 0.2% (w/v) 
Porcine Skin Gelatin in PBS and left in the last gelatin wash for at least 20min. 
The bottom of a plastic container was lined with wetted 3 MM paper
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(Whatmann) and a sheet of Parafilm (Pechiney Plastic Packaging, USA) placed 
on top of the paper. lOOpl droplets of antibody solution were placed onto it and 
then the coverslips placed, inverted, onto to the antibody solution. After 
washing 3 times with the gelatin solution, coverslips were then incubated with 
the secondary antibodies. Both the primary and secondary antibodies were 
diluted in the 0.2% gelatin solution. After incubation with the secondary 
antibodies the coverslips were washed 3 times with the gelatin solution, 3 times 
with PBS and then finally once with water. Coverslips were mounted using 
Mowiol 4-88 (Calbiochem). Slides were examined using a confocal laser 
scanning microscope (Zeiss) equipped with a 63x /1 .4NA plan- 
APOCHROMAT oil immersion objective lens and LSM510 software. Images 
were collected using the 493nm line of an argon laser and the 543nm and 
633nm lines of a helium-neon laser with 8x averaging.
2.2.5 Primary rat hepatocyte preparation and culture
2.2.5.1 Isolation of primary rat hepatocytes
Primary hepatocytes were isolated from approximately 300g male Wistar rats
by a two step collagenase perfusion method, according to Seglen (Seglen,
1976). See Figure 2.1 for a depiction of the perfusion setup. Wistar rats were 
first anaesthetised by an injection of 0.3ml / lOOg body weight of a solution of 
25% (v/v) Hypnorm (0.35mg/ml fentanyl citrate & lOmg/ml fluanisone, 
VetaPharma), 25% (v/v) Hypnovel (5mg/ml Midazolam, Roche) and 50% (v/v) 
water. The abdomen was opened just below the sternum and rib cage by a 
transverse incision using scissors, while the rat was lying on its back with its 
snout to the left. Care was taken to cut away from the rib cage so as not to
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puncture the diaphragm and to cut far enough so that blood / perfusate could 
drain away. The intestines were pushed to the far side and lOOOunits of heparin 
were injected into the right iliolumbar vein (Figure 2.2). Using a semi-circular 
surgical needle, a ligature was placed around the portal vein between the liver 
and the last tributary vein. The tube connected to the pump inlet of the 
perfusion apparatus was put into a bottle of 500ml perfusion buffer (150mM 
NaCl, 6mM KC1, lOmM HEPES, 4mM NaOH), the flow rate was set to 
20ml/min and the pump was switched on. The portal vein was then cut halfway 
through, approximately 5-10mm above the ligature, using fine surgical scissors. 
A cannula was inserted into the vein and secured in place using the ligature. 
Care was taken not to push the cannula past the first portal branch as this 
resulted in insufficient perfusion of the small lobes of the liver. Once the 
cannula was in place, the vena cava was cut to release the pressure of the 
perfusate flow and to sacrifice the animal. At this stage the perfusion buffer 
flow rate was increased to 50ml/min and the liver was removed from the 
carcass and placed into a glass funnel containing a metal mesh on top of a 
beaker. After most of the 500ml perfusion buffer had been used up, the glass 
funnel, containing the metal mesh and liver, was switched to a beaker 
containing 50ml collagenase buffer (12000units collagenase, 30mM CaCb, 
80mM NaCl, 3mM KC1, lOmM HEPES, 4mM NaOH). Collagenase buffer was 
recirculated through the liver for 8min before the liver was placed in a 10cm 
square dish with 37°C suspension buffer (55mM NaCl, 2mM KC1, ImM 
KH2PO4, ImM Na2S0 4 , 30mM HEPES, 30mM TES, 36mM Tricine, 50mM 
NaOH) and the cells were dissociated from the connective tissue using a metal 
toothed dog comb.
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The resultant suspension of cells was then filtered through a coarse 250pm 
nylon mesh to remove cell clumps and connective tissue debris. After a 30min 
incubation in a 20cm glass Petri-dish at 37°C with gentle rocking to allow the 
cells to recover from the perfusion, cells were cooled down to 4°C, filtered 
through a 250pm nylon mesh on top of a 100pm mesh and transferred into a 
125ml plastic beaker (Scientific Laboratory Supplies). Cells were then washed 
3x in wash buffer (perfusion buffer, containing ImM CaC^) with brief 
centrifugations steps in between (40g, 2min, 4°C). This washing procedure 
removed dead cells and separated the parenchymal cells from other cells of the 
liver, e.g. Kuffer cells. The isolated parenchymal cells were then either used in 
an autophagosome preparation or seeded in cell culture dishes.
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Figure 2.1. Perfusion apparatus. (1) Peristaltic pump. (2) Water-jacketed 
glass coil, connected to a circulating water bath to ensure that the perfusion and 
collagenase buffers are maintained at 37°C. (3) Bubble trap and cannula. (4) 
Liver support dish, a glass funnel with a metal mesh placed inside. (5) Buffer 
reservoir for the recirculation of the collagenase buffer. Figure reproduced 
from Seglen, 1993.
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Figure 2.2. Perfusion relevant liver anatomy. (1) Insertion site for the portal 
cannula. (2) Cannula aligned to the portal vein prior to insertion. (3) Heparin 
injection site, in the iliolumbar vein. Figure taken from Seglen, 1993.
2.2.5.2 Culturing of primary rat hepatocytes
Coverslips were coated with collagen en masse by placing them in a 15cm cell
culture dish, the bottom lined with a coarse nylon mesh, and covering them 
with a lOpg/ml collagen solution in 30% ethanol and leaving it to evaporate in 
the cell culture hood overnight.
After the final washes (see section 2.2.5.1) hepatocytes were diluted 1 to 5 in 
suspension buffer containing 20mM pyruvate and counted using a Neubauer 
(Germany) grided microscope slide.
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Isolated hepatocytes were cultured in Hepatozyme (Invitrogen) containing 
30ng/ml EGF, lOng/ml dexamethasone, 400ng/ml insulin and 10 g/ml 
collagen.
2.2.6 Preparation of rat liver Golgi stacks
Rat liver Golgi were prepared as described by Slusarewicz et al. (Slusarewicz et 
al., 1994). The procedure uses a discontinuous sucrose gradient made up of the 
sucrose solutions outlined in Table 2.6.
Solution A B C D E
Sucrose Concentration 0M 0.25M 0.5M 0.86M 1.3M
Table 2.6. Endosome preparation solutions. All sucrose solutions are diluted 
in 0.1 M potassium phosphate, pH 6.7, 5mM MgCb, 5pM pepstatin A with 1 
‘complete’ EDTA free protease inhibitor tablet (Roche) per 50ml.
Six discontinuous sucrose gradients were prepared consisting of 13ml of 
solution D underlain with 7.5ml of solution E in Beckman Ultraclear SW28 
tubes. Underlaying of solution E was performed using a syringe connected to a 
5 inch long metal needle.
Six female Sprague-Dawley rats were starved for 24h prior to the experiment. 
After sacrificing the rats by asphyxiation with CO2 followed by cervical 
dislocation, the livers were cut out using scissors and quickly immersed in 
200ml ice cold solution C and swirled and squeezed occasionally to expel any 
blood and to speed cooling. 36g of liver was placed into fresh solution C and
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cut into pieces to release as much blood as possible. Excess liquid was 
decanted to leave a volume of less than 80ml and the livers minced into small 
pieces, approximately 4-5mm square, using scissors. This material was 
homogenised by gently pressing it through a 150pm mesh steel laboratory sieve 
(Endecotts Ltd.) using the bottom of a 250ml conical flask. The homogenate 
was collected in a plastic dish. This relatively gentle method of 
homogenisation reduces the possibility of cisternal unstacking by mechanical 
shear (Hino et al., 1978). The homogenate was poured into a 100ml measuring 
cylinder and made up to a final volume of 80ml with solution C, then 
thoroughly mixed. 13ml of the homogenate was overlaid onto each of the six 
gradients and was topped up with solution B. These gradients were then 
centrifuged in a Beckman ultracentrifuge using a SW28 rotor at 28,000rpm for 
lh at 4°C. An aliquot of the homogenate was kept and snap frozen.
After centrifugation, the lipid layer on the surface of the gradient was removed 
by aspiration. The intermediate Golgi fraction from the interface between 
solutions C and D was collected using a Pasteur pipette and bulb 
(approximately 2-3ml from each gradient). The fractions from the six gradients 
were pooled and diluted to 8-9% (w/w) sucrose (0.25-0.28M) using solution A. 
The concentration was checked using a Delta refractometer (Bellingham and 
Stanley Ltd., UK). This intermediate fraction was poured into two SW28 tubes 
(Beckman) and topped up with solution B. An aliquot of the intermediate 
fraction was kept and snap frozen. To each tube 0.5ml of solution E was 
underlain, using a syringe coupled a 5inch long metal needle, to form a sucrose 
cushion. The tubes were then centrifuged at 7000rpm in an SW28 rotor for
96
Chapter 2, MATERIALS AND METHODS
30min at 4°C. The supernatant was removed by aspiration and the final 
membrane felt collected with a P200 Gilson pipette. This yielded 1-1.5ml of 
Golgi membranes, which were divided into lOOpl aliquots, snap frozen in 
liquid nitrogen and stored at -80°C. According to (Slusarewicz et a l , 1994), 
these membranes could be thawed and refrozen at least twice without 
significant change of morphology or loss of enzymatic activity.
2.2.7 Preparation of Endosomes from rat liver
Endosomes were purified from rat liver according to the protocol of (Ellis, 
1992), which essentially comprises of a continuous Ficoll gradient. The 
gradients were prepared the day before the experiment. Pre-dialysed Ficoll 
(Sigma; Cat. # F9378) was dissolved in water, 1ml water per gram of Ficoll. 
After the Ficoll had dissolved it was diluted until the refractive index was 1.37, 
to give a 25% (w/v) solution. 400mM TES pH 7.4, solid sucrose and 0.5M 
EDTA pH 7.4 were added to the 25% Ficoll solution to give 22% Ficoll, 
250mM sucrose, lOmM TES and ImM EDTA. Buffer STE (250mM sucrose, 
lOmM TES pH 7.4 and ImM EDTA pH 7.4) was used to dilute the 25% Ficoll 
to give a 1% Ficoll solution. 15ml of the 22% Ficoll was added to the chamber 
of a gradient maker closest to the exit tube and 15ml of the 1% Ficoll added to 
the other chamber. The 22% Ficoll chamber was stirred by means of a 
magnetic stir bar. 4ml of a 45% (w/v) Nycodenz (Axis-Shield, Norway) 
solution was placed into the bottom of a 39ml Quick-Seal centrifuge tube 
(Beckman, polyallomer, 25x89mm). The Ficoll gradient was overlaid onto the 
Nycodenz by connecting the gradient maker to a peristaltic pump and placing
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the tubing into the neck of the centrifuge tube such that the Ficoll solution 
dripped down onto the Nycodenz. To start pouring the gradient, the pump was 
turned on and the tap separating the chambers opened simultaneously. Once 
poured the gradients were left to sit at 4°C overnight in order to let them smooth 
by diffusion.
In a modification of the Ellis et al. protocol, in order to mark the late 
endosomes the liver was perfused with HRP-biotin prior to excision. The HRP- 
biotin conjugate was made using a Biotin-X-NHS coupling kit (Calbiochem) 
according to the manufacturer’s instructions and then dialysed overnight against 
PBS using ‘Snake Skin’ dialysis tubing (Pierce) with a lOkDa cut off. The 
initial perfusion was as described in section 2.2.5.1. After the perfusion buffer 
had been mostly used up, instead of recirculating the collagenase solution HRP- 
biotin was re-circulated for lOmin and then perfusion buffer was recirculated 
for 20min in order to chase the HRP-biotin into late endosomes.
After the HRP-biotin perfusion the liver was transferred to a beaker containing 
3ml/g liver of ice cold STM buffer (250mM sucrose, l OmM TES pH 7.4, ImM 
MgCb). The liver was then homogenised in a 4°C cold room using a Potter 
Elvejhem homogeniser (Thomas Scientific) fitted with a Teflon pestle rotating 
at 2400rpm, with three complete up and down strokes. The homogenate was 
then centrifuged at 1500g for lOmin at 4°C. The resulting post nuclear 
supernatant (PNS) was loaded on top of the Ficoll gradients, 5ml per gradient, 
using a syringe coupled to a 5 inch long blunt ended needle. The tubes were 
then heat sealed closed and centrifuged in a VTi50 rotor (Beckman) at
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50,000rpm (206,000g) for lh  at 4°C using slow initial acceleration and no 
braking for deceleration. After centrifugation, the top of each tube was 
removed using a scalpel. Working in a 4°C cold room, a 2mm diameter 
stainless steel tube was passed down to the bottom of the centrifuge tube. The 
metal tube was connected via a peristaltic pump to a fraction collector. The 
pump speed had been pre-calibrated to run at ~lml/min with water and the 
fraction collector was programmed to move to the next tube every 60sec, 
however the differing viscosities of the Ficoll across the gradient meant that 
there was variability in the volume of fractions collected. Approximately 30 
fractions were collected in total from each gradient, as this facilitated SDS- 
PAGE analysis using two 15 well gels. Fractions were snap frozen in liquid 
nitrogen and stored at -80°C.
2.2.8 Purification of autophagosomes
Autophagosomes were isolated from rat liver according to the protocol of 
Stromhaug et al. (Stromhaug et a l, 1998). Hepatocytes were prepared from 
starved male Wistar rats by the collagenase perfusion method described in 
section 2.2.5.1. After washing, the hepatocytes from one liver were suspended 
in suspension buffer containing pyruvate (20mM) and Mg2+ (2mM) to a final 
volume of 48ml. The cells were distributed as 0.4ml aliquots in 120 centrifuge 
tubes and incubated, with shaking at 200rpm, at 37°C for 2h, in the presence of 
50pM vinblastine to induce autophagosome accumulation. The cells were then 
washed twice in 10% (w/v) unbuffered electrolyte free sucrose, resuspended in 
10% (w/v) unbuffered sucrose to the original volume (48ml) and
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electrodisrupted, as 3ml aliquots, by a single high voltage pulse (2kV, 1,2pF 
using a BioRad Gene Pulser II). The disruptates were pooled and mixed with 
0.48ml of homogenisation buffer concentrate (1M Hepes / 0.1M EDTA) and 
homogenised using a Dounce homogeniser (Wheaton) and the result checked 
by trypan blue staining. Usually 20 strokes were required for greater than 90% 
breakage. The homogenate was diluted with 24ml of homogenization buffer 
(HB; 0.25M sucrose, lOmM Hepes, lmM EDTA, pH 7.3) containing 1.5mM 
glycyl-L-phenylalanine 2-naphthylamide (GPN) to a final GPN concentration 
of 0.5mM. After incubation for 7min at 37°C to destroy the lysosomes, the 
homogenate was cooled to 4°C, and the rest of the procedure was performed at 
this temperature. Four tubes each containing 18ml of GPN treated homogenate 
were centrifuged at 2000g for 2min to obtain a nuclear pellet and a supernatant. 
The nuclear pellets were washed once in 4ml of HB, and the supernatants 
(16ml) were combined with the previous one (72ml) to give a single PNS. The 
PNS was loaded on top of a discontinuous (two step) Nycodenz gradient, 
prepared by diluting isotonic (36% w/v) Nycodenz with HB to obtain a top 
layer of 17ml of 9.5% Nycodenz (1.072g/ml) and a bottom layer of 7ml of 
22.5% Nycodenz (1.127g/ml). The Nycodenz gradient was centrifuged for lh 
at 141000g in an SW28 rotor (Beckman). The band at the interface of the two 
Nycodenz concentrations, which contained the autophagosomes, was collected, 
diluted with 5ml of HB and layered on top of a discontinuous gradient of 21ml 
of 33% Percoll in HB on top of 7ml cushion of 22.5% Nycodenz in HB 
(1.127g/ml) and centrifuged for 30min at 72000g in the SW28 rotor. The 
autophagosomes banded at the lower interface and were recovered using a 
Pasteur pipette. The ER banded at the upper interface. Percoll was removed
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from the autophagosomes by mixing 5ml of the fraction with 3.5ml of isotonic 
60% (w/v) OptiPrep (iodixanol; Axis-Shield) in water, overlaying with 1.5ml of 
30% iodixanol and a top layer of 2.5ml of HB and centrifuging for 30min in a 
SW40 rotor (Beckman) at 71000g. The Percoll particles (colloidal silica) 
sedimented to the bottom of the tube, whereas the autophagosome band, formed 
at the iodixanol / HB interface. The autophagosomes were recovered using a 
Pasteur pipette.
Various fractions were collected from across the different preparation gradients 
for subsequent SDS-PAGE analysis. ‘Cytosol’ from the top of the Nycodenz 
gradient, AV / ER from the interface and a crude mitochondrial / peroxisomal 
pellet from the bottom of the Nycodenz gradient. ER was collected from the 
continuous Percoll gradient.
2.2.9 RNAi
2.2.9.1 Lipid based reagent mediated siRNA transfections
2.2.9.1.1 Reagents
For immortalised cultured cell lines, e.g. HEK293 cells, double stranded ~20 
nucleotide base pair RNA molecules were used, their entry into the cells 
mediated by lipid based reagents. A pool of four small interfering RNA 
(siRNA) oligonucleotide duplexes against Atg9Ll, termed a SMART pool, was 
purchased from Dharmacon (USA) and were designed using their proprietary 
algorithm. The four sequences were termed individual duplexes (ID) 1-4 and 
corresponded to DNA sequences:
ID1: GAAAATGGCTCCCTTATCA
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ID2: GT AC AT G A ATT GCTTCTTG 
ID3: AAG AAT GGCTT C AC AT GT A 
ID4: GGACCTGGCTCTCTGTTTC
The most effective, ID2, was often used alone. As a control a scrambled 
version of this sequence was produced using the Wistar siRNA selector 
(http://bioinfo.wistar.upenn.edu/siRNA/siRNA.htm) and designated Sc2: 
TACCTTTAGCATGATGTGT. When more than one siRNA had to be 
controlled for a Dharmacon non-targeting SMART pool was used.
siRNAs corresponding to ULK1, Atg5, Beclinl, Atg7, Atgl2 and Syntenin 
were purchased from the Dharmacon siGenome catalogue.
2.2.9.1.2 siRNA transfection protocol
The siRNA oligonucleotide SMART pools and individual duplexes were used 
at a final concentration of 25nM. The following is based on 1 well of a 6 well 
dish. For more than one well, or for larger dishes, the amounts were simply 
scaled up. HEK293 cells were split as described in section 2.2.3.1, the day 
before transfection, counted using a Neubauer (Germany) grided microscope 
slide and seeded at a density of 5x104 cells per well. A sufficient volume of the 
siRNA stock was added to 175pl Opti-MEM. In a separate tube, 2|nl of the 
transfection reagent, Oligofectamine (Invitrogen), was added to 15 pi Opti- 
MEM. After 5min the DNA and transfection reagent were mixed and then 
incubated at room temperature for ^ 20min. During this time the cells were
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washed once with Opti-MEM (Invitrogen) and finally placed in 800pl 
Opti-MEM. After the 20min incubation the siRNA transfection mix was added 
to each well. The transfection mix was left on the cells for at least 4h before 
returning the cells to their normal growth medium.
2.2.9.2 Adenovirus mediated RNAi
2.2.9.2.1 Reagents
For cultured primary rat hepatocytes, RNAi knockdown was conducted using 
the pMIGHTY adenovirus system (Viraquest Inc., USA). The Atg9Ll specific 
19 base sequence ID2 was incorporated into a synthetic 63mer oligonucleotide 
designed for hairpin RNA expression. Sense and anti-sense oligonucleotides 
were annealed and subsequently inserted into the pMIGHTY plasmid. The 
63mer’s sequence was: TT AAAGT AC AT G AATT GCTT CTTGTT C A AG AG A 
C AAG AAGC A ATT CAT GT ACTTTTT GG AAAG. A second sequence with a 
single guanine base deletion in the anti-sense strand was used as a control and 
was designated AG. The adenovirus was prepared using these pMIGHTY 
constructs by Viraquest Inc. and the final amplified and purified virus was 
purchased from them.
2.2.9.2.2 Infection protocol
The rat hepatocytes were infected with the pMIGHTY adenovirus three hours 
after seeding. The cells were incubated with the virus overnight and the 
medium exchanged in the morning. When applicable, cells were infected with 
GFP-LC3 adenovirus (Kochi et al., 2006) 48h after infection with the
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knockdown viruses. 72h after the initial infection the cell culture medium was 
either exchanged for fresh medium or Earle’s Saline (ES). Cells were starved 
for 2h before being fixed and processed for microscopy or extracted for protein 
gel analysis.
2.2.10 Protein degradation assay
Protein degradation assays were carried out and analysed as described 
(Gronostajski and Pardee, 1984). Cultured primary rat hepatocytes were treated 
with pMIGHTY adenoviruses as described in the beginning of section 2.2.9.2.2. 
The day after seeding, cells were placed in growth medium containing [14C]- 
valine (0.2 pCi/mL) and 65 pM ‘cold’ valine and incubated for 18h. Cells were 
then washed 3x in PBS at 37°C to remove unincorporated isotope and then 
chased overnight with full growth medium, containing 2mM valine (to prevent 
reincorporation of isotope into newly synthesised proteins). Next day cells 
were washed 3x in PBS at 37°C and then incubated in either Earle’s saline (ES) 
or full growth medium containing 2mM valine for 2h. Aliquots of the medium 
were removed at various time points during the 2h and trichloroacetic acid 
(TCA) precipitated, 10% TCA 1% phosphotungstic acid final. After 
centrifugation at 6000g for lh at 4°C, the TCA soluble fraction was added to 
10ml of Ultima-Gold scintillation fluid (Perkin-Elmer) and the amount of 
radioactivity present quantified using a scintillation counter (Beckman). After 
the 2h starvation, the cells were washed 3x with PBS at 37°C and lysed using 
1% TX-100 in PBS at 4°C, TCA precipitated and centrifuged at 6000g for lh at 
4°C. The pellet was resuspended in 9M urea, with the aid of sonication, and 
then added to 10ml of scintillation fluid and counted. For analysis, the amount
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of radioactivity in the cell culture medium was expressed as a percentage of the 
amount of radioactivity in the cells and medium combined.
2.2.11 High throughput microscopy
For the counting of GFP-LC3 positive puncta, cells were treated prior to 
fixation with 0.0625% (w/v) Saponin in 80mM PIPES pH 6.8, lmM CaCl2, 
5mM EGTA. Low magnification images were acquired with an automated 
high throughput Discovery-1 microscope (Molecular Devices). The 
microscope was equipped with a 20X, 0.75NA, S-Fluor objective lens and 
DAPI and GFP filter sets (Chroma). 16 images (a 4x4 grid) per coverslip were 
automatically captured using Metamorph 6.2 software (Molecular Devices).
The microscope was set up to focus automatically using the built in image 
based focusing algorithm with the following settings: Find 200nm, Wide 
200nm, Narrow 8nm.
2.2.12 Conventional electron microscopy and quantification of 
autophagosomes
Primary rat hepatocytes isolated by the procedure described in section 2.2.5
were seeded in 6 well dishes at a density of 7.5xl05 - lxlO6 cells per well.
Cells were infected with adenovirus as described in section 2.2.9.2.2 and 
starved for 2h in ES before fixation in 2.5% glutaraldehyde in 0.1 M Sorensen’s 
buffer, pH 7.4. They were then washed 3x in Sorensen’s buffer, scraped off the 
culture dish in 1% gelatin, pelleted and post fixed with 1% 0 s04  for 30 min. 
The cells were then dehydrated by incubating the pellet in increasing 
concentrations of ethanol, from 70% to 100%, before incubating overnight in
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50:50 epon:ethanol and finally embedded in AgarlOO resin (Agar Scientific). 
Sections were contrasted with 2% uranyl-acetate and lead-citrate and examined 
with a JEOL 1200 electron microscope. EM images were acquired with a 
GATAN Multiscan 600CW camera. Images were captured using conventional 
random sampling techniques. Approximately 30 pictures were taken for each 
condition, manually excluding images with grid bars or other non-relevant 
material. EM was performed by Dr. Xiao Wen Hu (Cancer Research UK). The 
samples were assessed in a double blind fashion. AVis and AVds were 
distinguished using well documented criteria (Eskelinen, 2004). Both AV area 
and cytoplasmic area were measured by grid point counting.
2.2.13 Immuno-electron microscopy
For subsequent immuno-labelling with anti-Atg9Ll antibodies, cells were fixed 
in 4% PFA in 0 .1M Sorensen’s buffer (pH 7.4) for lh  at room temperature. 
Cells were then processed as previously described (Tokuyasu, 1973). Sections 
were labelled with anti-GM130 (1:10 dilution), Atg9Ll (1:40 dilution) or anti- 
CI-MPR (1:25 dilution) followed by gold conjugated secondary antibodies or 
protein A gold. Immuno-electron microscopy was performed by Dr. Xiao Wen 
Hu (Cancer Research UK).
2.2.14 In vivo glycosylation analysis
HEK293 cells were transfected, as described in section 2.2.3.2, with one of four 
plasmids; (1) wt sequence Atg9Ll HA-tagged at the N-terminus (HA-Atg9Ll), 
(2) HA-Atg9Ll N99D mutant, (3) HA-Atg9Ll double mutant N224D and
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N507D, and (4) HA-Atg9Ll triple mutant N99D, N224D and N507D. 16h 
after transfection cells were homogenised using a ball bearing based cell 
cracker and the homogenate centrifuged at 2200g for lOmin at 4°C. The 
resulting PNS was centrifuged at 45000rpm in a TLA45 rotor (Beckman) for lh 
at 4°C to pellet the membranes. The membrane pellet was resuspended in PBS 
containing protease inhibitors (50pg/ml Chymostatin, 0.5pg/ml Leupeptin, 
50pg/ml Antipain, 0.5pg/ml Pepstatin A and 0.1 jig/ml Pefabloc (Roche)) and 
treated with glycosidase enzyme PNGase F (New England Biolabs (NEB), 
USA) as per the manufacturer’s instructions. The samples were analysed by 
SDS-PAGE and Western blotting. As throughout this thesis, samples for 
subsequent Atg9Ll detection were not boiled in the SDS-PAGE sample buffer.
2.2.15 In vitro topology analysis
In vitro transcription was performed using T7 RNA polymerase (Promega) and 
the RNA obtained was purified using an RNeasy purification kit (Qiagen). The 
mRNA was translated in a rabbit reticulocyte lysate system (Promega) for 
15min at 30°C in the presence of [35S]-methionine and ER microsomes. After 
15min, aurintricarboxylic acid was added (0.1M final) to inhibit translation 
initiation and then lOmin later translation was terminated by the addition of 
cyclohexamide (2mM final). After the in vitro translation, the reaction mix was 
loaded on top of a High Salt Cushion (HSC; 250mM sucrose, 0.5M KOAc, 
5mM Mg(OAc)2, 50mM HEPES KOH pH 7.9) and centrifuged at 55000rpm in 
a TLA100 rotor (Beckman) for lOmin at 4°C. The pellet was resuspended in 
Low Salt Cushion (LSC; 50mM sucrose, lOOmM KOAc, 5mM Mg(OAc)2, 
50mM Hepes KOH pH 7.9) and treated with either endoglycosidase H (Endo
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H, NEB) or proteinase K. Treatment with EndoH was carried out as per the 
manufacturer’s instructions. Proteinase K treatment took place in the presence 
or absence of 1% (w/v) TX-100. To stop the proteinase K activity, the 
reactions were TCA precipitated (10% TCA, 25% acetone final) then washed 
with ice cold acetone and resuspended in immunoprecipitation (IP) buffer 
(20mM Tris/HCl, pH 7.5, 150mM NaCl, 5mM EDTA, 0.3% TX-100). For IP 
samples were incubated with antibody overnight at 4°C rotating end over end. 
Then protein A Sepharose beads (Amersham Pharmacia Biotech) were added 
and incubated for at least 4h at 4°C rotating end over end. Protein A-Sepharose 
bound material was isolated by centrifugation at 16000g for lmin and washed 
four times with IP buffer. The bound material was eluted with SDS-PAGE 
sample buffer and analyzed by SDS-PAGE and autoradiography.
2.2.16 Real Time PCR
Total RNA was purified from cells using RNeasy mini kit (Qiagen). cDNA 
was reverse transcribed using the Superscript II kit (Invitrogen) and amplified 
using ULK1 primers (AGATGTTCCAGCACCGTGAG; 
ACAGCTTGCACTTGGTGACG) and |3-Actin, normalising control, primers 
(AGACCTGTACGCCAACACAG; AGGAGGAGCAATGATCTTG). mRNA 
was quantified using the MJ Research (USA) Chromo4 Real Time PCR system 
and SYBR Green (Applied Biosystems, USA). Fold changes in mRNA levels 
were determined by the ratio of |3-Actin normalized amplicon numbers between 
ULK1 siRNA and mock treated cells.
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RESULTS
3 Localisation of Atg9Ll
3.1 Aim
As a previously uncharacterised protein and at the time that this work began 
still a hypothetical one in the international bioinformatics protein databases 
(such as the National Centre for Biotechnology Information (NCBI) database at 
the National Institute for Health (NIH), USA) the localisation of Atg9Ll was 
unknown. Before starting to investigate this, it was first of all ensured that the 
ATG9L1 gene is ubiquitously expressed, throughout different tissues, and 
therefore of wide relevance. Once this was established, antibodies were raised 
against Atg9Ll to allow the investigation of the endogenous protein, in 
particular its localisation. To which membrane compartment Atg9Ll localises 
in mammalian cells is interesting because Atg9Ll is predicted to be a 
transmembrane protein. As a transmembrane protein Atg9Ll could only 
participate in autophagy by being resident on the membrane which forms the 
autophagosome or by trafficking from the membrane to which it normally 
resides to autophagosomes. Therefore there must be at least a contribution 
from the membrane to which Atg9Ll normally resides to autophagosomes and 
autophagy.
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3.2 Expression levels of ATG9L1 in different tissues
The distribution of Atg9Ll expression in different tissues was assessed by
Northern blotting analysis. A poly-A RNA northern blot was purchased from 
Ambion and was probed with a fragment corresponding to the 3’ region of the 
ATG9L1 open reading frame. ATG9L1 was ubiquitously expressed across the 
different tissue types present on the blot but showed the highest level of 
expression in skeletal muscle, heart and placenta (Figure 3.1). This is in stark 
contrast to ATG9L2, which is only expressed in the placenta and the pituitary 
gland (Yamada et al., 2005).
3.3 Development of Atg9Ll antibodies
Antisera were raised against Keyhole Limpet Haemocyanin (KLH) conjugated 
peptides. These peptides corresponded to the N- and C-terminal ~20 amino 
acids of Atg9Ll as well as an internal sequence, corresponding to amino acids 
338-357, located just after the 3rd predicted transmembrane domain (TMD) (see 
chapter 4 for analysis of Atg9Ll topology). See Materials and Methods, 
chapter 2, for the full peptide sequences. The N-terminal antiserum was 
designated ST0215, the internal ST0217 and the C-terminal antisera ST0218 
and 219. ST0214 and ST0216, additional N-terminal and internal peptide 
antisera respectively, were abandoned before reaching the terminal bleed stage. 
Although the amino acid sequences used for the peptides are conserved in rat 
and human they are not found in the homologous protein Atg9L2, described by 
Robb et al. (Robb et al., 2004). When used to probe Western blots of either
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Figure 3.1. Atg9Ll transcript levels in various different tissues. A poly-A 
Northern blot (Ambion) was probed with a radioactive probe ([ P]-dCTP) 
corresponding to 1771-2278bp of the^TGPLf open reading frame. Including 
UTRs the HsATG9Ll mRNA is ~3.8kb. The blot was tested by the 
manufacturer for equal loading.
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HEK293 cell lysate or primary rat hepatocyte lysate, two of the affinity purified 
antibodies recognised the same fuzzy band of approximately lOOkDa (Figure 
3.1 and e.g. Figure 3.8 for the rat protein). ST0219 also reacted with two other 
bands just below the lOOkDa fuzzy band. However, these two bands were not 
diminished by siRNA treatment whereas the fuzzy band at lOOkDa was 
completely ablated (Figure 3.2). Lysates from HEK293 cells, which had been 
transfected with a HA tagged Atg9Ll cDNA, probed with an anti-HA 
monoclonal antibody also gave a fuzzy band at lOOkDa (see chapter 4, Figure 
4.3D).
Taking the fact that two separate antibodies recognise the same fuzzy band, in 
human as well as rat cells. In addition, that this band is of the same size as that 
from an ecotopically expressed ATG9L1 cDNA. Then finally, that this band 
and not any other is diminished upon siRNA mediated knockdown of the 
ATG9L1 mRNA. Taken together these data indicate that the fuzzy band at 
lOOkDa picked up by both the STO215 and 219 antisera is Atg9Ll.
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Figure 3.2. Testing the various Atg9Ll affinity purified rabbit antibodies. 
HEK293 cells were treated with siRNA duplexes as described in Materials and 
Methods, section 2.2.9.1. Cells were lysed at the stated time points after 
transfection and knockdown efficiency analysed by SDS-PAGE and Western 
blotting. Blots were stripped and reprobed for Actin to ensure equal loading 
per lane. C = control siRNA, 96h time point shown. The numbers above the 
panels refer to hours post siRNA transfection.
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3.4 Atg9Ll localises to the trans-Golgi network
In immunofluorescence in HEK293 cells the anti-Atg9Ll antibodies revealed
two pools of staining, a juxta-nuclear pool as well as a more peripheral punctate 
pool (Figure 3.3A). Ectopically expressed HA tagged Atg9Ll gave a similar 
localisation pattern (Figure 3.3B). The staining produced by the anti-Atg9Ll 
antibodies was shown to be specific by siRNA mediated knockdown, which 
ablated both pools of staining (Figure 3.3C).
In order to determine which organelle(s) Atg9Ll localises to, colocalisation 
was attempted against a panel of antibodies raised against marker proteins for 
various organelles. Atg9Ll partially colocalised with EEA1, a marker for early 
endosomes (Mu et al., 1995). It showed little colocalisation with LAMP-2, a 
marker for late endosomes and lysosomes but predominantly associated with 
lysosomes (Chen et al., 1985; Lippincott-Schwartz and Fambrough, 1987). 
There was no colocalisation of Atg9Ll with PDI (Protein Disulphide 
Isomerase), a protein resident in the ER (Turano et al., 2002). Whereas Atg9Ll 
did colocalise to some extent with a marker of the ER Golgi Intermediate 
Compartment (ERGIC) p58 (Appenzeller-Herzog and Hauri, 2006), Figure 3.4. 
Atg9Ll also colocalised to some extent with a marker of the cis / medial Golgi, 
GM130 (Nakamura et al., 1995). The juxta-nuclear Atg9Ll pool colocalised 
best, however, with a marker of the trans Golgi Network (TGN), TGN46 
(Ponnambalam et al., 1996).
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Figure 3.3. Characterisation o f the Atg9Ll antibodies in immunofluorescence. 
(A) HA tagged Atg9LlcDNA was transiently transfected into HEK293 cells as 
described in Materials and Methods, section 2.2.3.2. After fixation, cells were 
probed with the anti-Atg9Ll antibodies ST0215 and ST0219, directly coupled 
to fluorescent dyes Alexa555 and 488, respectively. (B) A separate set of cells, 
also transiently transfected with HA-Atg9Ll, were probed with anti-HA and 
ST0219 antibodies. (C) Cells were treated with either control or Atg9Ll 
siRNA duplexes as described in Materials and Methods, section 2.2.9.1, and 
probed with STO219. Scale bars = 10pm.
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Figure 3.4. Assessing the colocalisation of Atg9LI with various 
endomembrane markers. EEA1 is a marker of early endosomes; LAMP-2, late 
endosomes and lysosomes but predominantly lysosomes; PDI, ER; p58, ER
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Golgi intermediate compartment (ERGIC); GM130, cis / medial Golgi; TGN46, 
trans Golgi network (TGN). Scale bars = 10pm.
From the colocalisation of the juxta-nuclear pool of Atg9Ll with Golgi markers 
in immunofluorescence it seemed that this pool represented the Golgi.
However, due to the limit of resolution imposed on light microscopy by the 
wavelength of the light itself, it remains impossible to discriminate between 
membranes of the Golgi stack and those of the TGN by immunofluorescence 
microscopy alone (Banting and Ponnambalam, 1997). This limitation of 
immunofluorescence microscopy can be circumvented by incubation of cells 
with the fungal metabolite brefeldin A (BFA). As mentioned in the 
introduction (section 1.3.2.3) BFA causes the Golgi cistemae to collapse back 
into the ER and the TGN to redistribute into endosomes. Hence BFA can be 
used to determine to which Golgi compartment a protein localises. After BFA 
treatment of HEK293 cells the Atg9Ll staining fragmented (Figure 3.5B) and 
this fragmented staining seemed to colocalise most readily with TGN46.
The juxta-nuclear position of the Golgi is maintained by its association with the 
microtubule organising centre (MTOC) and the influx of ER derived vesicles 
along microtubules into this region (Rios and Bomens, 2003). Another method 
to the same end as BFA treatment is to treat cells with nocodazole, a 
microtubules depolymeriser. In the presence of nocodazole the Golgi forms 
mini stacks at ER exit sites (Cole et al., 1996). Treatment of the HEK293 cells
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with nocodazole caused a relocalisation of Atg9Ll into a discrete punctate 
distribution, which colocalised better with TGN46 than GM130 (see Figure 
3.5C, the inserts in the bottom right comers of the merge pictures are digitally 
zoomed in using the LSM510 software). Taken together, the BFA and 
nocodazole experiments indicate that Atg9Ll localises to the TGN.
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Figure 3.5. BFA and nocodazole treatment ofHEK293 cells to determine 
whether the juxta-nuclear pool ofAtg9Ll corresponds to medial or trans Golgi. 
HEK293 cells were treated with (B) brefeldin A (BFA) for 30min or (C) 
nocodazole (noc) for lh  prior to fixation. (A) No drug treatment. Scale 
bars = 10pm.
119
RESULTS -  Chapter 3, Localisation of Atg9Ll
To confirm the localisation data from immunofluorescence, Golgi membranes 
were purified from rat liver according to the protocol of Slusarewicz et al. 
(Slusarewicz et al., 1994). This procedure essentially consisted of running 
freshly prepared rat liver homogenate on a discontinuous sucrose gradient 
followed by pelleting the Golgi membranes onto a sucrose cushion. On gels 
loaded with an equal amount of total protein per lane Mannosidase II (Mann II; 
a Golgi resident glycosidase enzyme (Dewald and Touster, 1973)) showed an 
enrichment in the purified Golgi fraction, confirming that the Golgi preparation 
was successful (Figure 3.6). Also on gels loaded with an equivalent volume of 
each fraction per lane, Mann II was present at a reasonable intensity in the final 
purified Golgi. The ERGIC marker p58 behaved in the same way as the Mann 
II, in that it was enriched in the final purified Golgi. However, the TGN marker 
TGN38, the rat equivalent of TGN46 (Banting and Ponnambalam, 1997; Luzio 
et al., 1990), was not enriched in the final purified Golgi and on gels loaded 
with an equivalent volume of each fraction per lane TGN38 was absent from 
the final purified Golgi fraction. TGN membranes are known to be largely 
separated from the Golgi cistemae by this preparation, being present at only 10- 
15% of their original level in the final purified Golgi fraction (Nakamura et al., 
1995). The procedure therefore purifying only the Golgi cistemae. Atg9Ll 
behaved in a similar manner to TGN38 on gels loaded with an equivalent 
volume of each fraction per lane, again congment with the previous 
immunofluorescence data indicating that Atg9Ll is localised to the TGN.
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Figure 3.6. Distribution ofAtg9Ll between the Golgi preparation fractions. 
Golgi membranes were purified from rat liver as described previously 
(Slusarewicz et al., 1994). Aliquots of the original liver homogenate, the 
intermediate fraction (crude Golgi membranes) and the purified Golgi cistemae 
were collected and probed with antibodies to ERGIC / p58, mannosidase II 
(Mann II), TGN38 (rat equivalent of TGN46) and Atg9Ll. For the gels loaded 
with an equivalent volume of each fraction per lane l/20th of the volume of the 
homogenate was loaded. The data is representative of two independent 
experiments.
Final confirmation that Atg9Ll is localised to the TGN came from immuno- 
electron microscopy (immuno-EM) analysis, Figure 3.7. Atg9Ll was detected 
on vesicles in close proximity to the Golgi cistemae, which are most likely 
TGN derived vesicles. The Golgi cistemae are labelled by GM130, 
unfortunately the TGN46 antibody did not work in immuno-EM.
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Figure 3.7. Immuno-electron microscopy analysis shows Atg9Ll on TGN 
membranes. (A) Immuno-gold labelling of Atg9Ll (lOnm gold, arrows) and 
GM130 (5nm gold, arrowheads (left panel)) in HEK293 cells. (B) Rat 
hepatocytes labelled with Atg9Ll (lOnm gold, arrows). G = Golgi. Scale bars = 
200nm.
Taking the immunofluorescence, subcellular fractionation and immuno-EM 
data together I conclude that the juxta-nuclear pool of Atg9Ll corresponds to 
TGN.
fi
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3.5 Endosomal localisation of Atg9Ll
3.5.1 Subcellular fractionation
Having shown that the juxta-nuclear pool of Atg9Ll overlaps with TGN 
membranes, the identity of the peripheral Atg9 pool was then addressed. It 
seemed reasonable to suppose that the compartment might be endosomal as 
TGN proteins, e.g. TGN38/46, have previously been described to traffic via 
endosomes (Maxfield and McGraw, 2004). Also, MPR cycles from the TGN to 
endosomes delivering lysosomal hydrolyses (Bonifacino and Rojas, 2006).
An endosome preparation was undertaken according to the protocol of Ellis, et 
al. (Ellis, 1992). This protocol uses fresh rat liver and involves loading liver 
homogenate post nuclear supernatant (PNS) onto a continuous gradient of 1- 
22% Ficoll with a Nycodenz cushion at the bottom (Materials and Methods, 
section 2.2.7). After centrifugation of the gradient, the protocol goes on to 
collect the fractions containing the endosomes and concentrate them by 
pelleting. However, here the fractions from the Ficoll gradient were simply 
collected and then run out a SDS-PAGE gel, blotted and the blot membrane 
probed with antibodies for various endomembrane markers and for Atg9Ll 
(Figure 3.8). The distribution of Atg9Ll across the gradient could then be 
compared to the endomembrane markers. To mark the position of the late 
endosomes on the gradient the liver was perfused in situ, by cannulation of the 
portal vein (Materials and Methods, section 2.2.5.1), with an HRP-biotin 
conjugate. The HRP-biotin solution was recirculated through the liver for 
lOmin and subsequently chased for 20min with perfusion buffer. The early
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endosomes were detected by probing the Western blot for EEA1. The early 
endosomes banded towards the top of the gradient. The late endosomes, as 
marked by the HRP-biotin and detected using ExtrAvidin-HRP (Amersham), 
overlapped to some extent with the early ones but came to a separate peak 
intensity as revealed by densitometry quantification. Atg9Ll’s peak intensity 
across the gradient was in the same fraction as the peak intensity for the late 
endosomes, fraction 24. CI-MPR came to a peak intensity in a neighbouring 
fraction, fraction 22. Not unexpectedly, TGN38 overlapped to some extent 
with the late endosome peak. However, its peak of intensity was in a heavier 
fraction, fraction 20. The Atg9Ll peak displayed a large shoulder towards the 
denser end of the gradient, which overlapped with the TGN peak. From this 
gradient then it would seem that Atg9Ll is overlapping with both the TGN and 
late endosomes.
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Figure 3.8. Distribution ofAtg9Ll across the endosomepreparation gradient 
fractions. Fresh rat liver homogenate PNS was loaded on top of a continuous 
Ficoll gradient and after centrifugation fractions were collected. The liver had 
first been perfused, in situ, with a HRP-biotin (HRP-B) conjugate for lOmin 
followed by a 20min chase in order to label the late endosomes. EEA1 is a
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marker of early endosomes; p58, ERGIC; PDI, ER. Samples of each fraction 
were analysed by SDS-PAGE and Western blotting analysis. Quantification by 
densitometry is shown in the graphs below.
3.5.2 Atg9Ll colocalises with the late endosomally associated Rab 
proteins 7 & 9
In order to assess the endosomal localisation of Atg9Ll in HEK293 cells, 
Atg9Ll ’s distribution was compared to relevant Rab proteins (see introduction, 
section 1.3.2.8, for information on Rab proteins). In the first instance, the 
localisation of Atg9Ll was compared to GFP conjugated Rabs 4, 5, 6, 7, 9 and 
11. The early endosomal Rab proteins, GFP-Rab4, 5, and 11 (Chavrier et al., 
1990; Ullrich et al., 1996; Van Der Sluijs et al., 1991), showed little 
colocalisation with Atg9Ll (data not shown). The TGN localised GFP-Rab6 
(Antony et al., 1992) showed good colocalisation with Atg9Ll (as expected 
from section 3.4), Figure 3.9A. Both GFP-Rab7 and GFP-Rab9, which localise 
to distinct populations of late endosomes (Barbero et al., 2002), colocalised 
well with Atg9Ll (Figure 3.9B & D). In addition, good colocalisation was 
observed between endogenous Rab7 and Rab9, and Atg9Ll (Figure 3.9C & E). 
Note that endogenous Rab7 was detected after permeabilisation with a low 
concentration of saponin, prior to fixation, to extract the confounding cytosolic 
proportion of the Rab7 protein.
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1
Figure 3.9. Colocalisation of Atg9LI with endosomally associatedRabs 7 & 9. 
HEK293 cells were transiently transfected with GFP-Rab6 (A), GFP-Rab7 (B) 
and GFP-Rab9 (D), then 24 h later fixed and labelled with the Atg9Ll 
antibody. Cells were also labelled with antibodies to endogenous Rab7 (C) and 
9 (E), the inset is an enlargement of the area of the merge defined by the white 
box to show the peripheral staining. For Rab7 staining, cells were extracted 
using 0.05% (w/v) saponin before fixation. Scale bars =10 pm.
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Final confirmation that Atg9Ll is localised to late endosomes came from 
immuno-EM analysis, Figure 3.10. In order to aid the identification of late 
endosomes cells were incubated in BSA-gold for 2h in full growth medium.
The gold can be seen to have clumped together in the late endosomes due to the 
acidity of the compartment. Atg9L 1 labelled the same vesicles as the clumped 
BSA-gold and also CI-MPR and therefore is present on late endosomes.
In conclusion then Atg9Ll has two loci, the TGN and late endosomes.
Figure 3.10. Immuno-electron microscopy analysis confirms A tg9L l’s 
presence on endosomal membranes. Cryoimmunogold labelling of Atg9Ll (red 
arrowheads, 10 nm gold) and CI-MPR (green arrowheads, 15 nm gold) on 
HEK293 cells labelled with 6nm conjugated BSA-Gold (arrows) internalized 
for 2h. Scale bar -  200nm.
3.6 Discussion
Antibodies raised against Atg9Ll revealed that the endogenous protein has two 
loci, a juxta-nuclear pool and a peripheral pool. The juxta-nuclear pool of
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Atg9Ll colocalised best with markers of the Golgi in immunofluorescence. To 
which compartment of the Golgi was established using BFA / nocodazole, it 
was found to be TGN. This was then confirmed by subcellular fractionation 
and also finally by immuno-EM. An endosome preparation revealed that the 
peripheral pool of staining corresponded to endosomes, in particular Atg9Ll 
was found to colocalise with those Rab proteins associated with late 
endosomes. This was then confirmed using immuno-EM. From the data 
presented here, Atg9Ll would seem to have two main loci in cells in normal 
conditions, both the TGN and late endosomes. The presence of Atg9Ll in 
these two locations suggests that at steady state, the protein maybe cycling 
between these two compartments.
The subcellular distribution of Atg9Ll is very similar to the distribution of 
WIPI49 (Jeffries et al., 2004), a mammalian orthologue of Atgl8p, a cytosolic 
protein which binds PI3P (Jeffries et al., 2004; Stromhaug et al., 2004). In S. 
cerevisiae Atg9p has been shown to bind Atgl8p (Reggiori et al., 2004), 
however such an interaction has not been confirmed in mammalian cells. 
Wipi49 has been shown to cycle between the TGN and endosomes using 
fluorescence video microscopy (Jeffries et al., 2004). Fluorescence video 
microscopy was attempted for Atg9Ll, but unfortunately mRFP-Atg9 
accumulated in the ER when transiently expressed in HEK293 cells (data not 
shown). However, evidence presented later in this thesis (chapter 5, section 
5.3, Figure 5.2) provides evidence that Atg9Ll is able to cycle. Upon 
starvation Atg9Ll redistributes from its juxta-nuclear location. Upon returning 
the cells to normal growth medium (in the presence of cyclohexamide, to rule
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out accumulation of newly synthesised protein) Atg9 returns to the juxta- 
nuclear area, suggesting that it can recycle back from its peripheral population. 
Other data also suggests that Atg9Ll is cycling. As described in chapter 6, 
section 6.4, Figure 6.3, overexpression of constitutively active Rab proteins 
causes Atg9 to accumulate in endosomes. This accumulation in endosomes 
comes at the expense of the juxta-nuclear population, indicating that the 
recycling of Atg9Ll from endosomes to TGN has been blocked.
The localisation of Atg9Ll is different from Atg9p in S. cerevisiae and P. 
pastoris, where Atg9 was not found on ER, Golgi, or endosomes but in a peri- 
vacuolar region, the pre-autophagosomal structure (PAS), and peripheral 
membranes (Chang et al., 2005; Lang et al., 2000; Noda et al., 2000). Recently, 
Reggiori et al. (2005) demonstrated that, in S. cerevisiae, some of the Atg9 
positive peripheral structures are associated with mitochondria, despite the lack 
of a mitochondrial targeting sequence. Atg9Ll did not colocalise with 
Mitotraker (Invitrogen) in immunofluorescence (Jemma Webber CRUK, 
personal communication) nor did it cofractionate with mitochondrial markers 
on the endosome preparation gradients, which were found in the fraction 
corresponding to the interface of the Nycodenz cushion and the Ficoll (Harold 
Jefferies CRUK, personal communication). The finding that mammalian Atg9 
does not localise to mitochondria is in agreement with published data 
concerning overexpressed APG9L1 and APG9L2 (Yamada et al., 2005). 
However, it cannot be excluded that in mammalian cells this association is 
transient and difficult to detect at steady-state, or unstable after lysis of cells.
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The evidence that Atg9p is not present on endosomes in S. cerevisiae comes 
from subcellular fractionation studies using a sucrose density gradient (Noda et 
al. 2000). Noda et al. did find an overlap with endosomal markers on that 
gradient but subsequently concluded that this overlap was not significant.
Other unpublished data may, of course, have lead them to that conclusion.
The localisation of Atg9Ll to the TGN and endosomes in mammalian cells is 
interesting because Atg9Ll is a transmembrane protein and as such if it should 
localise to autophagosomes upon starvation then there must be at least a 
contribution from the TGN and / or endosomal membranes to autophagosomes, 
and hence autophagy, as Atg9Ll could only have arrived there by membrane 
trafficking.
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4 Topology
4.1 Aim
Visual inspection of the primary amino acid sequence of Atg9Ll reveals 
several clathrin adaptor binding motifs. Eight tyrosine motifs and three 
dileucine motifs (see introduction section 1.3.2.5.2) were found as shown in 
Table 4.1.
Table 4.1. Potential clathrin adaptor binding motifs within Atg9Ll, see Figure 
4.2 to relate these to the protein’s predicted topology.
Position Sequence Position Sequence
8-11 YQRL 471-474 YKAV
89-92 YDIL 785-788 YGGI
157-160 YWEI
209-212 YHRI 22-27 EEDLLV
311-314 YAFF 128-133 ENGSLI
316-319 YAEV 616-621 EPLSLI
To be functional, these motifs must be accessible to the, cytosolic resident, 
adaptor proteins. Topology prediction algorithms identified 5 to 7 
transmembrane domains (TMD) within Atg9Ll (Figure 4.1), hence the 
protein’s topology is uncertain. The protein’s topology was investigated 
experimentally by glycosylation and protease protection analysis.
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Figure 4.1. Hydrophobicity plots for Atg9Ll. (A) Hydrophobicity plot 
produced using TopPredll with the Goldman-Engleman-Steitz (GES) 
hydrophobicity scale (Engleman et al. 1986) run on an in house server. (B) 
Topology predicted using the TMHMM model on the Centre for Biological 
Sequence analysis (CBS) server www.cbs.dtu.dk.
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TMD# TMD position Score
Certain 1 68-88 1.9146
Certain 2 128-148 1.4281
Putative 3 249-269 0.7719
Certain 4 290-310 1.7687
Certain 5 378-398 1.8125
Certain 6 401-421 1.2125
Certain 7 476-496 1.1000
Figure 4.2. TopPredll models for A tg9Ll’s topology and predictions for the 
locations o f its TMDs. The primary amino acid sequence of Atg9Ll was run 
through the TopPredll topology prediction algorithm on an in house server. 
This algorithm generated two topology prediction models. Candidate TMD are 
shown in the table below with their GES score (Engleman et al. 1986).
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4.2 Glycosylation analysis
Visual examination of the primary amino acid sequence of Atg9Ll revealed 
four potential N-linked glycosylation sites. If these potential sites are 
glycosylated, then they must be accessible to the glycosylating enzymes of the 
ER and could be used to determine whether a particular site is lumenal. To 
determine whether Atg9Ll is indeed glycosylated, lysate from HEK293 cells 
was treated with glycosidase enzymes, either Endoglycosidase H (Endo H) or 
Peptide N-Glycosidase F (PNGase F) and analysed by SDS-PAGE and Western 
blotting. Treatment with Endo H did not effect the electrophoretic mobility of 
Atg9Ll whereas treatment with PNGase F increased it, Figure 4.3A lane 1 vs. 3 
respectively. This confirms not only that Atg9Ll is glycosylated but also it 
demonstrates that the glycosylation is the sort of complex glycosylation added 
by enzymes resident in the Golgi. Endo H is only able to cleave high-mannose 
or some hybrid forms of N-glycosylation whereas PNGase F can cleave off 
nearly all forms, including complex oligosaccharides (see introduction -  section
1.3.1.2). This adds weight to data from the previous chapter that Atg9Ll is a 
Golgi resident protein as this shows that Atg9Ll must have at least passed 
through the Golgi.
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Figure 4.3. Glycosylation analysis. (A) Treatment of HEK293 PNS with the 
glycosidase PNGaseF, but not Endo H, altered the apparent molecular weight 
(MW) of Atg9Ll from 105 to 75kDa. (B) An in vitro synthesised 183aa N- 
terminal Atg9Ll fragment was treated (+) or not (-) with EndoH. The wt 
sequence fragment (lanes 1 and 2) was glycosylated (upper band, arrowhead) 
and sensitive to EndoH, while the N99D mutant fragment (lanes 3 and 4) was 
not sensitive to Endo H (lower band, *). (C) In vitro synthesised Atg9Ll was 
treated (+) or not (-) with Endo H. The wt sequence protein (lanes 5 and 6) was 
glycosylated and sensitive to Endo H, whereas the N99 & 224D and N99, 224 
& 507D mutants were not sensitive to Endo H. (D) Lysates from HEK293 cells 
transiently transfected with wt HA-Atg9Ll (lanes 1 and 2), HA-Atg9Ll N99D 
(lanes 3 and 4), N224/507D (lanes 5 and 6) or N99/224/507D (lanes 7 and 8) 
were treated (+), or not (-), with PNGaseF. The N99D, and N99/224/507D 
mutants were not glycosylated (lower band, *) whereas the N224/507D mutant 
was glycosylated (upper band, arrowhead) and sensitive to PNGaseF. In all 
cases an anti-HA antibody was used to detect the HA tagged proteins.
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The primary amino acid sequence of Atg9Ll contains 4 potential N-linked 
glycosylation sites conforming to the consensus NXS/T: N99, N129, N224 and 
N507. Null mutants of these potential sites were made by mutating the N 
residues to D. The N129 site was not mutated as it was assumed (and later 
shown, e.g. Figure 4.3D) that it would not be glycosylated as the topology 
prediction algorithms identify it as within the second TMD. To aid in the 
topological analysis of the N-terminal part of the protein, a truncated DNA 
construct was produced using PCR for both the wt and the N99D mutant 
corresponding to the N-terminal 183aa of Atg9Ll. The 183aa fragment was 
used instead of the full length protein in order to aid resolution of the 
glycosylated and non-glycosylated forms of the protein. By in vitro translation 
(including [35S]-methionine), in the presence of ER microsomes, the wt 
sequence truncated protein produced two bands on the phosphoimager, just 
above and below the 30kDa marker (Figure 4.3B, lane 1). The upper band 
could be digested by Endo H and therefore corresponds to the glycosylated 
form of the truncated protein (Figure 4.3B, lane 2). The N99D mutant, in the 
presence or absence of Endo H showed only one band and therefore was not 
glycosylated (Figure 4.3B, lanes 3 & 4). For the N99 site to be glycosylated it 
must be accessible to the glycosylation enzymes in the lumen of the ER 
microsomes. Therefore the N99 site, in the predicted loop between TMD 1 & 
2, must be lumenal.
The N507 site is situated just after the last predicted TMD and hence could be 
used to determine whether the C-terminal 343aa of Atg9Ll are lumenal or
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cytoplasmic. By in vitro translation, the band pattern produced by the N99D, 
N224D mutant resembled the glycosylation null mutant (N99D, N224D & 
N507D) rather than that of the wt protein (Figure 4.3C) and therefore the N507 
site is not glycosylated. However, as there are cases of characterised proteins 
that have sites that are predicted to be glycosylated which in reality are not 
(Stephen High, University of Manchester, personal communication), due to for 
example steric hindrance of the glycosylation enzymes through secondary 
structure within the protein, then this negative result cannot be taken as sole 
evidence of the C-terminal portion being cytoplasmic.
To determine if it is also only the N99 site that is glycosylated in vivo, the 
various HA tagged glycosylation mutant cDNA constructs were transiently 
transfected into HEK293 cells. When overexpressed the HA tagged wt 
sequence cDNA gave both the same band picked up by the antibodies against 
the endogenous protein (see Figure 3.2) running at the 105kDa marker and also 
a lower weight band running just above the 75kDa marker. PNGase F 
treatment of the wt HA-Atg9Ll transfected cell lysate digested the band at 
105kDa and left the band at ~80kDa. This 80kDa band therefore corresponds 
to the non-glycosylated protein. Mutation of the N99 site alone resulted in the 
absence of the glycosylated form of the protein at 105kDa with only the 80kDa 
non-glycosylated form remaining. Whereas dual mutation of the N224 and 
N507 sites in the same construct resulted in the wt band pattern. That the N99 
site alone can produce the same apparent molecular weight shift as the wt 
sequence protein indicates that N99 is the only site glycosylated. This result 
also confirms that the N99 site is lumenal in vivo. In addition it suggests that,
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as the predicted inter TMD1 & 2 loop is lumenal, if TMD 1 is a bona fide TMD 
then the N-terminus of Atg9Ll should be cytoplasmic.
4.3 Protease Protection experiments
To determine if the N and C-termini are on the lumenal or cytosolic side of the 
membrane in vitro protease protection experiments were performed on both the 
183aa truncation and the full-length proteins. These protease protection 
experiments are based on the premise that the protease is not able cross the 
membrane of the ER microsome and therefore can only digest the cytosolic 
portions of the protein. If the N and / or C-termini are lumenal then they will 
be protected from the protease and, after inactivation of the protease and lysis 
of the ER microsomal membrane, the N or C-terminal fragments could then be 
immunoprecipitated. However, if the N and / or C-termini are cytosolic then 
they will be digested by the protease and there will be no epitope containing 
piece left to immunoprecipitate (see Figure 4.4 for a diagrammatic 
representation).
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Proteinase K 
 ^
B
Proteinase K 
 ►
Figure 4.4. Diagrammatic representation o f the principle o f the protease 
protection experiments on Atg9Ll containing ER microsomes. (A) N and C- 
termini in a cytoplasmic orientation and hence digested by the protease. (B) N 
and C-termini within the ER microsome’s lumen and hence protected from the 
protease.
Bearing in mind that the N99 glycosylation site has already been established to 
be lumenal then for the N-terminus to be lumenal the predicted TMD1 would 
have to be translocated into the lumen. Proteinase K was selected as the 
protease of choice for these experiments as it shows less substrate specificity
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than, for example, Trypsin. Proteinase K was inactivated by TCA precipitation 
before lysing the microsomes for the subsequent immunoprecipitation. After 
Proteinase K treatment of ER microsomes containing the 183aa truncation 
fragment and subsequent immunoprecipitation using the antibody raised against 
the N-terminal epitope no discrete, protease protected, band was detected 
Figure 4.5A, lane 2. This result confirms that TMD1 exists and that the N- 
terminus is cytosolic. As a control to ensure that the in vitro translated products 
did in fact resuspend after the TCA precipitation a sample of the microsomes 
containing the 183aa fragment were simply treated with only the Proteinase K 
diluent. In Figure 4.5 A, lane 1 two discrete bands corresponding to the 
glycosylated and non-glycosylated forms of the 183aa fragment could be 
detected (as in Figure 4.3B) demonstrating that the N-terminal 183aa fragment 
could be immunoprecipitated after TCA treatment. To confirm that the ER 
microsomal membranes were impervious to the Proteinase K control lanes were 
included, designated totals. Here the protease digests were not 
immunoprecipitated but rather simply resuspended in SDS-PAGE sample 
buffer after the TCA precipitation. These lanes should show a band pattern of 
the protected TMDs and interconnecting loops of Atg9Ll (as in Figure 4.4A) 
and therefore confirm that the ER membrane is impermeable to protease. Such 
a band pattern can be seen in Figure 4.5 A, lane 5.
If the C-terminal 343aa of the protein is lumenal and therefore protease 
protected then a ~38kDa band would be expected after protease digestion in the 
absence of detergent. No such band was detectable and therefore it is likely
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that the C-terminus is also cytoplasmic, Figure 4.5B. The gel layout and 
controls are as for the N-terminus.
215 PI Tot
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Figure 4.5. Protease protection experiments. (A) Topology of the N-terminus: 
ER microsomes containing an Atg9Ll N-terminal 183aa fragment were treated 
with Prot. K in the absence or presence of TX-100, lane 2 and 3 respectively. 
The 183aa fragment could be immunoprecipitated (IP) using anti-N-terminal 
antibody ST0215 (lane 1) but no bands were detected after Prot. K treatment in 
the absence (lane 2) or presence (lane 3) of detergent, consistent with the 
removal of the N-terminal epitope (Model A). Note: If the N-terminus was 
lumenal (see Model B), then a ~25kDa band would have been detected. To 
ensure that the microsomes were impervious to the protease, samples were not
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IP but rather resuspended in SDS-PAGE sample buffer, totals (Tot) lanes. In 
the absence of TX-100 (lane 5) two bands can be seen (*) corresponding to the 
protected glycosylated and non-glycosylated forms of TMD1&2 and their inter- 
TMD loop (see Model A). The numbers shown on the models refer to amino 
acid position. C = Control, PI = Pre-Immune serum, Cyt = cytosol, Lum = 
Lumen. (B) Topology of C-terminus: Full length in vitro synthesised Atg9Ll 
was immunoprecipitated using anti-C-terminal ST0219 (lane 1, arrowhead). 
After Prot K treatment of the microsomes in the absence of TX-100 no 
fragment was immunoprecipitated (lane 2), consistent with removal of the C- 
terminal epitope (Model A). Note: If the C-terminus was lumenal, then a 
~40kDa fragment would have been expected (Model B). Controls are as for 
panel A.
4.4 Atg9Ll colocalises with clathrin adaptor proteins
Provisional immunofluorescence results indicate that there is good
colocalisation of Atg9Ll with clathrin and also with AP-1 and 3 but not AP-2 
(Figure 4.6). Both AP-1 and AP-3 are localised to the TGN and endosomes 
(Bonifacino and Traub, 2003) so this agrees with the data presented in chapter 
3. There was no overlap seen with AP- 2. AP-2 is primarily associated with 
the plasma membrane and so again this agrees with the previous data. That 
Atg9Ll colocalises with clathrin adaptors suggests that it may associate with 
these adaptors in vivo.
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1
Figure 4.6. Colocalisation of Atg9Ll with Clathrin and clathrin adaptors. 
HEK293 cells were stained with antibodies to the various adaptor proteins as 
well as clathrin and the C-terminal Atg9Ll antibody. Scale bar = 10pm.
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Provisional results from site directed mutagenesis experiments indicate that 
perhaps Atg9Ll does indeed require its clathrin adaptor binding motifs for its 
localisation. Mutation of the N-terminal dileucine motif (aa 22-27) to alanines 
(LL to AA) caused a redistribution of Atg9Ll from its usual juxta-nuclear 
localisation to a more dispersed distribution, Figure 4.7B. There are two other 
dileucine motifs present in the protein. One is present at aa 128-133 and is 
therefore within the second (predicted) TMD. The other dileucine motif is 
present within the C-terminus of the protein, aa 616-621. Removal of the C- 
terminus however caused the mutant protein to accumulate in the ER, as judged 
by its localisation in immunofluorescence alone, Figure 4.7C. Of the YXX0 
motifs, mutation of the N-terminal one (Y8A) had no discemable effect upon 
the localisation of Atg9Ll (data not shown). A full YXX0 and dileucine motif 
null mutant would give the best indication of whether or not Atg9Ll indeed 
does bind to adaptor proteins and this would be an immediate avenue for further 
investigation.
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B LL mutant C C-term deletion
Figure 4.7. Atg9Ll mutants. HEK293 cells were transfected with the stated 
cDNA constructs and detected using an anti-HA antibody. (A) HA-Atg9Ll, wt 
sequence. (B) HA-Atg9Ll with N-terminal dileucine motif mutated to alanine. 
(C) HA-Atg9Ll C-terminal deletion mutant.
4.5 Discussion
The data presented in this chapter shows experimentally that (a) A tg9Ll’s N99 
site is the sole site of N-linked glycosylation and therefore that that part of the 
protein in lumenal; (b) that its N and C-termini are cytoplasmic and therefore 
(c) that Atg9L 1 is a multi-spanning transmembrane protein. Proteins where the 
N and C termini are cytosolic are strongly preferred over the other possible 
topologies (Krogh et al., 2001) and so Atg9Ll therefore conforms to a normal 
multi-spanning membrane protein’s topology.
Although it has been established that Atg9Ll has an even number of TMD, 
how many is still unconfirmed. TopPredll identified 6 or 7 TMD, 6 ‘certain’ 
and 1 ‘putative’. The probable explanation is therefore that the putative TMD 
is just that, and that Atg9Ll has 6 TMD. However, this is still simply a
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prediction and the topology of the internal part of Atg9Ll remains to be 
determined experimentally.
The presence of adaptor binding motifs in accessible domains of Atg9Ll and 
it’s colocalisation with adaptor proteins (AP) 1 and 3 in immunofluorescence 
suggests that Atg9Ll may bind these adaptor proteins. If this were the case it 
could indicate a role for clathrin in Atg9 transport and therefore autophagy.
GST pulldown and immunoprecipitation experiments could be conducted to 
determine whether Atg9Ll binds clathrin adaptors. The main difficulty with 
these experiments would be that Atg9Ll is, as shown here, a highly 
hydrophobic transmembrane protein, which are typically extremely difficult to 
express as recombinant proteins. Nevertheless, determining interactions with 
other proteins would be an extremely interesting as it might lead to clues as to 
the function of Atg9Ll, in normal as well as starvation conditions.
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5 Atg9Ll redistributes upon starvation in a PI3-kinase 
and ULK1 (Atgl) dependent manner
5.1 Aim
Having established the localisation of Atg9Ll in cells in full growth medium its 
localisation under starvation conditions was now addressed. The primary 
reason for investigating Atg9Ll in the first instance was due to my interest in 
autophagy and autophagy is primarily established as an amino acid starvation 
response.
In S. cerevisiae Reggiori et a l  have shown that Atg9p cycles between 
peripheral puncta and the preautophagosomal structure (PAS) (Reggiori et a l, 
2004). At the PAS Atg9p colocalised with Atg8p, the marker for autophagic 
pathway. I therefore reasoned that Atg9Ll might colocalise with one of the 
mammalian orthologues of Atg8, LC3. Atg9p is not found on completed 
autophagosomes in yeast (Noda et a l, 2000). In mammalian cells, however, it 
is not known how the localisation of the endogenous Atg9Ll is affected by 
amino acid starvation, let alone if Atg9Ll localises to autophagosomes. The 
localisation of Atg9Ll upon starvation is interesting as it might provide clues as 
to its function. I addressed the question of whether or not Atg9Ll is present on 
autophagosomes in mammalian cells by analysis of Atg9Ll’s distribution 
across Stromhaug et a l ’s autophagosome preparation gradient (Stromhaug et 
a l, 1998).
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Reggiori et al. also showed that knockdown of other Atg genes has an effect 
upon Atg9Ll’s localisation, in S. cerevisiae (Reggiori et al., 2004). ScAtg9p 
accumulates at the PAS in atgl A cells. I therefore reasoned that knocking 
down the orthologous ULK (Unc51 like kinase -  see introduction, section
1.2.6.2) family members might affect the localisation of Atg9Ll upon 
starvation. Knockdown of other Atg proteins, like the PI3-kinase hVps34 
effector Beclin (Zeng et a l, 2006), was also tried to see whether Atg9Ll’s 
redistribution upon starvation would be affected.
5.2 Atg9Ll disperses upon starvation, colocalising with GFP- 
LC3 and Rab7
To address the effect of amino acid starvation upon Atg9Ll distribution,
HEK293 cells stably expressing GFP-LC3 (Kochi et al., 2006) were incubated 
in starvation medium, Earle’s saline (ES), for 2h. Upon starvation the juxta- 
nuclear Atg9Ll signal appeared to disperse (Figure 5.1). The resultant 
peripheral staining colocalised with Rab7 as well as with GFP-LC3. 
Quantification revealed that approximately 46% of the GFP-LC3 positive 
structures contained Atg9Ll (Table 5.1), although the amount of Atg9Ll 
colocalised with the GFP-LC3 positive structures was low (-7%), perhaps 
reflecting the fact there would seem to be more Atg9Ll structures than GFP- 
LC3-II structures. (The lipidated form of LC3 is designated LC3-II and the 
cytosolic form as LC3-I).
Immature autophagosomes (AVis) are not Rab7 positive and do not contain 
degradative enzymes, while AVds (degradative autophagosomes) have acquired
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both Rab7 and degradative enzymes (Gutierrez et al., 2004; Jager et a l, 2004). 
After 2h starvation approximately 50% of the GFP-LC3 positive puncta were 
also positive for Rab7, indicating that about half of the GFP-LC3 positive 
structures are AVds. However, of the structures which were double positive for 
Atg9Ll and Rab7 (30%), only 7% at most contain GFP-LC3.
Figure 5.1. Colocalisation of Atg9LI with GFP-LC3 upon starvation.
HEK293 cells stably expressing GFP-LC3 were starved for 2h in ES and 
labelled with antibodies for both endogenous Rab7 and Atg9Ll. Cells were 
treated with 0.05% (w/v) saponin prior to fixation to extract the cytosolic LC3-I 
and leave only the membrane associated LC3-II. The turquoise arrowhead
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points to an example of colocalisation between GFP-LC3 and Atg9Ll, the 
yellow GFP-LC3 and Rab7 and the white to an example of all 3 proteins 
colocalised, GFP-LC3, Atg9Ll and Rab7 together. Bar = 10pm.
Table 5.1. Quantification o f GFP-LC3, Rab7 andAtg9Ll colocalisation. 
Images were analysed using the colocalisation function of the Zeiss LSM-510 
software. Quantification was performed for each cell, using a region of interest, 
and data are the mean values of 20 cells obtained from two independent 
experiments, % ±SEM.
GFP-LC3 
with Rab7
Rab7 with 
GFP-LC3
GFP-LC3
with
Atg9Ll
Atg9Ll 
with GFP- 
LC3
Rab7 with 
Atg9Ll
Atg9Ll 
with Rab7
51.2 ±9.4% 6.7 ±1.2% 45.9 ±0.6% 7.4 ±0.7% 26.8 ±3.7% 32.3 ±5.0%
5.3 Atg9Ll’s redistribution upon starvation or rapamycin 
treatment is PI3-Kinase dependent
Starvation for 2h in ES also affected CI-MPR causing it to also appear
dispersed throughout the cell, although more subtly than for Atg9Ll (Figure 
5.2B). The fact that both Atg9Ll and CI-MPR are affected by starvation 
implies that the dispersion represents a general consequences of starvation upon 
membrane trafficking rather than a specific effect upon Atg9Ll itself or one its 
interacting proteins, through for example a signalling pathway kinase. An 
alternative method of inducing autophagy is by treatment with Rapamycin 
which inhibits TOR, a negative regulator of autophagy (Noda and Ohsumi, 
1998). Rapamycin allows the induction of autophagy in full growth medium.
151
RESULTS -  Chapter 5, Atg9Ll redistributes upon starvation in an ULK1 and
PI3K dependent manner
Treatment of HEK293 cells with Rapamycin for 2h in full medium also caused 
the redistribution of Atg9Ll away from the juxta-nuclear region, Figure 5.2C. 
CI-MPR also became more disperse after rapamycin treatment, Figure 5.2C. 
There was, however, no discemable change in TGN46 distribution upon 
starvation or rapamycin treatment.
Autophagy is inhibited by PI3-kinase inhibitors (Blommaart et al., 1997). 
Therefore, the PI3-kinase inhibitor LY290042 was used to see if the starvation 
induced redistribution of Atg9Ll was dependent on PI3-kinases. Indeed, 
Atg9Ll dispersion was inhibited by LY294002 treatment, Figure 5.2D and F. 
The dispersion of CI-MPR could also be blocked using LY294002, Figure 
5.2D.
The juxta-nuclear concentration of Atg9Ll could either be dispersing out to a 
peripheral pool upon starvation, which based on its colocalisation with Rab7 is 
presumably endosomes, or it could be being degraded. If it is not degraded 
then re-addition of amino acids after starvation, in the presence of 
cycloheximide to rule out new protein synthesis, should recover that juxta- 
nuclear pool of Atg9Ll. After a 2h starvation in ES followed by re-addition of 
full medium for 2h, in the presence of cycloheximide, Atg9L 1 returned to its 
juxta-nuclear compartment, Figure 5.2G. The juxta-nuclear staining was not 
quite as intense after recovery as it was in non-starved cells, perhaps indicating 
that a small percentage was degraded.
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CI-MPR
CI-MPR
CI-MPR
TGN46
Figure 5.2. Atg9Ll and CI-MPR re-distribute upon starvation in a reversible, 
PIS-kinase dependent manner. HEK293 cells were labelled with antibodies to
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Atg9Ll and CI-MPR (A-D) or TGN46 (E-G). Cells had first been treated with 
either rapamycin (C) or for 2h ES in the presence (D and F) or absence (B and 
E) of 65 pM LY294002. (G) Cells were starved for 2h in ES, before incubation 
in full growth medium (FM) for 2h in the presence of lOpg/ml cycloheximide 
(note that cycloheximide was also included in the final 15min in ES).
5.4 Atg9Ll trafficking is dependent on ULK1 (Atgl)
To elucidate if the starvation dependent redistribution of Atg9Ll reflected an
autophagy specific signal, a knockdown screen of several mammalian^ TG 
genes was performed to see whether the Atg9Ll redistribution could be 
inhibited by depletion of other autophagy proteins. HEK293 cells were treated 
with siRNA duplexes specific for human ULK1, ULK2, Atg5L, Beclinl 
(Atg6L), Atg7L or Atgl2L. Knockdown was confirmed by either RT-PCR or 
SDS-PAGE and Western blotting analysis (data not shown).
In starved HEK293 cells, depletion of ULK1 inhibited the redistribution of 
Atg9Ll, resulting in a distribution comparable to non-starved controls (Figure 
5.3C). There was no discemable change in TGN46 distribution after ULK1 
knockdown. Knockdown of ULK2, the next closest member of this family to 
ScAtgl, had no effect on the starvation induced dispersal of Atg9Ll, Figure 
5.3D. Knockdown of ULK1 also inhibited the redistribution of CI-MPR seen 
after starvation, Figure 5.3G.
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Figure 5.3. The starvation induced dispersal of Atg9Ll can be blocked by 
knockdown of ULK1 but not ULK2. HEK293 cells were treated with either
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control siRNA (siC) (A, B, E and F), ULK1 siRNA (C and G) or ULK2 siRNA 
(D) and incubated in full medium (A and E) or for 2h in Earle’s saline (B-D, F 
and G). The cells were then fixed and labelled with antibodies to Atg9Ll and 
TGN46 or CI-MPR. The starvation induced dispersal of both Atg9Ll (B and F) 
and CI-MPR (F) could be blocked by siRNA mediated knockdown of ULK1 (C 
and G) but not ULK2 (D). Scale bars = 5pm.
To quantify the magnitude of the effect of ULK1 knockdown upon the 
inhibition of Atg9Ll redistribution I used TGN46 as a reference signal, as there 
was no discemable change in TGN46 upon starvation. As shown in Table 5.2, 
in full growth medium approximately 50% of Atg9Ll in the juxta-nuclear 
region colocalised with TGN46, decreasing to 30% after starvation. ULK1 
knockdown under starvation conditions inhibited the reduction in colocalisation 
of Atg9Ll with TGN46, in fact increasing it to 60%, higher than that seen in 
full medium. siRNA mediated depletion of the other Atg proteins did not show 
a dramatic effect on Atg9Ll ’s redistribution upon starvation. Knockdown of 
ULK2, Atg5L, Atg7L or Atgl2L did not significantly inhibit the dispersal of 
Atg9Ll upon starvation, as judged by the colocalisation of Atg9Ll with 
TGN46 compared to control siRNA (siC) treated cells. Although Beclinl 
knockdown resulted in a slight inhibition in the dispersal of Atg9Ll and an 
increase in the juxta-nuclear colocalisation of Atg9Ll and TGN46, from 30% 
to 42%, it did not reach the level of colocalisation seen in full medium.
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Table 5.2. Percent colocalisation ofAtg9Ll with TGN46 upon starvation after 
knockdown o f various Atg proteins. Images were analysed using the 
colocalisation function of the Zeiss LSM-510 software. Quantification was 
performed using a region of interest surrounding the TGN staining. siC = 
control siRNA. Data are the mean values of 10 cells from a representative 
experiment.
Culture
Medium FM ES
RNAi siC siC ULK1 ULK2 Beclin Atg5 Atg7 Atg 12
Average
±SEM
51.2%
±1.2
29.1%
±1.7
61.6%
±1.9
32.9%
±2.6
41.6%
±1.6
31.9%
±1.9
32.7%
±1.5
34.4%
±2.2
5.5 Atg9Ll is found on purified autophagosomes
In order to confirm the autophagosomal localisation of Atg9Ll suggested by its
colocalisation with GFP-LC3 in immunofluorescence, autophagosomes were 
purified from rat liver according the method of Seglen and co-workers 
(Stromhaug et a l, 1998). This procedure essentially comprises of a 
discontinuous Nycodenz gradient, followed by a Percoll gradient (described in 
full detail in the Materials and Methods). To confirm the purity of the 
autophagosomes resulting from the preparation, samples were examined by EM 
(Figure 5.4). The final autophagosomal fraction looked to be of a high purity, 
judging by well documented morphological criteria (Eskelinen, 2004).
Samples of the various fractions from different stages of the preparation were 
kept and analysed by SDS-PAGE and Western blotting to see at which stage 
known endomembrane markers were either enriched or depleted. Of the
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endomembrane markers examined, only Atg9Ll and LC3-II were progressively 
enriched from the semi-pure autophagosomal fraction obtained from the 
Nycodenz gradient through to the final purified autophagosomal fraction,
Figure 5.5. LC3 was detected using an antibody to the endogenous protein 
(Kochi et a l , 2006). SOD1, a cytosolic enzyme, was also enriched in the final 
purified autophagosome fraction. PDI, representing ER, was depleted from the 
semi-pure autophagosomal fraction to the final purified autophagosomes as was 
p58 / ERGIC and TGN38.
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Figure 5.4. EM analysis of the final purified autophagosomal fraction. The 
autophagosomes from the final purified fraction of the autophagosome 
preparation were analysed for their purity by conventional EM. Scale bars: top
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image, 10pm; middle two, 2pm and; bottom two, 0.5pm. EM was performed 
by Dr Xiao-Wen Hu (Cancer Research UK).
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Figure 5.5. Atg9Ll is enriched over the course o f the autophagosome 
preparation. Autophagosomes were purified from rat liver according to the 
protocol of Stromhaug et al. (1998). Fractions were collected from each stage 
of the preparation procedure and analysed by SDS-PAGE and Western blotting. 
Gels were loaded with an equal amount of protein per lane. The blots were 
probed for various endomembrane markers as well as for A tg9Ll. PDI, ER; 
p58, ERGIC; SOD1, cytoplasm. AV = Autophagic vacuoles or 
autophagosomes; Mito = mitochondria; Perox = peroxisomes. Cytosol is 
inverted commas to indicate the impure nature of this fraction. The data for 
Atg9Ll and LC3 are representative of three independent experiments. The 
other data are from a single preparation.
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Figure 5.5 continued. Densitometry o f the blots from the previous page. 
Densitometry was performed using ImageJ software.
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Final confirmation that Atg9Ll is localised to autophagosomes came from 
immuno-EM analysis, Figure 5.6. Atg9Ll can be seen to be labelling the inner 
and outer membranes of the autophagosome as well as structures within them.
Figure 5.6. Immuno-EM o f rat hepatocytes showing autophagosomes labelled 
with Atg9Ll antibody. Cultured primary rat hepatocytes were starved for 2h in 
ES before fixing and processing for immuno-EM. Autophagosomes were 
identified by well documented criteria (Eskelinen, 2004). Scale bars = 200nm. 
EM was performed by Dr Xiao-Wen Hu (Cancer Research UK).
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Taking the colocalisation of Atg9Ll with GFP-LC3 in immunofluorescence, 
the enrichment of Atg9Ll across the autophagosome preparation and the 
presence of Atg9Ll on autophagosomes by immuno-EM together, these results 
indicate that Atg9 is present on autophagosomes in mammalian cells, in 
contrast to the situation in yeast.
5.6 Discussion
5.6.1 Atg9Ll ’s juxta-nuclear pool disperses upon starvation
The juxta-nuclear TGN associated pool of Atg9Ll seen in immunofluorescence
seems to disappear upon starvation. This could either reflect a degradation or a
dispersal of the protein. By Western blotting analysis, levels of Atg9 do not
appear to be altered after starvation (see chapter 7, Figure 7.1 A). Further
evidence for this is that Atg9Ll recovered to its juxta-nuclear concentration
after the re-addition of full growth medium. It would seem, therefore, that the
disappearance of the juxta-nuclear Atg9Ll signal reflects a dispersal of the
protein. Atg9Ll colocalises with Rab7 upon starvation and although, as stated
earlier, some of the Rab7 is present on autophagosomes the majority is still,
presumably, associated with endosomes. The proportion of Rab7 present on
endosomes and autophagosomes was not specifically addressed by Gutierrez et
al. or Jager et al. (Gutierrez et a l, 2004; Jager et al., 2004). The colocalisaton
of Atg9Ll with a greater proportion of Rab7 than is colocalised with GFP-LC3-
II indicates that it is still associated with endosomes upon starvation.
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Rapamycin was used to try to distinguish whether the redistribution of Atg9Ll 
upon amino acid starvation was a general consequence of starvation on 
membrane trafficking. Both starvation and rapamycin treatment affected CI- 
MPR causing it to redistribute in a similar, although somewhat subtler, way to 
Atg9Ll. This result therefore suggests that the starvation induced redistribution 
of Atg9Ll may be due to the general consequences of starvation upon 
membrane trafficking rather than a specific effect upon Atg9Ll itself or one its 
interacting proteins, for example through a signalling pathway kinase. That 
TGN46 seemed unaffected by starvation could reflect a difference in the 
trafficking itineraries of CI-MPR and TGN46 (see figure 1.8). More careful 
analysis of TGN46’s and indeed the TGN’s response to starvation, possibly by 
electron microscopy, would be required to address this issue further.
5.6.2 Possible molecular mechanisms o f Atg9 dispersion upon starvation 
Thomas and co-workers (Nobukuni et al., 2005) have shown that hVps34’s
PI3-kinase activity is affected by amino acid starvation. hVps34 has a pivotal
role in membrane trafficking through its production of PI3P. This lipid recruits
effector proteins, almost all of which contain FYVE and PX domains
(Birkeland and Stenmark, 2004). Expression of a construct solely containing
two tandem FYVE domains localises predominantly to endosomes (Gillooly et
al., 2003), indicating that the PI3P hVps34 produces is predominantly involved
in recruiting effectors to endosomes. Retromer function in endosome to Golgi
retrograde transport is regulated by Vps34 in yeast (Burda et a l, 2002). Two
components of the mammalian retromer complex are sorting nexins (Snx) 1 and
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2, PX domain containing proteins. Studies using siRNA to knockdown one of 
the central components of the retromer, mammalian Vps26 (mVps26), have 
shown that retromer is required for the endosome to Golgi retrieval of CI-MPR 
(Arighi et al., 2004). These observations would suggest that a reduction in 
hVps34 activity upon starvation could result in a reduction in CI-MPR’s 
retrieval from endosomes to the TGN by the retromer complex and may explain 
CI-MPR’s dispersed appearance in immunofluorescence upon starvation. 
Retromer is suggested to function as coat protein complex (Seaman, 2005) and 
could therefore have a more general role in trafficking from endosomes to 
TGN, which might then also explain the dispersion of Atg9Ll. siRNA 
mediated knockdown of mVps26 in HEK293 cells would establish whether 
Atg9Ll requires the retromer complex for its steady-state localisation and also 
whether a disruption of the retromer complex in cells in full medium could 
mimic Atg9Ll dispersal upon starvation.
Recently it was shown that Rab9 is localised to late endosomes by binding its 
effector TIP47 (Aivazian et al., 2006). TIP47’s association with late 
endosomes was suggested to be via a binding partner, which may well be a 
phosphoinositide (Aivazian et al., 2006). Rab9 has been shown to mediate 
retrieval of CI-MPR from endosomes to the Golgi (Riederer et al., 1994).
TIP47 binds to the tail of the MPRs in vitro and has been proposed to mediate 
cargo selection in endosome to Golgi retrieval (Diaz and Pfeffer, 1998). If 
indeed TIP47 turns out to require a phosphoinositide, perhaps PI3P or 
PI(3,5)P2, then the down-regulation of hVps34 activity upon amino acid
165
RESULTS -  Chapter 5, Atg9Ll redistributes upon starvation in an ULK1 and
PI3K dependent manner
starvation, and hence PI3P and PI(3,5)P2 production, may also affect the 
Rab9/TIP47 retrieval system and contribute to the dispersion of CI-MPR, and 
perhaps Atg9Ll as well, upon starvation. It has been suggested that retromer 
and Rab9 might function sequentially in the same pathway, retromer mediating 
retrieval from early endosomes to a late endosomes and Rab9 mediating 
transport from the late endosome to the Golgi (Seaman, 2005). RNAi mediated 
knockdown of TIP47 and / or Rab9 expression would address the involvement 
of these proteins in the localisation of Atg9Ll at steady-state and also its 
dispersion upon starvation.
The VFT complex has also been implicated in the endosome to TGN transport 
pathway. Although this complex may well be involved in Atg9Ll trafficking, 
how the VFT complex would be affected by starvation is not clear.
The proposed mechanisms above, of how Atg9Ll’s localisation is affected by 
starvation, suggest that Atg9Ll and MPR are in the same trafficking pathway. 
Indirect evidence for this assertion is that overexpression of Atg9Ll perturbed 
the distribution of CI-MPR causing it to accumulate in the juxta-nuclear region 
(data not shown). A similar perturbation of CI-MPR localisation was reported 
following overexpression of WIPI-49 (HsAtgl8), which has been demonstrated 
to cycle from TGN to endosomes, like CI-MPR (Jeffries et al., 2004).
5.6.3 LY294002 causes both Atg9Ll and CI-MPR to accumulate in the TGN
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LY294002 was shown to block the redistribution of Atg9Ll and CI-MPR upon 
starvation. This result would appear to contradict my explanation above of how 
a reduced activity of hVps34 might cause the dispersion of Atg9Ll upon 
starvation. However, LY294002 inhibits class I, II and III PI3-kinases with a 
similar potency (Vanhaesebroeck et al., 2001). Which class of PI3-kinase 
LY294002 affects to inhibit the dispersion of Atg9Ll and CI-MPR is therefore 
undetermined. The trafficking of MPR has been examined in detail in relation 
to PI3P and in fact PI3-kinases are known to inhibit CI-MPR cycling, as was 
first reported based on the Wortmannin sensitivity of the transport of the 
lysosomal protease cathepsin D (Brown et a l, 1995; Davidson, 1995). 
(Wortmannin has a similar PI3-kinase specificity to LY294002 
(Vanhaesebroeck et al., 2001)). Brown (1995) showed that both Wortmannin 
and LY294002 caused the accumulation of MPR in a Golgi region. The 
incorporation of CI-MPR into TGN derived clathrin coated vesicles was found 
to be inhibited by Wortmannin (Gaffet et al., 1997). To date the PI3-kinase 
affected by LY294002 at the TGN is unknown. LY294002’s block of Atg9Ll 
in the juxta-nuclear area could be through a PI3-kinase other than hVps34 or by 
affecting multiple PI3-kinases. Clarification in the membrane traffic field of 
the role of PI3-kinases in MPR exit from the TGN would be necessary to 
resolve this issue.
5.6.4 Role o f  ULK1 in A tg 9 L l’s cycling
Since ScAtg9p retrieval from the PAS depends on ScAtglp (Reggiori et al.,
2004) I reasoned that knockdown of the putative mammalian Atgl orthologue
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might affect Atg9Ll ’s potential cycling. Indeed, siRNA mediated knockdown 
of ULK1, but not its paralogue ULK2, caused Atg9Ll to accumulate in the 
juxta-nuclear region. In S. cerevisiae Atg9p cycles between a peripheral 
punctate population and the PAS (Reggiori et al., 2004). It is hypothesised that 
the knockdown of ULK1 effects the cycling of Atg9Ll from the TGN to 
endosomes, thereby blocking it in the TGN. Indeed, even in full growth 
medium ULK1 knockdown causes a more intense juxta-nuclear Atg9Ll signal 
(data not shown). An alternative explanation, to Atg9Ll being blocked in the 
TGN, might be that knockdown of ULK1 could effect endosomes, and hence 
Atg9Ll, causing them to accumulate in the juxta-nuclear region and giving the 
appearance of a TGN enrichment. Thomas and co-workers (Nobukuni et al.,
2005) showed that the class III PI3-kinase hVps34 can also affect mTOR 
activity. The effect of the class III PI3-kinase hVps34 on mTOR and, by 
extrapolation, autophagy is presumably ultimately through Atgl, which is to 
date the only (non-ribosomal) protein kinase downstream of TOR shown to 
regulate autophagy. This will be addressed in the next chapter of this thesis.
In S. cerevisiae, knockout of Atglp causes Atg9p to accumulate at the PAS 
(Reggiori et al., 2004) suggesting that the membrane that Atg9Ll accumulates 
at upon ULK1 knockdown might be a mammalian PAS equivalent. Hence the 
exact identity of the juxta-nuclear membrane that Atg9Ll is present on upon 
ULK1 knockdown is of great interest in the identification of the source of the 
autophagosomal membrane.
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5.6.5 Effect o f  knocking down other Atg proteins on A tg9Ll 
Depletion of the human homologues of Atg5, Beclin/Atg6 or Atg7 did not
significantly inhibit Atg9L 1 redistribution in starved cells. In agreement with a
previous genetic classification from work with S. cerevisiae, it was anticipated
that knockdown of both HsAtg5 and HsAtgl2 would have no affect on Atg9Ll
localization (Suzuki et al., 2001). However, deletion of Atg7 in P. pastoris has
been shown to inhibit movement of PpAtg9 from the peri-vacuolar structures to
the sequestering membranes (Chang et a l, 2005). The difference between their
results and those presented here could be attributed to the unique nature of the
membranes involved in the process of pexophagy, or a difference in the role of
Atg9 in selective autophagy versus non-selective macroautophagy.
Recent data suggests that Beclinl is required for autophagy but not other 
endosomal pathways requiring class III PI3-kinase (Zeng et a l, 2006). This 
suggests that hVps34 activity is directed towards autophagy by specific 
autophagy effectors i.e. Beclin. If autophagosomally associated PI3P 
generation was inhibited then Atg9Ll’s localisation upon starvation could also 
be affected. However, knockdown of Beclinl had only a minor effect on the 
starvation-induced redistribution of Atg9Ll.
In yeast Atg2p and Atgl8p are key players in the cycling of Atg9 (Reggiori et 
a l, 2004). A mammalian orthologue of Atg2p is uncharacterised to date. 
However, orthologues of Atgl8p have now been identified and characterised 
and given the family name WIPI (Jeffries et a l, 2004; Proikas-Cezanne et al, 
2004). Investigation of the effects of the knockdown of the many paralogues of
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WIPI on Atg9Ll would be interesting as W IPIla, or WIPI49, has been shown 
to be a PI3P (and to a lesser extent PI5P and PI(3,5)P2) binding protein (Jeffries 
et al., 2004) and could therefore be part of Atg9Ll’s response to PI3-kinase 
inhibition.
5.6.6 Atg9Ll localises to autophagosomes
That Atg9Ll localises to autophagosomes is somewhat surprising considering 
the data concerning Atg9p in yeast. Noda et al. (Noda et al., 2000) found no 
labelling for Atg9 on the autophagic bodies or autophagosomes by immuno- 
EM. Lang et al. did not address this in their published study (Lang et al., 
2000). However they too do not believe Atg9p localises to autophagosomes in 
S. cerevisiae (M. Thumm, personal communication). The data presented here 
demonstrates that Atg9Ll is present on autophagosomes in mammalian cells, 
consistent with recent data showing that overexpressed mAPG9Ll-DsRed2 
colocalised with GFP-LC3 after 24h starvation (Yamada et al., 2005). From 
the immunofluorescent data, shown in Table 5.1, only a small fraction of the 
total Atg9Ll, -7%, is found colocalised with GFP-LC3-II and, judging from 
the colocalisation of GFP-LC3-II with the late autophagosome marker Rab7, 
not all of that 7% represents mature autophagosomes. Atg9Ll could still, 
therefore, be mostly recycled, avoiding degradation, as is the situation in yeast 
(Reggiori et al., 2004). Alternatively, that proportion of Atg9Ll may be 
degraded. Interestingly, upon siRNA mediated knockdown of the retromer, CI- 
MPR is partially degraded in the lysosome (Arighi et al., 2004). Investigation
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of the levels of Atg9Ll upon starvation by a more sensitive method than 
Western blotting would be required to address this issue.
That only 7% of Atg9Ll colocalises with GFP-LC3-II upon starvation, means 
therefore that the majority of the Atg9Ll population is not present on 
autophagosomes and has another, as yet undetermined, function.
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6 Investigating the pathway by which ULK1 effects 
Atg9Ll
6.1 Aim
Having seen that there was an effect of ULK1 knockdown on the localisation of 
Atg9Ll (chapter 5) I wanted to investigate the mechanism of this effect. 
Although ULK1 is a protein kinase, the only (non-ribosomal) one downstream 
of TOR so far known to regulate autophagy, work with S. cerevisiae suggests 
that the Atg Ip’s kinase activity is not required for its regulation of autophagy 
(Abeliovich et a l, 2003). As described in the introduction (section 1.2.7), 
Reggiori et al. (Reggiori et al., 2004) addressed the involvement of various 
other Atg proteins in the trafficking of Atg9. While this study elegantly 
elucidated the Atg proteins involved in Atg9 cycling it did not address the 
involvement of non-Atg proteins nor did it provide an explanation of how 
Atgl ’s effect on Atg9 was mediated, in terms of the molecular mechanism. 
They simply concluded that Atg9p trafficking was modulated by Atglp 
independently from its kinase activity.
Shortly after Reggiori et aV s (2004) work was published an intriguing study 
was reported identifying binding partners for ULK1 (Tomoda et al., 2004). 
Although the study was concerned with ULK1 in neuronal elongation, the 
experiments were generally applicable, i.e. yeast-2-hybrid, GST pulldowns and 
immunopreciptaions in HEK293 cells. They linked ULK1 via a GAP to Rab5 
and Ras. I have shown Atg9Ll is localised to both the TGN and endosomes in 
HEK293 cells and that it may well be cycling between the two compartments.
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Therefore the possibility that ULK1 can affect a Rab protein which has the 
potential to alter the characteristics of endosomes, and therefore potentially 
Atg9Ll cycling, was interesting. I therefore set out to investigate whether the 
pathway Tomoda et al. (2004) proposed for the involvement of ULK1 in 
neuronal elongation could also explain the effect of ULK1 on Atg9Ll and 
perhaps autophagy.
6.2 Dominant negative Rab mutants cause Atg9Ll to remain 
in the juxta-nuclear area after starvation
In order to investigate whether ULK1 could be mediating its affect upon
Atg9Ll through altering the activity of Rab proteins, constitutively active and 
inactive Rab mutants were used to try and replicate the effect of ULK1 
knockdown. In the first instance, cells were transiently transfected with 
dominant negative endosomal Rab constructs. Surprisingly, considering the 
data presented in chapter 3 that Atg9Ll is more of a late than an early 
endosomally associated protein, the Rab5 empty mutant, Rab5N133I, had the 
most striking effect on the localisation of Atg9Ll, causing it to remain localised 
in the juxta-nuclear area after starvation colocalising with both the Rab mutant 
and CI-MPR, Figure 6.1. Note the contrast between the juxta-nuclear 
localisation of Atg9Ll in the dominant negative GFP-Rab mutant transfected 
cells verses its usual dispersion in non-transfected cells upon starvation.
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Figure 6.1. Over expression o f GFP tagged Rab5N133I causes Atg9Ll to 
remain in the juxta-nuclear area after starvation. HEK293 cells were 
transiently transfected with GFP tagged Rab5 mutant Rab5N133I. 16h after 
transfection cells were starved for 2h in Earle’s saline (ES) then fixed and 
labelled with antibodies to Atg9Ll and CI-MPR. Bars = 10pm.
Overexpression of GFP tagged Rab9S21N also caused Atg9Ll to remain in a 
juxta-nuclear area after starvation, Figure 6.2.
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Figure 6.2. Overexpression o f GFP tagged, dominant negative, Rab9S21N 
causes Atg9Ll to remain in the juxta-nuclear area after starvation. HEK293 
cells were transiently transfected with the GFP tagged constitutively inactive 
Rab9 mutant Rab9S21N. 16h after transfection cells were starved for 2h in ES 
then fixed and labelled with the Atg9Ll antibody. Bar = 10pm.
6.3 Constitutively active Rab mutants cause an accumulation 
of Atg9Ll in enlarged endosomes
Overexpression of GFP tagged, constitutively active, Rab5 (GFP-Rab5Q79L)
in transiently transfected and subsequently starved HEK293 cells caused 
Atg9Ll to accumulate in large puncta throughout the cytoplasm, colocalising 
with the constitutively active Rab mutant, Figure 6.3. This phenomenon could 
be seen in cells expressing GFP-Rab5Q79L in full medium, as well as (to a 
lesser extent) with the overexpression of the wild-type Rab in full medium (data 
not shown). Overexpression of GFP-Rab7Q67L in full medium also caused 
Atg9 to accumulate in puncta throughout the cell, Figure 6.3, bottom panel.
That these structures are labelled by the Rab proteins, in conjunction with 
previously published data (Stenmark et al., 1994), indicates that they are 
enlarged endosomes.
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Figure 6.3. Overexpression of GFP tagged, constitutively active, Rab5Q79L or 
Rab7Q67L caused Atg9 to accumulate in enlarged endosomes. HEK293 cells 
were transiently transfected with GFP tagged constitutively active Rab mutants 
Rab5Q79L and Rab7Q67L. 16h after transfection the cells expressing GFP- 
Rab5Q79L were starved for 2h in ES then fixed and labelled with the Atg9Ll 
antibody. Bars = 10pm.
6.4 Overexpression of ULK1 also causes an accumulation of 
Atg9Ll in large puncta, presumably enlarged endosomes
Overexpression of either the FLAG tagged mouse ULK1 wild type (wt) or
kinase dead mutant cDNA by transient transfection of HEK293 cells caused a 
redistribution of the normal Atg9Ll juxta-nuclear signal into large punctate
cn
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structures distributed throughout the cytoplasm, Figure 6.4. Overexpression of 
the FLAG tagged mouse ULK1 C-terminal domain deletion mutant, lacking 
amino acids (aa) 829-1051 of the 1051aa protein, did not however have any 
effect upon Atg9Ll localisation. The mouse ULK1 is very similar to the 
human ULK1, in terms of their primary amino acid sequences they are 89% 
identical. Unserendipitously all the ULK1 constructs lack 14 amino acids from 
their N-termini.
The puncta observed in cells overexpressing either wt or kinase dead ULK1 
resembled those seen in cells expressing the constitutively active Rab5Q79L 
mutants and are therefore presumably also enlarged endosomes, although this 
requires further verification.
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Figure 6.4. Over expression o f the wt and kinase dead but not the C-terminal 
deletion mutant ofU LKl causes a redistribution of Atg9LI into punctate 
structures. HEK293 cells were transiently transfected with either FLAG tagged 
mouse ULK1 wt, an ULK1 kinase dead mutant and an ULK1 mutant lacking 
the final 222aa, C-term deletion (unserendipitously all these constructs lack 14 
amino acids from their N-termini). 16h after transfection cells were fixed and 
processed for immunofluorescence. Cell are in their full growth medium. Bar 
= 10pm.
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6.5 siRNA mediated knockdown of the ULK1 binding protein 
syntenin inhibits the redistribution of Atg9Ll upon 
starvation
As described in the previous section, whereas overexpression of ULK1 resulted 
in a punctate distribution of Atg9Ll, overexpression of the ULK1 C-terminal 
deletion mutant did not. Tomoda et al. (2004) assigned this region of ULK1 to 
bind to synGAP and syntenin and suggested that syntenin plays a structural 
role, bringing Rab5 and ULK1 into close proximity so that ULK1 can exert its 
effect. In order to investigate whether syntenin does in fact play a role in 
mediating ULK1 ’s effect on Atg9Ll distribution, siRNA mediated knockdown 
of syntenin was performed. In humans there are two syntenin paralogues, 
siRNA mediated knockdown of both of these inhibited the redistribution of 
Atg9Ll after starvation, comparably to ULK1 knockdown. The Atg9Ll 
remaining concentrated in the juxta-nuclear area even after 2h starvation, 
Figure 6.5.
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Figure 6.5. siRNA mediated knockdown o f syntenin inhibits the starvation 
induced redistribution o f Atg9Ll. HEK293 cells were transiently transfected 
with either siRNA against syntenin 1&2 or ULK1 and 72h later starved for 2h in 
ES before fixation and staining for Atg9Ll and TGN46. Bar = lOpm.
6.6 siRNA mediated knockdown of the ULK1 binding protein 
syntenin increases LC3-I to II conversion
To assess whether syntenin is involved in autophagy as well as Atg9’s
redistribution, the effect of its siRNA mediated knockdown on LC3-I to LC3-II 
conversion (or LC3 lipidation) was assessed, which is an established read-out 
for autophagy (Mizushima, 2004). Atg7 knockdown was used as a positive
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control. Unexpectedly, syntenin knockdown caused a statistically significant 
increase in the amount of LC3-I to LC3-II conversion, p < 0.05 compared to the 
control siRNA (Figure 6.6).
Figure 6.6. Syntenin knockdown increased the amount o f lipidatedLC3 
present after starvation. HEK293 cells stably expressing GFP-LC3 were 
treated with the stated siRNAs and 72h later starved for 2h in ES before lysis. 
The lysates were analysed by SDS-PAGE and Western blotting using an anti- 
GFP antibody and the Li-Cor system. The image from the Li-Cor was analysed 
and signals quantified using MetaMorph software (Molecular Devices). The 
amount of GFP-LC3-II was normalised to the total amount of GFP-LC3. Syn = 
syntenin. FM, full growth medium.
6.7 Discussion
6.7.1 Additional evidence that Atg9Ll is cycling from the TGN to endosomes 
Overexpression of constitutively active Rab mutants is well documented to
cause an enlargement of endosomes, as first described by Stenmark et al.
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(Stenmark et al., 1994). In Figure 6.3, the constitutively active Rab mutants 
have caused an accumulation, or concentration, of Atg9Ll in these enlarged 
endosomes at the expense of the juxta-nuclear staining, providing evidence in 
favour of my hypothesis that Atg9Ll is trafficking between the TGN and 
endosomes. This represents evidence for Atg9Ll trafficking, as the probable 
explanation for the juxta-nuclear pool of Atg9Ll staining dispersing in cells 
overexpressing the constitutively active Rab mutants is that Atg9Ll is 
trafficking to endosomes from the TGN but is prevented from returning, or 
rather Atg9Ll’s rate of exit from endosomes is decreased. Alternatively 
Atg9Ll ’s rate of trafficking to endosomes could be increased, either way the 
data support the hypothesis that Atg9Ll is trafficking / cycling. That proteins 
accumulate in endosomes in cells expressing a constitutively active endosomal 
Rab mutants has precedent, although most studies have looked at the effect of 
these mutants on uptake of material from the extracellular milieu rather than the 
trafficking of intracellular transmembrane proteins. However, Mesa et al. 
(2005) showed that in cells expressing the constitutively active, early 
endosomal, Rab22Q64L, CI-MPR accumulated in early endosomes (Mesa et 
a/., 2005). Immuno-electron microscopy studies of cells expressing the 
constitutively active Rab mutants could be used to determine whether Atg9Ll 
is in fact more concentrated on endosomes under these conditions relative to 
cells simply expressing GFP as a control, for example.
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6.7.2 Constitutively active /  dominant negative Rab mutants can mimic the 
effect o f ULK1 overexpression /  knockdown, respectively, suggesting 
ULK1 ’s effect on Atg9 is through Rabs
The constitutively inactive Rab mutants were able to mimic the effect of ULK1 
knockdown on the redistribution of Atg9Ll upon starvation seen in chapter 5, 
causing Atg9Ll to remain concentrated in the juxta-nuclear area upon 
starvation. Overexpression of ULK1 mimicked the effect of the constitutively 
active Rabs, causing Atg9Ll to accumulate in puncta throughout the cell. That 
constitutively inactive / active Rab mutants can mimic the effect of ULK1 
knockdown / overexpression, respectively, in conjunction with the work of 
Tomoda et al. (2004) on the ability of ULK1 to influence Rab activity through a 
GAP, suggests that ULK1 ’s effect on Atg9Ll is through Rabs and their effect 
upon endosomes. As to how the inactive Rabs are causing a juxta-nuclear 
concentration of Atg9Ll, this could either be through a inhibition of the exit of 
Atg9Ll from the TGN or through an accumulation of Atg9Ll containing 
endosomes in the juxta-nuclear area. Again, immuno-electron microscopy of 
ULK1 knockdown and / or Rab5N133I expressing cells would determine which 
of these possibilities is in fact the case.
Inactive Rabs are usually cytosolic, sequestered by GDI (see Introduction, 
section 1.3.2.8) however that inactive Rabs should accumulate in a juxta- 
nuclear region is not unprecedented. Barr and co-workers (Haas et al., 2005) 
found that the dominant negative GDP-bound form of Rab5 (Rab5S34N) 
colocalised with GM130. Interestingly they also saw that overexpression of 
RabGAP-5 caused an accumulation of Rab5 in the juxta-nuclear area at the 
expense of the peripheral Rab5 population (see Haas et al. (2005), supplemental
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figure S2). This is similar to observations made for Rab22a, another member of 
the Rab5 subfamily, by Jones and co-workers (Simpson et al., 2004) where 
Rab22T33N colocalised with the TGN marker p230. Pfeffer and co-workers 
(Riederer et al., 1994) also saw a juxta-nuclear localisation of Rab9S21N in 
stably expressing cell lines. Galperin and Sorkin (Galperin and Sorkin, 2003) 
saw that, “in some cells, CFP-Rab5(S34N) was seen associated with distinct 
organelles often located in the perinuclear area of the cell”.
That the effect of ULK1 is mediated through Rabs has not been directly 
demonstrated here. Only that Rabs can effect Atg9Ll and that another 
component in the model of Tomada et al. (2004), syntenin, is also capable of 
effecting Atg9Ll. Haas et al. (Haas et al., 2005) showed that overexpression of 
RabGAP-5 caused an accumulation of Rab5 in the juxta-nuclear area at the 
expense of the peripheral Rab5, similar to the effect of the dominant negative 
Rab mutant. A further experiment would be to overexpress RabGAP5 in 
HEK293 cells and see whether Atg9Ll ’s redistribution upon starvation is 
inhibited. If RabGAP-5 is indeed the major GAP for Rab5, as Haas et al.
(2005) suggest then its overexpression should have a similar effect to the 
Rab5N133I mutant. An extension of that would be to then knockdown both 
ULK1 and RabGAP-5 simultaneously and look to see whether Atg9Ll’s 
redistribution upon starvation is inhibited. If ULKl’s effect is through 
RabGAP5, ordinarily keeping the RabGAP’s activity in check, then whereas 
knocking down ULK1 would, according to Tomoda et al.’s model, increase 
RabGAP activity then removing the GAP would remove ULK1 ’s target and 
hence there should be no effect upon Atg9Ll localisation. However, this may
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not be so simple and could potentially result in an imbalance with the opposing 
RabGEF still remaining.
6.7.3 ULK1 ’s effect on Atg9Ll is most likely through the syntenin proteins 
and a GAP
ULK1 overexpression perturbed Atg9Ll’s normal localisation whereas 
overexpression of ULK1 missing its C-terminal domain did not perturb it. This 
result indicates that an element in the C-terminal domain is required for that 
perturbation. In light of the data demonstrating that the C-terminal domain of 
ULK1 contains the synGAP and syntenin binding sites (Tomoda et al., 2004), 
and the data presented here showing that syntenin knockdown can effect 
Atg9Ll localisation upon starvation, then U LKl’s interactions with syntenin 
and a GAP most likely mediate the effect of ULK1 overexpression on Atg9Ll. 
Especially as overexpression of the kinase dead mutant of ULK1 has the same 
effect as the wild type and therefore most likely, as in S. cerevisiae, the effect 
of Atgl on Atg9 (and autophagy) is not through its kinase activity (Abeliovich 
et al., 2003; Reggiori et al., 2004). Interestingly it is thought that the kinase 
activity of Fused (the fifth member of the ULK family) is not required for its 
function in Hedgehog signalling (Kalderon, 1997).
Tomoda et al. (2004) showed that SynGAP was the GAP influencing Rab5 in 
axonal elongation. However, SynGAP is unlikely to be the GAP which ULK1 
regulates in HEK293 or liver cells as SynGAP is a neuronal specific protein. 
SynGAP’s expression is confined to the brain and spinal cord with none at all 
detectable in the liver or muscle, either by Northern or in immunoblots of rat
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tissue (Kim et al., 1998). siRNA mediated knockdown of SynGAP in HEK293 
cells did not effect Atg9Ll redistribution upon starvation (data not shown). 
RabGAP-5 (Haas et al., 2005) is an obvious candidate, however further 
experiments would be necessary to determine whether ULK1 can influence the 
activity of RabGAP-5. RabGAPs for Rabs 7 and 9 would also be possible 
candidates.
6.7.4 Suggestions for additional experiments before proceeding further 
The redistribution of Atg9Ll upon starvation and the ability of ULK1 and
syntenin knockdown to block it, as observed by immunofluorescence, are not
readily amenable to absolute quantification and are therefore somewhat
subjective. To remove subjectivity and really be sure of the ability of other
proteins to effect Atg9Ll’s redistribution upon starvation a biochemical assay
would be required, a quick and easy subcellular fractionation method. Attempts
were made to develop such an assay but the were unsuccessful (data not
shown). Before any further experiments are attempted to define this pathway,
like those suggested above, then first a non-subjective assay for the Atg9Ll
starvation redistribution would be required.
6.7.5 Concluding remarks
Other interesting observations in the published literature include Hennig et al.
(2006) (Hennig et al., 2006). Hennig et al. (2006) found that starvation and 
TOR over-expression altered the distribution of GFP-Rab5 and 7. Also, it has 
been reported that insulin is capable of inhibiting Rab5 activity in a PI3-kinase
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dependent manner (Huang et al., 2001). Snippets of information suggesting 
that other factors, central in the TOR signalling pathway, may influence Rabs.
The data presented here has preliminarily established that ULK1 affects 
Atg9Ll through an indirect effect upon Rabs. Further experiments are required 
to confirm these preliminary observations.
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7 Effect of Atg9Ll knockdown on autophagy
7.1 Aim
In S. cerevisiae Atg9p is absolutely required for autophagy. Atg9A cells have 
no autophagic bodies in their vacuole in the presence of protease inhibitors, 
unlike wt cells (Noda et a l, 2000). Furthermore, Suzuki et al.’s (Suzuki et al., 
2001) genetic classification results classified Atg9p as an early acting protein 
Atg protein, see introduction section 1.2.5. It was anticipated, therefore, that 
Atg9Ll would also be required for autophagy in mammalian cells. 
Understanding the effect of Atg9Ll knockdown on autophagy is interesting as 
it may provides clues as to its function in autophagy.
There are a number of ways of measuring autophagy. GFP-LC3 conversion to 
the lipidated form, the appearance of GFP-LC3 puncta by fluorescence 
microscopy, long-lived protein degradation assays and quantification of 
autophagosome number and type by EM. Each of these assays was employed 
to determine what the consequences of Atg9Ll knockdown would be for 
autophagy. Primary rat hepatocytes were used for these experiments as they 
consistently gave a robust autophagy response to the starvation stimulus.
7.2 Atg9Ll knockdown inhibits LC3 lipidation
Conversion of LC3-I to its membrane associated LC3-II form is an established
assay for autophagy (Mizushima, 2004). In order to investigate the effect of 
Atg9Ll knockdown on autophagy, primary rat hepatocytes were infected with
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either control adenovirus or adenovirus expressing a 57mer RNAi 
oligonucleotide corresponding to the forward and reverse stands of a 20bp 
region of the 5’ section of the Atg9Ll cDNA and a hairpin loop in a pMIGHTY 
vector (designed and purchased from Viraquest inc). The control virus 
expresses the same RNAi hairpin but with a single base pair deletion. 48h later 
cells were infected with GFP-LC3 adenovirus (Kochi et al., 2006). Cells were 
lysed 72h after the initial infection and the resultant samples were analysed by 
SDS-PAGE and Western blotting, using a GFP antibody for detection of the 
GFP-LC3, Figure 7.1 A. In one experiment an antibody to the LC3 itself was 
used to detect the effect upon endogenous LC3, Figure 7. IB. In both cases, 
knockdown of Atg9Ll inhibited the conversion of LC3-I to the smaller, 
autophagosomally associated, LC3-II form.
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Figure 7.1. siRNA mediated knockdown o f Atg9LI in primary rat hepatocytes 
inhibits the processing o f LC3-I to the smaller autophagosomally associated 
LC3-I1 form. Primary rat hepatocytes were infected with either Atg9Ll 
knockdown (KD) or control (C) virus 3h after seeding then 48h later with GFP- 
LC3 virus (Kochi et al., 2006). 72h after the initial infection cells were starved 
for 2h in ES, lysed and analysed by SDS-PAGE and Western blotting. (A) Top 
blot: probed with ST0215 to verify Atg9Ll knockdown. Bottom blot: probed 
with an anti-GFP antibody. Data are representative of three independent 
experiments. (B) Lysate from the same cells as in A probed with an antibody 
against endogenous LC3. The data is from a single experiment.
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The effect of Atg9Ll knockdown on LC3-I to LC3-II conversion was also 
assessed in HEK293 cells. As a means to assess the extent of the effect of 
Atg9Ll on LC3 processing, another Atg protein, Atg7, was also knocked down 
as a positive control. Atg7 is involved in the ubiquitin-like conjugation of 
phosphatidylethanolamine to LC3. It is also involved in the other ubiquitin-like 
conjugation reaction resulting in the Atg5-12 complex. Of the Atg proteins, 
depletion of Atg7 has one of the strongest effects upon LC3-I to LC3-II 
conversion in HEK293 cells (Edmond Chan CRUK, personal communication). 
Atg9Ll knockdown had a comparable effect, on LC3-I to LC3-II conversion, to 
Atg7 knockdown, Figure 7.2.
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Figure 7.2. siRNA mediated knockdown ofAtg9Ll in HEK293 cells inhibits 
GFP-LC3-I to II conversion. HEK293 cells stably expressing GFP-LC3 were 
starved for 2h in Earle’s saline (ES) then lysed and analysed by SDS-PAGE and 
Western blotting (A) Blot probed with anti-GFP antibody and signal detected 
using the Li-Cor system. (B) Densitometry of the blot from A, normalised to 
the total amount of LC3. FM = Full Medium. The data is from a single 
experiment, with three replicates.
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7.3 Atg9Ll knockdown inhibits GFP-LC3 puncta formation
The appearance of GFP-LC3 puncta by fluorescence microscopy is also used as
a measure of the extent of autophagy (Mizushima, 2004). In order to assess the 
effect of Atg9Ll knockdown on GFP-LC3 puncta formation primary rat 
hepatocytes were infected with either control or Atg9Ll knockdown adenovirus 
as well as GFP-LC3 adenovirus. Cells were fixed for fluorescence microscopy 
analysis 72h after the initial infection. Pictures were captured and GFP-LC3 
positive puncta quantitated as described in section 2.2.10. Atg9Ll knockdown 
was assessed by SDS-PAGE and Western blotting (data not shown). Atg9Ll 
knockdown caused a statistically significant reduction in the number of GFP- 
LC3 positive puncta per nucleus, Figure 7.3.
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Figure 7.3. siRNA mediated knockdown o f Atg9Ll in primary rat hepatocytes 
decreases the number o f GFP-LC3 puncta observed upon starvation. Primary 
rat hepatocytes were infected with either control or Atg9 knockdown 
adenovirus 3h after seeding then 48h later with GFP-LC3 virus. 72h after the 
initial infection cells were permeabilised with 0.0625% (w/v) saponin, to wash 
out the cytoplasmic LC3-I, fixed and examined using a Dicovery-1 automated 
microscope (Molecular Devices). 16 images were captured per condition, each 
containing approximately 200 cells per image. Images were analysed using the 
granularity plug-in of Metamorph software (Molecular Devices). The data are 
the mean, ±SEM, of two independent experiments. FM = full growth medium; 
ES = Earle’s saline, starvation medium. * = p<0.0001, Student t-test.
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7.4 Effect o fA tg 9 L l knockdown on long-lived protein 
degradation
Autophagy is primarily a process of protein degradation. To assess the effect of 
the knockdown of Atg9Ll on long-lived protein degradation, primary rat 
hepatocytes were infected with either control or Atg9Ll knockdown 
adenovirus. 24h after the initial infection cells were treated with 2pCi/ml 
[14C]-valine overnight and then chased overnight with normal growth medium 
containing excess cold valine. 72h after infection cells were either starved or 
not for 4h in ES and aliquots of the medium taken at 2h and 4h. The amount of 
TCA soluble radioactivity in the aliquots was counted and expressed as 
percentage of the total amount present in the cells, which were lysed and 
collected after the 4h time point. Atg9Ll knockdown was assessed by SDS- 
PAGE and Western blotting (data not shown). Surprisingly, Atg9Ll 
knockdown did not dramatically inhibit long-lived protein degradation, Figure
7.4 -  no drug treatment. However, if the ratio of protein degradation occurring 
under starvation to that occurring in full medium was compared between no 
virus, control virus and Atg9Ll knockdown virus then there was difference.
The ratio (starved/full medium) was 2.2 for no virus and control virus, 
compared to 1.6 for the Atg9Ll knockdown virus treatment. This decreased 
ratio in the Atg9Ll knockdown treatment may, however, be due to the 
increased protein degradation seen under full medium in this treatment, perhaps 
because Atg9Ll knockdown might be detrimental to the health of the cells.
Many controls were included in the assay. Protease inhibitors ensured that the 
protein degradation measured was lysosomally associated. Wortmannin is a
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potent inhibitor of autophagy (Blommaart et a l , 1997). In the presence of 
protease inhibitors or Wortmannin protein degradation was reduced 
significantly. Lactacystin, which is a specific inhibitor of the proteasome, had 
little effect on the amount of protein degradation observed. This indicates that 
the assay really does measure only long-lived, autophagy associated, protein 
degradation. MG 132, an inhibitor of both the proteasome as well as lysosomal 
proteases, reduced protein degradation down to minimal levels.
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Figure 7.4. siRNA mediated knockdown of Atg9LI in primary rat hepatocytes 
did not inhibit long-lived protein degradation. Primary rat hepatocytes were 
treated with either control or Atg9L 1 knockdown adenovirus 3h after seeding 
and the protein degradation assay performed 3 days later. Protease inhibitors 
were pepstatin A (28pg/ml) and E64d (lOpg/ml). Filled bars, complete 
medium; dashed bars, starved 2h ES. Gray bars, no virus; green bars, control 
virus; red bars, Atg9Ll knockdown virus. Except for wortmannin and 
proteasome inhibitor treatments, the data represents the mean of two 
independent experiments. For each experiment, each condition was performed 
in triplicate.
7.5 Atg9Ll knockdown results in smaller immature A Vs
The ultimate way of looking at autophagy is still morphologically, i.e. by
conventional electron microscopy (EM), as this does not rely on assuming that
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the GFP-LC3 puncta actually represent autophagosomes . Primary rat 
hepatocytes were infected with either control or Atg9Ll knockdown adenovirus 
3h after seeding. 72h after the initial infection cells were either starved or not 
for 2h in Earle's saline (ES), fixed and processed for EM as described in the 
materials and methods, section 2.2.12. Samples were analysed in a double 
blind fashion and images captured systematically starting from a randomly 
selected area of the section. Once all the pictures had been captured the number 
of autophagosomes present for each condition were counted, using well 
established morphological criteria for their identification (Eskelinen et al., 
2004). The corresponding cytosolic area was measured using a grid point 
counting method. The autophagosomal area was measured by the same 
method. Atg9Ll knockdown was assessed by SDS-PAGE and Western 
blotting (data not shown). As shown in Figure 7.5, there was no statistically 
significant difference in the number of early or initial autophagosomes (AVi) 
present after starvation in Atg9Ll depleted cells compared to those treated with 
the control virus. However there was a statistically significant difference in the 
area of the early autophagosomes after Atg9Ll RNAi mediated knockdown. A 
statistically significant increase in the number of degradative autophagosomes 
(AVd) was also noted.
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Figure 7.5. Atg9Ll knockdown results in smaller immature autophagosomes 
(A Vis). Primary rat hepatocytes were treated with the either control or Atg9Ll 
knockdown adenovirus 3h after seeding and then 72h later starved for 2h in ES 
before fixing for EM. Autophagosome size and cytoplasmic area were 
quantified by grid point counting. The data are the mean, ±SEM, of three 
independent experiments. * p < 0.05, Mann Whitney U test.
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7.6 Discussion
7.6.1 A Vis are smaller upon Atg9Ll knockdown
Atg9 deletion mutants of S. cerevisiae display an absence of autophagic bodies 
within their vacuoles upon starvation in a pep4 mutant background (Tsukada 
and Ohsumi, 1993). Furthermore, Atg9p was classified as an early acting 
protein by Suzuki et al.’s genetic classification (Suzuki et al., 2001). It was 
therefore expected that the mammalian orthologue of Atg9 would have a 
similarly deleterious effect upon autophagy. However, the effect of Atg9Ll 
knockdown upon autophagy was not as dramatic as reported in S. cerevisiae. 
Surprisingly, there was no statistically significant reduction in the number of 
early autophagosomes upon starvation after Atg9Ll knockdown in cultured 
primary rat hepatocytes, as observed by EM. Rather, the early autophagosomes 
were smaller. That there was no statistically significant effect on early 
autophagosome number would be consistent with there being no effect on long- 
lived protein degradation and presumably that the smaller AVi are still 
functional.
It has been previously demonstrated that S. cerevisiae Atg8 deletion mutants 
have smaller autophagosomes (Abeliovich et al., 2000). LC3 lipidation was 
consistently reduced upon Atg9Ll knockdown in primary rat hepatocytes and 
HEK293 cells. The reduction in LC3 processing together with the data of 
Abeliovich et al. (2000), that Atg8 deletion mutants have smaller 
autophagosomes, is consistent with the fact that Atg9 causes a reduction in AVi 
area. This is however an extrapolation of yeast data to mammalian cells. 
Further experiments would be required to confirm whether it is Atg9Ll’s effect
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on LC3 that causes the smaller early autophagosomes. To validate this 
hypothesis one would need to observe the same effect by reducing LC3 
lipidation by another means. The El-like enzyme Atg7 that activates LC3 for 
lipidation is also required for Atg5 activation and was therefore ruled out. 
Preliminary results knocking down Atg4, the cysteine protease which is 
necessary to cleave LC3 before lipidation, unexpectedly caused an increase in 
the amount of LC3 lipidation observed upon starvation (data not shown). 
Another means of inhibiting LC3 lipidation would be required to investigate 
this further, perhaps knocking down the E2-like enzyme Atg3 (see section 
1.2.4).
Atg9Ll knockdown not only resulted in a decrease in AVi size but also in an 
increase in AVd number, as observed by EM. This increase in AVd number is 
probably the reason for the apparent, but not statistically significant, increase in 
AVd area. That the number of AVi are the same indicates that the increase 
AVd number is not due to a greater rate of the formation of autophagosomes. 
One reason for an increase in AVd number in Atg9Ll knockdown cells would 
be if the AVd were prevented from being degraded and therefore accumulated. 
Perhaps knockdown of Atg9Ll expression is having more than one effect upon 
the cell. Perhaps Atg9Ll, or one of binding proteins, is required for the fusion 
of autophagosomes with the endosomal / lysosomal system. A fusion assay for 
autophagosomes and endosomes has been developed by a colleague in the 
laboratory, Atg9Ll knockdown could be assessed for a potential inhibitory 
effect on this assay. This inhibition of fusion would most likely be partial
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however as the rate of protein degradation observed after Atg9Ll knockdown 
not greatly affected.
7.6.2 Experimental detail
As detected by Western blotting, the siRNA mediated knockdown of Atg9Ll 
was >90% effective. However, even if 1% of the Atg9Ll population remained 
this may be sufficient to perform its function. Although, as shown here,
Atg9Ll knockdown at the very least has partially compromised its function. It 
cannot however be ruled out that repetition of these experiments in true 
knockout cells would not have a more definitive phenotype.
Protein degradation in rat hepatocytes was not negatively effected by Atg9Ll 
knockdown, whereas it was in HEK293 cells (Young et a l , 2006). That long- 
lived protein degradation was not affected in primary rat hepatocytes could 
reflect the trend for the autophagic capacity of the primary rat hepatocytes to 
drop off over time in culture (Per Seglen, personal communication). If the 
autophagic capacity of the cells at earlier time points is greater, then perhaps a 
subtle effect of Atg9 knockdown upon protein degradation would be more 
obvious. Perhaps repetition of the experiments with shorter times allowed for 
the Atg9Ll protein level to decay would give a different result.
7.6.3 Atg9L2 knockdown did not affect LC3 lipidation in HEK293 cells 
The non-detrimental effect of Atg9Ll knockdown on autophagy could be due
to the redundancy of there being two orthologues of ScAtg9 in mammals.
However, Atg9L2 expression is confined to the placenta and pituitary gland
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according to northern blot and RT-PCR analysis and was completely absent 
from HeLa cells and the other cell lines tested by quantitative RT-PCR 
(Yamada et al., 2005). However, to be rigorous Atg9L2 siRNA was tested 
upon HEK293 cells and the effect on autophagy assayed by the interconversion 
of GFP-LC3-I to GFP-LC3-II, Figure 6.6. The knockdown of Atg9L2 did not 
affect the amount of GFP-LC3-II compared to the control siRNA, whereas 
Atg9Ll, as usual, decreased the amount of lipidated LC3-II. That Atg9L2 
knockdown had no effect on LC3-I to LC3-II conversion probably indicates, 
given Yamada et al.'s data, that there are insignificant levels of Atg9L2 present 
in these cells.
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8 Concluding remarks
As a transmembrane Atg protein Atg9Ll offered the promise of revealing the 
source of the autophagosomal membrane. Atg9Ll has been shown herein to be 
localised to the TGN and to late endosomes in full growth medium as well as 
autophagosomes in starvation medium. As a transmembrane protein, the 
population of Atg9Ll on the autophagosomes must have arrived there by 
vesicular traffic from either the TGN, endosome or possibly transport structures 
intermediate between the two. From my data I cannot conclude from which of 
these locations the Atg9Ll on the autophagosomes originates. An ideal way of 
looking at this would be to follow Atg9Ll by live cell video microscopy. A 
mRFP tagged Atg9Ll construct was synthesised, however mRFP-Atg9Ll’s 
localisation did not resemble that of the endogenous protein but rather an ER 
distribution by fluorescence microscopy. The ER is a site of protein quality 
control, mis-folded proteins accumulate in the ER, waiting to be removed for 
degradation by the proteasome (Meusser et al., 2005). Perhaps mRFP-Atg9Ll 
does not fold properly and a different fluorescent protein tag would circumvent 
this problem.
In S. cerevisiae, Atg9p cycles from a peripheral pool to the pre-autophagosomal 
structure (PAS) and Atgl knockdown causes Atg9 to accumulate at the PAS.
To take this model and apply it to mammalian cells, my data showed that ULK1 
knockdown caused Atg9Ll to accumulate in a juxta-nuclear area, colocalising 
with TGN46. By analogy, this would suggest that the TGN is the PAS. 
However, judging from the data in chapter 6 with Rab5N133I, Atg9Ll’s juxta-
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nuclear accumulation could also represent an accumulation of Atg9Ll in 
endosomes in the juxta-nuclear area. Whether ULK1 ’s knockdown effect 
represents an accumulation of Atg9Ll in the TGN via a block in cycling or 
whether it represents an accumulation of Atg9Ll in endosomes in the juxta- 
nuclear area requires clarification by immuno-EM on ULK1 knockdown cells. 
For the juxta-nuclear area to represent a PAS equivalent, many of the Atg 
proteins should colocalise there, this would be interesting to determine.
What is the function of Atg9Ll? As a multi-spanning transmembrane protein, 
it could be imagined that Atg9Ll is the site of nucleation around which the 
autophagosome forms. A hub upon which the different components assemble. 
However, that the knockdown of Atg9Ll does not detrimentally effect the 
number of early autophagosomes (AVi) would seem to indicate that the 
function of Atg9Ll in mammalian cells is not as crucial as something like a 
nucleation site. That the AVis are smaller and that there are more degradative 
autophagosomes (AVds) perhaps indicates a role for Atg9Ll in the delivery of 
components to the forming autophagosome as one could imagine that 
autophagosomes deficient in certain essential components might not enlarge 
correctly or, as discussed in chapter 7, have the necessary components for 
fusion with the endosomal / lysosomal pathway. Atg9Ll would seem to be 
cycling from the TGN to endosomes, based on the ability of Atg9 to recover to 
its juxta-nuclear pool when cells are replaced in full growth medium after a 
period of starvation and also the ability of Rab mutants to accumulate Atg9Ll 
in endosomes. Another protein that cycles around in this manner is MPR. 
Atg9Ll also behaves very similarly to CI-MPR upon ULK1 knockdown or
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dominant negative Rab overexpression. Perhaps therefore Atg9Ll performs a 
similar role to MPR, trafficking proteins to the endosomal / lysosomal system, 
and upon starvation, to autophagosomes. It would be interesting to look at the 
protein complement of the autophagosome in the absence of Atg9Ll to see how 
this differs.
I have shown that Atg9Ll localises to the TGN and endosomes. My data also 
suggests that Atg9Ll is cycling around between the two structures. I have tried 
to use the idea that Atg9Ll is cycling to explain what happens to Atg9Ll upon 
starvation, in that I hypothesise that it is accumulating in endosomes. If indeed 
Atg9Ll turns out to be accumulating in endosomes upon starvation then one 
possible reason for this could be attributed to the dependency of retromer (or 
Rab9/TIP47) upon hVps34 and in turn hVps34’s inhibition by starvation. This 
would be an interesting avenue for further investigation. I have also tried to 
establish that the effect of ULK1 upon Atg9Ll is also one of effecting 
membrane traffic. ULK1 was shown by Tomoda et al. (2004) to effect Rab5, 
via a GAP, and I have demonstrated that constitutively active / dominant 
negative Rab mutants are able to mimic the effects of ULK1 overexpression / 
knockdown, respectively. One of the biggest questions still unanswered in 
autophagy is how Atgl / ULK1 regulates autophagy. In yeast A tgl’s kinase 
activity is not required for autophagy (Abeliovich et al., 2003), although 
Abeliovich et al. (2003) did show that structural changes took place in Atgl 
upon induction of autophagy dependent on its C-terminus. This study has gone 
some way to addressing the question of how Atgl effects Atg9Ll.
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Autophagy has received much attention recently, since the elucidation of the set 
proteins involved in the process allowed the investigation of its molecular 
mechanisms. Considerable progress has been made since the identification of 
the proteins, however much of how these proteins function in autophagy is still 
unknown. Given the emerging importance of autophagy in neurological 
diseases such as Alzheimer’s and also in cancer, as well as in processes such as 
development, the further investigation of autophagy is of paramount 
importance.
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Appendix
Appendix
Table Al. The Amino Acid Code.
Amino acid Abbreviation Single Letter Code
Alanine Ala A
Cysteine Cys C
Aspartate Asp D
Glutamate Glu E
Phenylalanine Phe F
Glycine Gly G
Histidine His H
Isoleucine lie I
Lysine Lys K
Leucine Leu L
Methionine Met M
Asparagine Asn N
Proline Pro P
Glutamine Gin Q
Arginine Arg R
Serine Ser S
Threonine Thr T
Valine Val V
Tryptophan Trp W
Tyrosine Tyr Y
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